AOP Networks: Decoding Complex Toxicity Mechanisms for Next-Generation Ecological and Health Risk Assessment

Abstract

This article provides a comprehensive exploration of Adverse Outcome Pathway (AOP) networks as a transformative framework for modern ecological and human health risk assessment. Tailored for researchers, scientists, and drug development professionals, it details how AOP networks connect molecular initiating events to adverse outcomes through modular key events, offering a systems-level view of toxicity that transcends single-pathway limitations. The scope covers foundational principles, methodological workflows for network derivation and quantitative modeling, strategies for troubleshooting data quality and uncertainty, and approaches for validation and regulatory application. By synthesizing these elements, the article demonstrates how AOP networks are critical for implementing New Approach Methodologies (NAMs), assessing complex mixtures, enabling cross-species extrapolation, and ultimately supporting more predictive and mechanism-based safety decisions.

From Linear Pathways to Predictive Networks: Core Concepts and the Rationale for AOP Networks

The Adverse Outcome Pathway (AOP) framework has revolutionized mechanistic toxicology and risk assessment by providing a structured representation of the sequence of biological events leading from a molecular initiating event to an adverse outcome. This whitepaper posits that the true predictive power of this framework is unlocked not through isolated AOPs, but through interconnected AOP networks, where shared Key Events (KEs) serve as the fundamental functional units. These shared biological perturbations act as critical hubs and conduits, enabling the prediction of complex, intersecting toxicological outcomes essential for modern ecological risk assessment and drug safety evaluation. We delineate the conceptual architecture of AOP networks, detail methodologies for their quantitative construction and validation, and present integrated computational tools and experimental protocols that operationalize this approach. By framing KEs as predictive nodes within a dynamic network, this work provides a roadmap for advancing New Approach Methodologies (NAMs) and moving towards a systems-level understanding of chemical toxicity.

The Adverse Outcome Pathway (AOP) is a conceptual framework that describes a sequential chain of causally linked biological events at different levels of organization—from molecular to organismal or population levels—that lead to an adverse effect following exposure to a stressor [1]. An AOP typically starts with a Molecular Initiating Event (MIE), proceeds through measurable Key Events (KEs), and culminates in an Adverse Outcome (AO) relevant for risk assessment [2]. Initially developed in ecotoxicology, the AOP framework has become a cornerstone for organizing mechanistic knowledge in human toxicology and regulatory science [2] [3].

However, biological systems are not composed of isolated linear pathways. A single stressor can trigger multiple MIEs, and a single KE (e.g., oxidative stress, inflammation, or specific receptor activation) often plays a role in the progression of several different AOs [4]. This interconnectivity necessitates a shift from viewing AOPs as standalone entities to understanding them as interconnected networks. An AOP network is defined as two or more related AOPs linked together by shared biological components, most pivotally, by shared KEs [1].

This whitepaper advances the thesis that within these networks, shared Key Events are the functional units of prediction. They are the measurable, mechanistically anchored points where biological perturbations converge and diverge. By mapping and quantifying the relationships around these shared KEs, researchers can predict not just single outcomes, but networks of potential adversity, identify susceptible biological targets, and prioritize chemicals for testing. This network-based perspective is particularly critical for ecological risk assessment, where organisms are exposed to complex mixtures of environmental contaminants, and effects can cascade across biological scales in non-linear ways [5]. The following sections define the core architecture of AOP networks, detail methods for their construction and evaluation, and demonstrate their application in risk assessment and drug development.

Core Conceptual Framework: Anatomy of an AOP Network

Foundational Components: MIE, KE, AO, and KER

An AOP network's architecture is built upon the core components of individual AOPs, linked through shared elements. The definitions below establish a common vocabulary [1] [2].

• Molecular Initiating Event (MIE): The initial interaction between a stressor (e.g., a chemical) and a specific biomolecule (e.g., receptor binding, protein inhibition, DNA binding) within an organism.
• Key Event (KE): A measurable, essential change in biological state at the cellular, tissue, or organ level that is a necessary step in the progression from the MIE to the AO. KEs are the primary nodes in an AOP network.
• Adverse Outcome (AO): A biological change at the organism or population level considered relevant for risk assessment, such as impaired survival, growth, development, or reproduction [1].
• Key Event Relationship (KER): A scientifically established, causal link describing how one KE leads to another. KERs provide the directional edges (connections) between nodes (KEs) in the network.

Table 1: Core Components of an AOP and Their Role in Network-Based Prediction

Component	Definition	Role in AOP Network as a Predictive Unit
Molecular Initiating Event (MIE)	Initial stressor-biological target interaction.	Entry Point: Identifies the network's activation point by a specific stressor class.
Key Event (KE)	Measurable, essential biological change.	Functional Node/Hub: The primary unit for prediction. A shared KE indicates convergent toxicity and a point for mechanistic screening and intervention.
Key Event Relationship (KER)	Causal link between two KEs.	Connective Edge: Defines the predictive logic and directionality of perturbation flow through the network. Quantitative KERs enable dose-response modeling.
Adverse Outcome (AO)	Toxicity endpoint relevant for risk assessment.	Network Output: Represents a terminal node. A single AO can be reached via multiple pathways in the network, informing on multiple modes of action.

Shared Key Events as Network Hubs

The transition from a linear AOP to an AOP network occurs when a KE is documented in more than one AOP. For example, "Sustained Activation of the Hepatic Stellate Cell" is a KE in AOPs for both chemical-induced and cholestatic liver fibrosis [2]. Similarly, "Reduced Thyroid Hormone (T4) Levels" is a KE that can link AOPs for developmental neurotoxicity, impaired reproduction, and impaired swim bladder inflation in fish.

In a network visualization, these shared KEs become hubs with multiple incoming and outgoing connections. The predictive power lies in this connectivity: if a chemical is shown to induce a hub KE, the network model predicts a heightened risk of all AOs downstream of that hub. This allows for the prediction of multiple adverse outcomes from a single measured biomarker and identifies points of convergence for chemical mixtures acting through different MIEs.

Diagram: Shared Key Event as a Network Hub Converging on Multiple Adverse Outcomes. A single hub KE ("Cellular Apoptosis") receives inputs from three distinct AOPs initiated by different MIEs and predicts the risk for three different AOs.

Methodological Pipeline: Constructing and Quantifying AOP Networks

Knowledge Assembly and Network Reconstruction

The foundational step is aggregating documented AOPs from structured knowledge bases. The primary source is the AOP-Wiki, a collaborative platform housing hundreds of AOPs developed according to OECD guidance [2] [4]. Manual assembly of networks by experts reviewing the wiki is possible but inefficient for large-scale analysis.

Protocol: Automated Network Reconstruction with AOP-networkFinder The AOP-networkFinder tool exemplifies a modern, reproducible methodology for network construction [4].

• Data Retrieval: The tool executes automated SPARQL queries against the AOP-Wiki's semantic web endpoint (RDF format). Users can query for specific AOPs, KEs, or stressors.
• Network Generation: The software parses the query results and automatically generates a network graph. The core algorithm connects AOPs that share identical KEs, creating nodes (KEs, AOs, MIEs) and edges (KERs).
• Graph Manipulation and Cleaning: Users can filter AOPs based on OECD endorsement status. A fuzzy logic algorithm (Levenshtein distance) suggests merging KEs with highly similar names to reduce redundancy.
• Visualization and Export: The interactive network is displayed within the tool. Users can highlight specific pathways, explore neighboring nodes (1-2 degrees away from a KE of interest), and export the graph for further analysis in tools like Cytoscape.

Table 2: Key Research Reagent Solutions for AOP Network Development

Tool/Resource	Type	Primary Function in AOP Network Research
AOP-Wiki	Knowledge Base	Central repository for curated, structured AOP information; the primary data source for network construction [1] [4].
AOP-networkFinder	Computational Tool	User-friendly application to automatically retrieve, construct, visualize, and manipulate AOP networks from the AOP-Wiki via SPARQL [4].
Cytoscape	Network Analysis Software	Advanced platform for network visualization, topological analysis (e.g., identifying hub KEs), and integration with molecular data.
Effectopedia	Collaborative Modeling Platform	Allows for the quantitative description of KERs using computational models and facilitates collaborative AOP/network development [2].
Intermediate Effects Database	Chemical Effects Database	Links chemical screening data (e.g., from ToxCast) to MIEs and KEs, enabling the "chemical-agnostic" AOP network to be anchored to specific stressors [2].

Diagram: Workflow for Constructing and Applying an AOP Network.

Quantitative Development of Key Event Relationships (KERs)

For a network to be predictive, the connections (KERs) must be quantitative. A qualitative KER states "KE A contributes to KE B." A quantitative KER (qKER) defines the mathematical relationship, such as a dose-response curve, a correlation coefficient, or a computational model output [2].

Protocol: Establishing Quantitative KERs Using Bradford-Hill Considerations The Bradford-Hill criteria provide a framework for building confidence in causal relationships and defining their quantitative nature [2].

• Dose-Response Concordance: Collect empirical data showing how the magnitude of change in the upstream KE (e.g., receptor occupancy) correlates with the magnitude or incidence of the downstream KE (e.g., gene expression). This can be modeled using benchmark dose (BMD) software.
• Temporal Concordance: Design time-course experiments to demonstrate that the upstream KE reliably occurs before the downstream KE.
• Biological Plausibility & Consistency: Use structured databases (e.g., Kyoto Encyclopedia of Genes and Genomes - KEGG) and literature mining to document the established biological pathway linking the KEs across multiple studies.
• Experimental Modulation: Apply inhibitors, agonists, or genetic knockdowns to the upstream KE and measure the expected directional change in the downstream KE, strengthening causal evidence.

Confidence Assessment and FAIRification

Before application, the assembled network must be evaluated for scientific confidence and reusability.

Protocol: Weight-of-Evidence and Confidence Assessment

• Evaluate Essentiality of Each KE: For each KE, assess whether modulating it (inhibiting or amplifying) blocks or mitigates the progression to the AO, based on experimental evidence.
• Assess Empirical Support for KERs: Score the strength and consistency of data supporting each KER (strong, moderate, weak) based on the Bradford-Hill evaluation [2].
• Answer OECD Key Questions: Evaluate the network's domain of applicability: Is it specific to certain tissues, life stages, or species? How conserved are the KEs across taxa (critical for ecological assessment)? [2]

Protocol: Ensuring FAIR (Findable, Accessible, Interoperable, Reusable) Data Adherence to the FAIR principles is essential for network utility and integration with other data streams (e.g., omics, exposure) [6].

• Findable: Each KE, MIE, and AO in the network must have a unique, persistent identifier (e.g., from the AOP-Wiki).
• Interoperable: Network metadata should use standardized ontologies (e.g., Gene Ontology, Cell Ontology) to describe biological processes, enabling linkage to other biological databases.
• Reusable: The network model, its underlying data, and confidence assessments should be richly described with provenance and shared in open, accessible formats (e.g., using the AOP-Wiki RDF format) [4].

Application in Ecological Risk Assessment and Drug Development

AOP networks transform risk assessment from a chemical-by-chemical, endpoint-specific exercise to a predictive, mechanism-based science.

Prioritization of Environmental Chemicals and Pharmaceuticals

For the thousands of data-poor chemicals in the environment, testing all for every possible AO is impossible [3] [5]. AOP networks enable intelligent prioritization.

• Mechanism-Based Screening: High-throughput in vitro assays can be targeted to measure hub KEs in a network (e.g., oxidative stress, specific receptor activation). A chemical's activity in these assays predicts its potential to trigger multiple adverse outcomes downstream in the network [1].
• Read-Across and Grouping: Chemicals that share a common MIE or that are shown to affect a common hub KE can be grouped. Toxicity data from a well-studied chemical can be "read-across" to predict hazard for data-poor members of the group, informed by the network structure [3].
• Case Study - Pharmaceuticals in Water: An AOP network centered on shared KEs like "estrogen receptor activation" or "cyclooxygenase inhibition" can prioritize pharmaceuticals for environmental monitoring and testing based on their prescribed mechanism of action, predicted bioavailability in fish (Fish Plasma Model), and potency, rather than mere environmental concentration [5].

Supporting New Approach Methodologies (NAMs) and Integrated Approaches

AOP networks are a conceptual backbone for NAMs, which aim to reduce reliance on animal testing [1] [3].

• Defining Integrated Testing Strategies (IATA): A network identifies a minimal set of in vitro and in chemico assays needed to measure critical KEs across multiple pathways. This battery of tests provides a weight-of-evidence for hazard prediction that is more robust than any single assay.
• Extrapolating from In Vitro to In Vivo: Quantitative KERs within a network can be used in Physiologically Based Kinetic (PBK) models to translate effective in vitro concentrations at a KE to predicted internal doses and organ-level effects in whole organisms [3].
• Case Study - Liver Steatosis: An established AOP network for liver steatosis starts with MIEs like "Liver X Receptor activation," proceeds through KEs like "Increased triglyceride synthesis," and leads to the AO of "fatty liver." This network guides the use of human liver spheroid models to measure triglyceride accumulation and transcriptomic changes, providing a human-relevant NAM for screening chemicals that could cause metabolic disorder [2].

Table 3: Applications of AOP Networks in Risk Assessment

Application Area	How Shared KEs as Functional Units Enable Prediction	Example Context
Chemical Prioritization	Screening for activity at a hub KE (e.g., aryl hydrocarbon receptor activation) predicts risk for multiple AOs (cancer, immunosuppression, developmental toxicity).	Prioritizing PFAS or pharmaceutical compounds for ecological risk assessment [1] [5].
Mixtures Risk Assessment	Chemicals with different MIEs that converge on a shared KE are predicted to have additive or synergistic effects at that node.	Assessing combined effects of pesticides and industrial chemicals on mitochondrial function.
Interspecies Extrapolation	If the sequence of KEs from a hub to an AO is conserved across taxa, hazard data from one species can predict risk in another.	Using rodent or fish data to inform amphibian or avian risk assessment for endocrine disruptors.
NAM Development	Identifies the essential KEs that must be measured by in vitro assays to cover a network of toxicity pathways.	Designing a battery of high-throughput cell-based assays for screening drug-induced liver injury [2] [3].

Defining the AOP network through the lens of shared Key Events establishes a powerful, predictive framework for modern toxicology. By treating KEs as functional units, the approach mirrors biological reality—where perturbations propagate through interconnected networks rather than linear tracks. This paradigm is indispensable for addressing the core challenges in ecological risk assessment: complex chemical mixtures, data-poor substances, and the need for mechanistically informed, rapid decision-making.

The future of this field lies in enhancing the quantitative, dynamic, and accessible nature of AOP networks. Priorities include:

• High-Throughput qKER Development: Leveraging computational modeling, AI, and large-scale in vitro dose-response data to populate networks with probabilistic, quantitative relationships.
• Dynamic Network Modeling: Integrating AOP networks with systems biology models to simulate network behavior under continuous exposure, recovery, and adaptive responses.
• Expansion and FAIRification: Continued community-driven development of AOPs in the AOP-Wiki, coupled with stringent application of FAIR principles as outlined in the 2025 FAIR AOP Roadmap, to ensure networks are interoperable with emerging chemical, exposure, and omics data [6].
• Regulatory Adoption: Formalizing guidance on how AOP network-based evidence, particularly from NAMs, can be used in regulatory contexts for chemical safety assessment and prioritization [3].

By embracing the network view, the scientific community can move beyond isolated pathways to a systems-level understanding of toxicity, where shared Key Events serve as the fundamental units for predicting and preventing adverse outcomes in both human and ecological health.

The Adverse Outcome Pathway (AOP) framework has emerged as a powerful mechanistic construct for organizing biological knowledge to support chemical safety assessment and ecological risk prediction [6]. An AOP describes a sequential chain of causally linked key events (KEs), beginning with a molecular initiating event (MIE) within an organism and culminating in an adverse outcome (AO) of relevance to risk assessment at the individual or population level [6]. While individual AOPs are essential for structured knowledge development, the real-world predictive power required for ecological risk assessment is unlocked through the construction of interconnected AOP networks [7]. These networks more accurately reflect biological complexity, where multiple stressors can converge on shared biological pathways, and a single perturbation can lead to multiple adverse outcomes.

This whitepaper articulates the core principle that rigorous, standardized individual AOPs form the essential building blocks, while their strategic assembly into networks enables predictive, systems-level application in ecological risk assessment research. We explore the methodologies for developing standalone AOPs according to international guidance, detail protocols for constructing and validating AOP networks, and provide a research toolkit for scientists in toxicology, environmental science, and drug development.

The Building Block: Development of Individual AOPs

The development of a scientifically credible, regulatory-ready AOP adheres to a strict, harmonized process. The foundational principles ensure each AOP is a reliable, reusable unit of knowledge that can be confidently linked with others.

Table 1: Core Components and Standards for Individual AOP Development

Component	Description	Development Standard/Guidance
Molecular Initiating Event (MIE)	The initial interaction of a stressor with a biological target.	Must be defined as a specific, measurable biochemical interaction [6].
Key Events (KEs)	Measurable biological changes at different levels of organization.	Must be essential, observable, and quantifiable. "Gardening" efforts remove redundancies [7].
Key Event Relationships (KERs)	Descriptions of causal, mechanistic linkages between KEs.	Must be supported by a documented Weight of Evidence (WoE) assessment [7].
Adverse Outcome (AO)	The apical endpoint of regulatory concern.	Must be relevant to population or ecosystem-level risk [6].
Domain of Applicability	The boundaries for which the AOP is presumed valid.	Must specify taxonomic, life stage, and sex applicability [7].

Experimental Protocol: Key Event Relationship (KER) Weight of Evidence Assessment

The credibility of an AOP rests on the strength of its KERs. The following protocol, based on OECD guidance, is used to assess and document the WoE for each KER [7].

• Biological Plausibility: Compile evidence from established biological knowledge (e.g., pathway databases, fundamental biology) supporting a causal link between the upstream and downstream KE. This includes understanding of normal biological function and how its disruption leads to the downstream event.
• Empirical Support: Gather and evaluate dose-response, temporal, and incidence concordance data from experimental studies.
  • Dose-Response Concordance: The upstream and downstream KEs must show consistent changes in magnitude or incidence across a range of stressor doses.
  • Temporal Concordance: The upstream KE must occur prior to or simultaneously with the downstream KE, and the time-to-onset should be consistent with a causal sequence.
  • Incidence Concordance: The incidence (frequency of occurrence) of the upstream and downstream KEs across test subjects should be consistent.
• Essentiality Assessment: Design and conduct "block, mimic, or modulate" experiments. The linkage is considered essential if blocking the upstream KE prevents the downstream KE, or if directly mimicking the upstream KE induces the downstream KE in the absence of the stressor.
• WoE Integration and Documentation: Synthesize evidence from steps 1-3 using a structured framework (e.g., the Bradford-Hill considerations). Document the strength (Strong, Moderate, Weak) and the underlying evidence in the AOP-Wiki or similar repository to ensure transparency and reusability [6] [7].

The Predictive Engine: Construction of AOP Networks

Individual AOPs are linear simplifications, but biology is a network. An AOP network is a graph-based model where individual AOPs are interconnected via shared key events, forming a web that can represent combined exposures, compensatory pathways, and multiple potential adverse outcomes from a single MIE [7].

Table 2: Standalone AOPs vs. AOP Networks: A Functional Comparison

Aspect	Standalone AOP	AOP Network
Primary Purpose	Hypothesis-driven knowledge assembly and organization for a specific pathway.	Predictive modeling of systemic perturbation and identification of emergent properties.
Complexity	Linear, simplified causal chain.	Non-linear, web-like structure representing biological complexity.
Regulatory Utility	Identifies potential mechanistic biomarkers (KEs) for a single endpoint.	Supports integrated approaches to testing and assessment (IATA), predicts mixture toxicity, and identifies critical network nodes for monitoring.
Development Focus	Depth of evidence for each KER within the chain.	Topology, connectivity rules, and network dynamics (e.g., feedback loops).

Experimental Protocol: AOP Network Construction via Shared Key Events

This protocol outlines the steps to build a biologically meaningful AOP network from a set of curated individual AOPs [7].

• Curate Component AOPs: Select individual AOPs that have been developed according to OECD principles and share a common biological or toxicological domain (e.g., hepatotoxicity, endocrine disruption).
• Identify Shared Key Events: Systematically analyze the selected AOPs to identify KEs that are common to two or more pathways. These shared KEs become the network nodes where AOPs intersect. The OECD Coaching Program's "gardening" work, which harmonizes KE definitions, is critical for this step [7].
• Define Connection Rules: Establish logical rules for connecting AOPs. The primary rule is a "shared KE" connection: if AOP1 ends with a KE that is also the MIE or an intermediate KE in AOP2, they are linked at that node. This can create convergent networks (multiple MIEs leading to one AO) or divergent networks (one MIE leading to multiple AOs).
• Map and Visualize the Network: Use graph visualization software to create a network diagram. Shared KEs should be represented as single, merged nodes with multiple incoming and outgoing edges (KERs). The diagram must clearly distinguish MIEs, intermediate KEs, and AOs.
• Conduct Network Analysis: Analyze the network's topological properties to gain insights.
  • Identify Critical Nodes: Calculate betweenness centrality to find KEs that act as major hubs or bottlenecks. These are high-priority candidates for biomarker development or chemoprevention targets.
  • Predict Emergent Effects: Simulate perturbations (e.g., inhibition of a high-centrality KE) to predict outcomes not evident from single AOPs, such as compensatory pathway activation or off-target effects.

Network Construction from Individual AOPs via Shared Key Events

Successful AOP development and networking require a suite of collaborative, computational, and data resources that adhere to the FAIR principles (Findable, Accessible, Interoperable, Reusable) [6].

Table 3: Research Reagent Solutions for AOP Development & Networking

Tool/Resource	Type	Primary Function	Key Utility
AOP-Wiki (aopwiki.org)	Collaborative Knowledge Base	The primary repository for submitting, hosting, and reviewing AOPs.	Provides a centralized, public platform for AOP development and access to existing pathways for network building [6] [7].
OECD AOP Development Handbook	Guidance Document	Provides the definitive international standard for AOP structure, KER WoE assessment, and review.	Ensures harmonized, high-quality AOPs that are suitable for regulatory use and interoperable for networking [7].
Effectopedia	Modeling & Networking Platform	An open-source platform for building qualitative and quantitative AOPs and networks with systems biology features.	Enables dynamic linking of KEs, incorporation of modulating factors, and simulation of network perturbations.
FAIR Enabling Resources (e.g., Bioregistry, AOP-DB)	Data Interoperability Tools	Provide standardized identifiers and annotations for AOP entities (MIEs, KEs, chemicals, genes) [6].	Critical for machine-actionability, allowing computational discovery of shared KEs and automated network assembly [6].
OECD AOP Coaching Program	Expert Mentorship	Pairs novice AOP developers with experienced coaches for guidance [7].	Accelerates high-quality AOP development and promotes the "gardening" necessary for network-ready, non-redundant KEs [7].

The principle of "individual AOPs for development, networks for prediction" provides a clear roadmap for advancing ecological risk assessment. The future of the field hinges on implementing the FAIR AOP Roadmap for 2025, which focuses on making AOP knowledge computationally accessible and interoperable [6]. This involves standardizing data formats, enriching AOPs with connections to other biological databases (e.g., genomics, exposure data), and developing tools for the automated or semi-automated generation of predictive network models.

For researchers, the immediate priorities are to: 1) develop new AOPs using the coached, harmonized approach; 2) actively engage in "gardening" the existing AOP knowledgebase to refine KE definitions; and 3) leverage FAIR-enabled resources to construct and validate AOP networks for complex endpoints like systemic chronic toxicity and population-level ecological impacts. Through these efforts, the AOP framework will fully transition from a descriptive knowledge-organizing system to a predictive engine for 21st-century risk assessment.

The Adverse Outcome Pathway (AOP) framework is a conceptual tool designed to organize mechanistic knowledge about how stressors, such as chemicals, lead to adverse effects relevant to human health or ecological risk assessment [8]. An AOP describes a sequential chain of causally linked biological events, beginning with a Molecular Initiating Event (MIE)—the initial interaction between a stressor and a biological target—and culminating in an Adverse Outcome (AO) of regulatory concern, such as population decline or organ dysfunction [8] [9]. The power of the AOP framework lies in its modular architecture, which is built upon two fundamental, reusable components: Key Events (KEs) and Key Event Relationships (KERs) [9].

KEs are measurable, essential biological changes at different levels of organization (e.g., cellular, tissue, organismal) that mark the progression from the MIE to the AO [10] [8]. KERs provide the causal and evidentiary glue, describing the biologically plausible and empirically supported linkage between a pair of KEs [8]. This modular design is not merely an organizational convenience; it is a core principle that enables the AOP framework to efficiently capture the complexity of toxicology. Individual KEs and KERs can be reused in multiple AOPs, facilitating the assembly of AOP networks that more accurately reflect real-world biological systems where multiple pathways converge, diverge, and interact [10] [9]. For ecological risk assessment, this network-based perspective is critical for understanding the cumulative effects of multiple stressors, extrapolating effects across species, and identifying pivotal points for biological monitoring or testing [8]. This technical guide explores the strategies, best practices, and quantitative tools for developing and leveraging these modular KE and KER building blocks to construct predictive AOP networks.

Foundational Principles: Modularity, Reusability, and Network-Based Prediction

The construction and utility of AOPs are governed by five core principles that directly enable network thinking [9]. These principles ensure that AOPs are consistent, scalable, and suitable for application in regulatory and research contexts, particularly for ecological risk assessment.

Table 1: Core Principles of the AOP Framework Enabling Network Development

Principle	Core Tenet	Implication for Network Building
1. Chemical Agnosticism	AOPs describe generalizable biological pathways, not chemical-specific effects [8] [9].	A single network can predict effects for diverse stressors that share a common MIE or intermediate KE.
2. Modularity	AOPs are composed of reusable units: Key Events (KEs) and Key Event Relationships (KERs) [10] [9].	KEs/KERs are shared building blocks, allowing efficient assembly of complex networks from validated parts.
3. Pragmatic Unit	A single, linear AOP (MIE → KE1 → KE2 → ... → AO) is the basic unit for development and review [10] [9].	Provides a standardized "subroutine" that can be linked to others to form networks.
4. Network as Functional Unit	Networks of interconnected AOPs are the functional unit for prediction in real-world scenarios [8] [9].	Captures adaptive/toxicological complexity, such as multiple pathways leading to one outcome or one stressor affecting multiple outcomes.
5. Living Documents	AOPs evolve with new scientific knowledge [8] [9].	Networks are dynamic; new KEs or evidence can update multiple connected AOPs simultaneously.

Adherence to these principles, particularly modularity, prevents redundancy and promotes a cumulative knowledgebase. A significant ongoing challenge, however, is the proliferation of synonymous or near-identical KEs within the central AOP-Wiki repository, created by authors with varying levels of expertise [11] [7]. This undermines reusability and network integrity. In response, initiatives like the OECD's AOP Coaching Program and community "gardening" efforts have been established to harmonize KE descriptions, merge duplicates, and ensure new AOPs are built from existing, high-quality modules [7].

Defining the Building Blocks: Key Events (KEs) and Key Event Relationships (KERs)

Key Events (KEs): The Measurable Nodes

A Key Event is a measurable change in biological state that is essential for the progression toward the Adverse Outcome [10]. Best practices dictate that each KE should be defined as an independent measurement at a specific level of biological organization (e.g., molecular, cellular, tissue, organ, organism) [10]. The definition of a KE should include:

• A clear description of the biological state and its context.
• The methodologies available for its measurement or observation.
• Its taxonomic applicability [10].

A critical concept in KE definition is "functional equivalence." When deciding whether to split a broad biological process into multiple KEs or combine them, developers should consider if the sub-events are independently measurable and essential, or if they collectively represent one functional step in the pathway [10]. For example, "Increased Reactive Oxygen Species (ROS)" and "Oxidative DNA Damage" are functionally distinct, measurable, and essential steps in a genotoxicity pathway, warranting separate KE status [11].

Key Event Relationships (KERs): The Causal Edges

A KER describes the causal linkage between two KEs, supported by evidence structured according to modified Bradford-Hill considerations [11] [8]. The evidence supporting a KER falls into three primary categories:

• Biological Plausibility: The relationship is consistent with established biological knowledge.
• Empirical Support: Experimental data shows dose, temporal, and incidence concordance between the upstream and downstream KE.
• Essentiality: Evidence that blocking or preventing the upstream KE inhibits the downstream KE [11] [8].

KERs also summarize the quantitative understanding of the relationship (e.g., dose-response models) and identify uncertainties and inconsistencies in the evidence [11]. Strong empirical support for non-adjacent KERs (e.g., linking an MIE directly to a cellular-level KE, skipping an intermediate) can provide particularly powerful weight of evidence for the overall AOP [11].

Methodological Protocols: Developing and Integrating KEs and KERs

Systematic Evidence Gathering for KERs

Developing a well-supported KER requires a transparent and documented review of the scientific literature. A systematic review (SR) approach is advocated to ensure reproducibility and strength of evidence [11]. For data-rich fields, a full SR may be impractical, but its principles can be adapted. A documented case study for integrating a new KE ("Increased ROS") into an existing genotoxicity AOP provides a replicable protocol [11]:

• Define the KER Scope: Identify all potential new KERs required to connect the new KE to the existing AOP network.
• Preliminary Evidence Mapping: Conduct a broad literature search using terms for the KEs. Use SR software (e.g., DistillerSR, Rayyan) to screen titles/abstracts against a Population, Exposure, Comparator, Outcome (PECO) statement. Create a map of which papers support which KERs.
• Prioritize Critical KERs: Focus on gathering high-quality quantitative evidence for the first adjacent KER (the direct link from the new KE to the next one in the chain), as it is most critical for causal inference.
• Targeted Search for Quantitative Evidence: Perform a second, focused search using terms for specific methodologies that measure the paired KEs (e.g., "dichlorofluorescin assay" for ROS and "Comet assay" for DNA damage). Extract quantitative data on dose and temporal concordance.
• Evidence Synthesis: Summarize the weight of evidence, highlighting the nature of support (plausibility, empirical, essentiality) and any uncertainties.

Table 2: Evidence Summary from a Case Study Integrating "Increased ROS" into a Genotoxicity AOP [11]

Search Phase	Search Target	Papers Screened	Papers Supporting KER(s)	Primary Evidence Type
Phase 1: Preliminary Mapping	All five new KERs linking "Increased ROS" to the AOP.	100	39	Primarily dose/temporal concordance for non-adjacent KERs. Limited evidence for the first adjacent KER.
Phase 2: Targeted Search	First adjacent KER ("Increased ROS → Oxidative DNA Damage").	Focused search using methodological terms.	12	Quantitative evidence supporting dose and temporal concordance for the first adjacent KER.

Best Practices for KE and KER Description

To maximize reusability and network connectivity, AOP developers should adhere to established best practices [10]:

• Avoid Redundancy: Before creating a new KE, exhaustively search the AOP-KB (AOP-Wiki) to see if an equivalent KE already exists.
• Ensure Essentiality: A KE must be a necessary step in the causal chain. A correlative biomarker that is not itself essential should not be listed as a KE.
• Balance Specificity and Generality: KEs should be defined generally enough to be applicable across contexts (e.g., "hepatocyte apoptosis") but specific enough to be measurable and distinguishable from other KEs.
• Leverage Existing KERs: When describing a KER between two established KEs, reference and build upon any existing KER description between them, adding new evidence rather than creating a duplicate.

From Linear Pathways to Networks: Construction and Analysis

Constructing an AOP Network

An AOP network is formed when two or more AOPs share one or more common KEs [12]. These shared KEs become convergence or divergence points within the network, revealing how different MIEs can lead to a common intermediate injury (e.g., oxidative stress) or how one MIE can trigger multiple adverse outcomes [8] [12]. Construction follows a logical process:

• Seed Selection: Start with a single AOP or a specific KE of interest relevant to the research question (e.g., reproductive toxicity) [12].
• Network Derivation: Use specialized software (e.g., Biovista Vizit, AOP-Wiki functions) to automatically or manually identify all other AOPs in the knowledgebase that share KEs with the seed. This creates the initial network graph.
• Harmonization and Pruning: Review the network for synonym KEs (e.g., "Cell death" vs. "Apoptosis"). Merge synonymous nodes to ensure true connectivity, a step crucial for accurate analysis [12].
• Characterization: Analyze the network's topology to identify central, highly connected KEs.

Analyzing Network Topology for Predictive Insight

Quantitative network analysis transforms a conceptual map into a predictive tool. Key metrics include [12]:

• Degree Centrality: The number of connections a KE has. A high-degree KE is a major hub (e.g., "Apoptosis," "Increased ROS").
• Betweenness Centrality: Identifies KEs that act as critical bridges or bottlenecks between different parts of the network.
• Identification of Feed-Forward Loops: Reveals potential points for amplification of toxicity. These analyses identify pivotal KEs that have high predictive value. For example, in a reproductive toxicity network induced by oxidative stress, "Increased ROS," "DNA Damage," and "Apoptosis" were found to be highly connected central hubs [12]. This indicates that assays measuring these KEs could effectively screen for chemicals with the potential to cause reproductive toxicity via multiple upstream mechanisms.

Table 3: Research Reagent Solutions for AOP Network Development

Tool / Resource	Primary Function	Relevance to Modularity & Networks
AOP-Wiki (aopwiki.org)	Central repository for authoring, sharing, and browsing AOPs, KEs, and KERs [11] [8].	Foundation for reusability. Essential for searching existing modules before creating new ones and for discovering connections to build networks.
FAIR AOP Roadmap & Tools	Guidelines and tools (e.g., from the FAIR AOP Cluster) to make AOP data Findable, Accessible, Interoperable, and Reusable [6].	Promotes machine-actionability and standardization, which is critical for computational network assembly and analysis.
Biovista Vizit, Cytoscape	Software for visualizing, exploring, and constructing biological networks [12].	Enables derivation and visualization of AOP networks from AOP-Wiki data, allowing topological analysis.
OECD AOP Coaching Program	Pairs novice developers with experienced coaches to ensure consistent application of AOP principles [7].	Harmonizes development practices, reduces KE synonymy, and improves the quality of modular building blocks.
Systematic Review Software (e.g., DistillerSR, Rayyan)	Platforms for managing transparent, documented literature reviews [11].	Provides rigorous evidence to support KERs, strengthening the validity of the connections within a network.
SeqAPASS	An in silico tool from the EPA for cross-species extrapolation based on protein sequence similarity [8].	Assesses the taxonomic applicability of a KE (e.g., MIE), determining if a module can be reused in a network for a different species.

The modular architecture of the AOP framework, with KEs and KERs as its fundamental, reusable building blocks, provides a powerful and scalable strategy for organizing toxicological knowledge. By moving from single pathways to interconnected networks, researchers can more effectively model the complexity of ecological systems, where multiple stressors and biological interactions are the norm. The future utility of AOP networks in ecological risk assessment depends on continued efforts to standardize KE definitions (addressing synonymy), enhance the quantitative rigor of KERs through systematic review, and implement FAIR data principles to enable computational network discovery and analysis [6] [7]. As these networks grow and become more refined, they will increasingly serve as robust, predictive maps to guide the development of New Approach Methodologies (NAMs), prioritize chemical testing, and ultimately support more mechanistic and efficient ecological risk assessments.

The fundamental challenge in modern ecological risk assessment lies in bridging the gap between simplified laboratory models and the intricate reality of environmental exposures. Organisms in ecosystems are not exposed to single, pure chemicals in isolation. Instead, they face complex mixtures of contaminants—such as pesticides, pharmaceuticals, industrial chemicals, and non-chemical stressors like microplastics or temperature changes—that interact in dynamic ways [13] [14]. Traditional toxicity testing and the adverse outcome pathway (AOP) framework, when applied as isolated linear sequences, were developed primarily for single stressors and often fail to capture this complexity [8] [15].

An AOP is a conceptual framework that organizes information linking a molecular initiating event (MIE)—a direct interaction between a stressor and a biological molecule—to an adverse outcome (AO) relevant to risk assessment, through a series of measurable key events (KEs) [8]. While individual AOPs provide valuable mechanistic insight, they represent a deliberate simplification. Real-world biological systems are characterized by pleiotropy (one stressor affecting multiple pathways), redundancy (multiple stressors converging on one outcome), and emergent interactions (synergistic or antagonistic effects) [15].

This whitepaper argues that for ecological risk assessment research, the AOP network, not the single AOP, must be considered the functional unit of prediction [8] [15]. By moving from linear pathways to interconnected networks, researchers can better model mixture effects, address knowledge gaps systematically, and develop robust testing strategies for complex exposures that ultimately protect population and ecosystem health [16].

Theoretical Foundations: From Linear Pathways to Interconnected Networks

Core Concepts and Definitions

The AOP framework is modular by design, consisting of two basic units: Key Events (KEs) and the causal Key Event Relationships (KERs) that link them [15]. This modularity allows KEs to serve as connection points, or nodes, where different pathways intersect. When multiple AOPs share common KEs or KERs, they can be assembled into an AOP network [8] [15].

Table 1: Foundational Concepts in AOP and Network Science [8] [15]

Concept	Definition	Role in Network Analysis
Key Event (KE)	A measurable biological change at any level of organization (molecular, cellular, organ, organism, population).	Serves as a node in the network graph.
Key Event Relationship (KER)	A scientifically supported description of a causal or mechanistic link between two KEs.	Serves as a directed edge (arrow) connecting nodes.
Molecular Initiating Event (MIE)	The initial interaction between a stressor and a biomolecule that triggers the pathway.	A specialized type of KE that is often a network entry point.
Adverse Outcome (AO)	A biological change at the organism or population level relevant for regulatory decision-making.	A specialized type of KE that is often a network endpoint.
Modularity	The property of AOPs being composed of reusable KEs and KERs.	Enables the construction and expansion of networks.

An AOP network is more than a collection of pathways; it is a structured representation of the biological system's potential response landscape. It explicitly maps how perturbations can propagate through shared biological processes, revealing points of convergence (where different stressors cause the same KE) and divergence (where one stressor leads to multiple possible AOs) [15].

How Networks Capture Biological Realism

Biological systems are inherently networked. A single molecular perturbation, such as the binding of a chemical to a receptor (an MIE), can send ripples through interconnected cellular signaling, metabolic, and regulatory circuits. A linear AOP captures one plausible route for those ripples. In contrast, an AOP network can represent several routes simultaneously, acknowledging biological redundancy and compensatory mechanisms [15].

Crucially, AOP networks differ from other biological networks (e.g., protein-protein interaction networks) in important ways. In an AOP network, each node represents a measurable change in a biological state (e.g., "Increased Oxidative Stress"), not a static entity (e.g., "Glutathione"). Furthermore, the edges (KERs) often connect different levels of biological organization (e.g., from a cellular KE to a tissue-level KE). The primary focus is on predictive utility—accurately forecasting the system's response to perturbation—rather than on creating a complete map of all biological entities [15].

Diagram: An AOP Network Integrating Multiple Stressors and Pathways. This network shows how chemical and non-chemical stressors (colored circles) can trigger different MIEs or directly affect shared Key Events (grey ellipses). The linear AOPs (within dotted borders) converge on common KEs, demonstrating how mixture effects arise through biological interaction points. Dashed lines represent modulating relationships that are not part of a formal KER [13] [15] [17].

Methodological Framework: Building and Analyzing AOP Networks

Network Development Workflow

Constructing a biologically meaningful AOP network is an iterative process that combines knowledge curation with computational tools.

• Problem Formulation & Scoping: Define the risk assessment context (e.g., "reproductive failure in fish populations downstream of wastewater effluent") and identify the relevant stressors and AOs [16] [14].
• Knowledge Assembly:
  • Manual Curation: Systematic review of literature to identify established AOPs, KEs, and KERs related to the problem. This involves extracting information from resources like the AOP-Wiki [8] [18].
  • Computational Mining: Use of text-mining tools (e.g., AOP-helpFinder) to scan large volumes of scientific literature for co-occurrences of stressor and event terms, helping to identify potential novel connections and fill knowledge gaps [13].
• Network Construction: Assemble identified KEs (nodes) and KERs (directed edges) using graph database or specialized software. Shared KEs automatically become junctions linking different AOPs [15].
• Qualitative Analysis & Hypothesis Generation: Apply graph theory metrics to understand network structure and identify critical points (see Section 3.2).
• Evidence Weighting & Uncertainty Evaluation: Use frameworks like the Bradford Hill criteria to assess the strength of evidence for each KER within the network. This highlights well-supported paths versus those requiring further research [13].

Table 2: Quantitative Topological Metrics for AOP Network Analysis [15]

Metric	Calculation	Interpretation in AOP Networks	Risk Assessment Utility
Degree Centrality	Number of connections (edges) a node (KE) has.	A high-degree KE (hub) is involved in many pathways. Perturbing a hub likely has widespread effects.	Identifies potential high-impact biomarkers for monitoring and points of high susceptibility for mixture effects.
Betweenness Centrality	The number of shortest paths between all node pairs that pass through a given node.	A high-betweenness KE is a critical bottleneck or connector between different network modules.	Identifies leverage points where an intervention (e.g., a blocking agent) could efficiently disrupt multiple adverse pathways.
Path Length	The number of steps (edges) between an MIE and an AO.	Shorter paths may represent more direct, less buffered mechanisms.	Helps prioritize rapid-response biomarkers (shorter paths) versus chronic effect indicators (longer, more integrative paths).
Modularity	The extent to which a network can be divided into distinct, densely connected sub-groups.	High modularity suggests functional modules (e.g., all KEs related to oxidative stress).	Guides targeted testing strategies (focusing on a specific module) and helps understand if mixture components affect independent modules (additive effect) or the same module (potential synergy).

Experimental Protocols for Validating Network Predictions

Validating interactions predicted by an AOP network requires moving beyond single-endpoint tests.

Protocol 1: Testing Convergent Effects on a Shared KE This protocol tests the hypothesis that two different stressors, acting through distinct MIEs, converge to perturb a common KE (a network hub), leading to an additive or synergistic effect on a downstream AO [15] [17].

• System: A relevant in vitro model (e.g., fish hepatocyte cell line) or a small in vivo model (e.g., early life-stage zebrafish).
• Design: A full factorial design exposing systems to: a) Vehicle control, b) Stressor A alone, c) Stressor B alone, d) Combined Stressor A+B.
• Endpoint Measurement:
  • Upstream MIEs: Use specific assays for each stressor's purported MIE (e.g., CYP19 activity assay for an aromatase inhibitor; sodium-iodide symporter (NIS) uptake assay for a perchlorate-like chemical) [17].
  • Shared KE: Quantify the hypothesized shared KE (e.g., measure a panel of oxidative stress biomarkers like glutathione levels, lipid peroxidation, and expression of sod1) [13] [19].
  • Downstream AO: Measure an apical endpoint (e.g., vitellogenin induction for reproductive output, or morphological development score) [16].
• Analysis: Use statistical models (e.g., Generalized Linear Models) to determine if the combined effect on the shared KE and the AO is greater than the sum of individual effects (synergy), equal to it (additivity), or less (antagonism).

Protocol 2: High-Throughput Screening for Network Activation This protocol uses high-content in vitro screening to map a complex mixture's activity onto multiple nodes of a predefined AOP network [20] [14].

• System: A battery of cell-based assays, each engineered to report on a specific KE node in the network (e.g., antioxidant response element (ARE) luciferase assay for oxidative stress; estrogen receptor (ER) transactivation assay for endocrine activity).
• Exposure: Expose each assay to serial dilutions of the environmental mixture (e.g., water sample extract).
• Data Acquisition: Measure reporter activity (luminescence, fluorescence) in a high-throughput plate reader.
• Network Mapping & Analysis:
  • Calculate benchmark concentrations (e.g., EC10) for each assay.
  • Plot the activity profile onto the AOP network diagram, visually highlighting which pathways are activated and at what potency.
  • Use the network topology to interpret the results: Is a single hub KE activated, or are multiple independent pathways? This pattern informs the prediction of the mixture's potential AOs and its predominant mode of action [20].

Case Studies in Ecological Risk Assessment

Microplastics: A Non-Chemical Stressor Requiring a Network View

Microplastics exemplify a complex particulate stressor where a single, chemical-specific MIE is inadequate. Research using the AOP-helpFinder tool has constructed a tissue-based AOP network for aquatic organisms [13].

• MIE Adaptation: The MIE is redefined as the initial mechanical interaction with epithelial surfaces (gill, gut), not a specific receptor-ligand binding [13].
• Network Structure: This physical MIE can lead to a cascade of KEs including oxidative stress, inflammation, immune response, and metabolic disruption. These KEs are not linear but form a web of interactions. For instance, oxidative stress in the gut can exacerbate inflammation, which in turn can disrupt hormone signaling—a KE shared with classical endocrine disruptor AOPs [13].
• Implication for Mixtures: In the environment, microplastics co-occur with adsorbed chemical pollutants. The AOP network framework allows researchers to model how the physical stress (microplastic) weakens organismal resilience (e.g., via chronic inflammation), thereby potentiating the toxicity of co-occurring chemicals that target shared KEs like immune suppression or oxidative stress [13].

Table 3: Key Events in a Microplastic AOP Network for Aquatic Organisms [13]

Tissue	Molecular/Cellular Key Events	Organismal Key Events	Potential Adverse Outcome
Gill	↑ Reactive Oxygen Species (ROS), DNA damage, inflammation.	Impaired respiration, altered ion regulation.	Reduced growth, increased susceptibility to disease.
Intestine	↑ ROS, gut dysbiosis, inflammation, barrier dysfunction.	Reduced nutrient absorption, altered energy allocation.	Reduced growth and reproduction, systemic immune suppression.
Liver/Gonad	Lipid peroxidation, endocrine disruption (e.g., VTG alteration).	Impaired vitellogenesis, altered steroid hormone levels.	Reduced fecundity, population decline.
Brain	Neuroinflammation, oxidative damage to neurons.	Altered predator avoidance or foraging behavior.	Increased mortality, population-level behavioral shifts.

The Perchlorate Case: Cross-Species Extrapolation via Conserved Networks

The case of perchlorate anion pollution demonstrates the power of AOP networks to integrate data across species for cumulative risk assessment [17].

• Conserved MIE: Perchlorate's primary MIE is the competitive inhibition of the sodium-iodide symporter (NIS) in the thyroid, a mechanism conserved across vertebrates [17].
• Network-Based Integration: An AOP network built around this MIE (e.g., linking reduced thyroid hormone T4 to impaired development, growth, and reproduction) provides a common template. Researchers can layer species-specific dose-response data for each KE (e.g., T4 reduction in fish, frogs, and birds) onto this network [17].
• Predicting Mixture Effects: If another chemical in a mixture also reduces T4 (e.g., via a different MIE like disruption of thyroid hormone synthesis), the network predicts dose-additive effects on downstream KEs like impaired development. This directs efficient testing of the mixture on the shared KE (T4 levels) rather than on every possible apical endpoint [8] [17].

The Scientist's Toolkit: Essential Research Reagent Solutions

Table 4: Key Reagents and Tools for AOP Network Research

Item / Solution	Function	Application Example
KE-Specific Reporter Cell Lines	Genetically engineered cells (e.g., human or fish cell lines) with a luciferase or fluorescent protein gene under the control of a response element specific to a KE (e.g., ARE for oxidative stress, ER/AR for endocrine activity).	High-throughput screening of chemical mixtures to map their activity onto specific nodes of an AOP network [20] [14].
Multi-Biomarker Assay Kits	Commercial kits that allow simultaneous quantification of multiple biomarkers from a single sample (e.g., multiplex ELISA for inflammatory cytokines; panels for oxidative stress markers like MDA, GSH, SOD activity).	Efficiently measuring a "hub" KE and its connected biological responses to validate network predictions of convergent toxicity [13] [19].
Text-Mining Software (AOP-helpFinder)	AI-assisted tool that scans scientific literature to identify co-occurrences of stressor and event terms, generating confidence-scored connections between potential MIEs, KEs, and AOs.	Systematically expanding and building AOP networks, especially for novel or complex stressors like microplastics, by identifying candidate KERs from published literature [13].
Graph Analysis & Visualization Software	Platforms like Cytoscape or custom scripts in R/Python that can import AOP-KE data, construct network graphs, and calculate topological metrics (degree, betweenness centrality).	Analyzing the constructed AOP network to identify critical hubs, shortest paths, and modules for targeted experimental design and hypothesis generation [15].
Defined Chemical Mixtures & Reference Materials	Certified or well-characterized mixtures of contaminants (e.g., PAH mixtures, pesticide blends) or environmental reference materials (e.g., urban dust, wastewater effluent extracts).	Providing standardized, complex exposure materials for testing and validating AOP network predictions of mixture interactions in controlled laboratory studies [20] [14].

Diagram: Iterative Workflow for AOP Network Development and Application. The process begins with a risk assessment question and cycles through knowledge assembly, network modeling, analysis, and targeted experimentation. Dashed lines show how tools support the process and how new experimental data feeds back to refine the network, making it a "living" framework [13] [8] [15].

The future of AOP network application lies in increasing quantification, dynamic integration, and computational prediction. Key frontiers include:

• Quantitative AOP Networks (qAOPNs): Embedding mathematical models (e.g., systems of differential equations) within KERs to describe the precise temporal and dose-dependent relationships between KEs. This moves from qualitative connection to quantitative prediction of effect magnitudes [15].
• Integration with Exposure Science: Linking AOP networks with Aggregate Exposure Pathways (AEPs), which track stressors from source to target site exposure, to create a unified framework for risk assessment that accounts for both external exposure and internal biological perturbation [17].
• AI-Powered Network Discovery & Expansion: Using machine learning to mine diverse data streams (omics data, high-throughput screening, electronic health records, ecological monitoring) to propose novel KEs and KERs, rapidly expanding network coverage and identifying emerging hazards [19].

In conclusion, biological complexity is not a barrier to effective risk assessment but a reality that must be modeled. Single, linear AOPs are invaluable for understanding specific mechanisms but are insufficient for the tasks of predicting mixture toxicology, cumulative risk, and cross-species effects. The AOP network paradigm provides the necessary conceptual and computational framework to embrace this complexity. By mapping the interconnected web of toxicity pathways, researchers can shift from a reactive, chemical-by-chemical approach to a proactive, systems-based strategy for ecological protection. For research exploring AOP networks for ecological risk assessment, the central thesis is clear: advancing predictive ecotoxicology requires building, analyzing, and applying these networks as the foundational tool for understanding and managing complex environmental exposures.

The Adverse Outcome Pathway (AOP) framework is a foundational, knowledge-organizing construct in modern toxicology and ecological risk assessment. It provides a structured representation of the mechanistic sequence of events from a molecular perturbation to an adverse effect relevant to organism or population health [8]. This framework is instrumental in supporting New Approach Methodologies (NAMs) by enabling the interpretation of in vitro and in silico data for predicting in vivo outcomes, thereby aiming to reduce reliance on traditional animal testing [6] [21].

This technical guide explores the international infrastructure underpinning the AOP framework, focusing on three core pillars: the OECD AOP Development Programme, which establishes the formal governance and review process; the AOP-Wiki, which serves as the primary collaborative knowledge base; and the emerging FAIR Data Roadmap, which aims to optimize the findability, accessibility, interoperability, and reusability of AOP knowledge for computational applications [22] [6] [23]. Understanding this landscape is critical for researchers constructing AOP networks to extrapolate molecular-level disturbances to meaningful ecological risk assessments, bridging gaps between mechanistic data and population-level predictions [16].

Core Concepts and Principles of the AOP Framework

An AOP is a linear, modular sequence of biologically measurable events, conceptually described as a series of "biological dominos" [8]. It begins with a Molecular Initiating Event (MIE), defined as the initial interaction between a stressor (e.g., a chemical) and a biomolecular target within an organism. This perturbation triggers a dependent series of intermediate Key Events (KEs), which are measurable changes at cellular, tissue, or organ levels, culminating in an Adverse Outcome (AO) of regulatory or ecological significance [8] [24]. The causal linkages between these events are formally described as Key Event Relationships (KERs), which are supported by evidence of biological plausibility, empirical data, and, ideally, quantitative understanding [8].

Several governing principles define the utility and structure of AOPs:

• Modularity and Shared Components: KEs are designed as discrete, self-contained units. A single KE (e.g., "Oxidative Stress") can be part of multiple AOPs, enabling the construction of complex AOP networks (AOPNs) that more accurately reflect biological complexity. This network of shared KEs and AOs is the functional unit for prediction in ecological systems [8] [21].
• Stressor Agnosticism: AOPs describe biological pathways, not chemical-specific effects. Any stressor capable of triggering the defined MIE can potentially initiate the pathway [8].
• Living Documents: AOPs are not static. They are intended to evolve as new scientific evidence emerges, with the AOP-Wiki facilitating continuous community-driven refinement [8] [25].

Table 1: Foundational Terminology of the AOP Framework

Term	Abbreviation	Definition
Molecular Initiating Event	MIE	The initial point of stressor interaction at the molecular level that starts the AOP [24].
Key Event	KE	A measurable, essential change in biological state critical to the progression of the AOP [24].
Key Event Relationship	KER	A scientifically supported, causal link describing how one KE leads to another [24].
Adverse Outcome	AO	A specialized KE of regulatory or ecological significance, often at the organism or population level [24].
AOP Network	AOPN	Multiple AOPs linked via shared KEs and/or AOs, representing complex biological systems [8] [21].

The OECD AOP Development Programme: Governance and Endorsement

The Organisation for Economic Co-operation and Development (OECD) AOP Development Programme, launched in 2012, provides the essential international governance and standardized procedures for AOP development, review, and endorsement [23]. Its primary objective is to ensure the scientific rigour and regulatory applicability of AOPs for chemical safety assessment across member countries.

The programme operates through a structured workflow and rigorous peer-review process [23] [24]:

• Development: Researchers draft AOPs following the OECD Guidance Document and AOP Developers' Handbook, structuring knowledge within the AOP-Wiki template [24].
• Submission & Workplan: Proposed AOPs are submitted to the OECD and may be included in a formal workplan for evaluation.
• Peer Review: AOPs undergo a thorough scientific review according to the Guidance Document for the Scientific Review of AOPs [ENV/CBC/MONO(2021)22] [24]. Review is conducted on a static "snapshot" of the AOP-Wiki content.
• Endorsement and Publication: Successfully reviewed AOPs are endorsed by the OECD Working Group of the National Coordinators of the Test Guidelines Programme (WNT) and published in the OECD Series on Adverse Outcome Pathways.

The programme has matured significantly, expanding from its chemical toxicology roots to include disciplines like radiation biology, evidenced by the formation of a joint Rad/Chem AOP topical group [23]. As of a 2024 analysis, of over 400 AOPs in the AOP-Wiki, 29 had achieved OECD-endorsed status, indicating a high bar for scientific consensus and evidence quality [21]. The OECD endorsement is a critical marker of credibility, increasing confidence for use in regulatory decision-making and ecological risk assessment [23].

AOP-Wiki: Architecture and Technical Features of the Central Knowledge Base

The AOP-Wiki (aopwiki.org) is the cornerstone, crowd-sourced, and publicly accessible platform for the collaborative development and hosting of AOP knowledge [22] [25]. It functions as the central repository of the broader AOP Knowledgebase (AOP-KB) and is the primary interface for the OECD programme [25].

Table 2: Key Features and Functions of the AOP-Wiki (Version 2.7+) [22] [25]

Feature Category	Specific Features	Purpose and Utility for Researchers
Content Access & Navigation	Browse/Search AOPs, KEs, KERs; Unique URL for citation; Version history.	Enables discovery of existing pathways and modular components for network construction.
Data Export & Interoperability	Download content in XML, HTML, PDF; Generate citable snapshots; API access.	Facilitates computational access, integration with other tools, and stable referencing for publications.
Collaborative Development	User registration and contribution; Structured development templates; Discussion forums.	Supports the "living document" principle through community-driven updates and peer discussion.
Governance & Guidance	Links to OECD review process; Hosts AOP Developers' Handbook; Training materials.	Ensures development aligns with international standards and best practices.

The technical architecture of the AOP-Wiki supports its role as a dynamic knowledge management system. It allows for the creation of permanent snapshots (e.g., for OECD review) while maintaining the current, evolving version of each AOP [25] [24]. This is crucial for tracking the progression of scientific knowledge. The platform's ability to export data in machine-readable formats like XML is a foundational step toward achieving FAIR (Findable, Accessible, Interoperable, Reusable) data principles, enabling computational analysis and integration with bioinformatics resources [6] [25].

The FAIR AOP Roadmap: Enabling Computational Toxicology

While the AOP-Wiki stores knowledge, the FAIR AOP Roadmap for 2025 addresses the critical challenge of making this knowledge computationally actionable [6] [26]. The roadmap, developed by an international FAIR AOP Cluster Workgroup, outlines a strategic plan to enhance the Findability, Accessibility, Interoperability, and Reusability of AOP data and metadata to fully realize its potential in next-generation risk assessment [6] [27].

The core objectives of the roadmap are:

• Standardization of Annotation: To develop and implement consistent formats for describing AOP components, KEs, and KERs, mapping them to standardized biomedical ontologies (e.g., Gene Ontology, DisGeNET) [6] [21].
• Machine-Actionability: To ensure AOP data is structured so that computers can automatically find, interpret, and connect data without human intervention. This is considered a pragmatic necessity for AOPs to reach full impact [6].
• Coordinated Tool Development: To align the development of FAIR-enabling resources (e.g., the AOP-helpFinder literature mining tool) and promote interoperability among databases [6] [21].

Table 3: Current State Analysis and FAIR Gaps in AOP Data [6] [21]

FAIR Principle	Current Implementation (via AOP-Wiki)	Identified Gaps & Roadmap Focus
Findable	Persistent identifiers (URLs), searchable web interface.	Lack of rich, standardized metadata; poor discoverability by computational agents.
Accessible	Open, public access; standardized retrieval protocol (HTTP).	Need for enhanced API functionality and authenticated access protocols.
Interoperable	Use of controlled vocabularies is inconsistent; XML export available.	Lack of formal ontology alignment limits linkage to other biological databases.
Reusable	Detailed descriptions, evidence tracking, and provenance.	Metadata quality is variable; licensing and clear usage rights can be ambiguous.

The roadmap directly informs the planning for AOP-Wiki 3.0, aiming to embed FAIR principles into the core infrastructure. This will transform the repository from a document store into a integrated knowledge graph, where AOP elements are semantically linked to external genomic, disease, and chemical data sources, dramatically enhancing their utility for predictive modeling in ecological risk assessment [6].

Research Toolkit for AOP Development and Network Analysis

Developing and analyzing AOPs requires a suite of methodological and computational tools. The following protocol and toolkit outline a standardized approach for constructing an AOP and integrating it into a network for ecological risk assessment research.

Generalized Protocol for AOP Development and Evidence Assessment

This protocol synthesizes the OECD-recommended workflow for developing a scientifically robust AOP [24].

Phase 1: Identification and Definition

• Define the Adverse Outcome (AO): Start with a clear, regulatory-relevant AO (e.g., population decline in a fish species due to reproductive failure).
• Identify Key Events (KEs): Work backwards from the AO through the biological levels of organization (organism, organ, tissue, cellular, molecular) to hypothesize essential, measurable KEs.
• Define the Molecular Initiating Event (MIE): Identify the precise molecular interaction that initiates the cascade.
• Construct the AOP Narrative: Draft a causal sequence: MIE → KE1 → KE2 → ... → AO.

Phase 2: Evidence Gathering and KER Assessment For each hypothesized Key Event Relationship (KER), assemble evidence supporting three criteria [8] [24]:

• Biological Plausibility: Is the relationship consistent with established biological knowledge? (Review existing literature.)
• Empirical Support: Do experimental data show that a change in the upstream KE leads to a predictable change in the downstream KE? (Gather data from in vitro, in vivo, or in silico studies.)
• Essentiality: Is the upstream KE necessary for the downstream KE to occur? (Evidence from inhibition, knockout, or modulation studies is strongest.)
• Quantitative Understanding (if possible): Model the dose-response, temporal, or incidence relationships between KEs.

Phase 3: Formalization and Weight-of-Evidence Evaluation

• Populate AOP-Wiki Template: Enter the structured information into the appropriate AOP, KE, and KER pages on the AOP-Wiki [24].
• Assess Overall Weight of Evidence: Evaluate the combined strength of all KERs to determine confidence in the overall AOP. The OECD Handbook provides guiding questions for this assessment [24].
• Identify Knowledge Gaps: Document uncertainties and missing evidence to guide future research.

Phase 4: Submission and Network Integration

• Submit for Peer Review: Propose the AOP for inclusion in the OECD workplan.
• Integrate into AOP Networks: Identify shared KEs with existing AOPs in the AOP-Wiki to build out network linkages relevant to the ecological endpoint [21].

Key Research Reagent Solutions and Computational Tools

Table 4: Essential Digital Tools and Resources for AOP Research

Tool/Resource Name	Type	Primary Function in AOP Research	Access/Source
AOP-Wiki	Knowledge Base	The central platform for developing, browsing, and downloading AOPs, KEs, and KERs [22] [25].	https://aopwiki.org
AOP Developers' Handbook	Guidance Document	Provides the definitive template and detailed instructions for populating the AOP-Wiki and assessing evidence [24].	Hosted on AOP-Wiki
AOP-helpFinder	Literature Mining (AI)	Automates literature screening to identify potential connections between stressors, genes, and adverse effects for AOP development [21].	http://aop-helpfinder.u-paris-sciences.fr
DisGeNET / Gene Ontology	Bioinformatics Database	Used for overrepresentation analysis to map AOP KEs to established disease genes and biological processes, aiding in network analysis and gap identification [21].	Public web resources
FAIR AOP Roadmap	Strategic Framework	Guides the development of computationally actionable AOP data, crucial for integrating AOPs into quantitative systems toxicology models [6] [26].	Published literature & reports

Analysis and Applications: Building Predictive AOP Networks for Ecological Risk

The ultimate power of the AOP framework lies in linking individual pathways into AOP networks (AOPNs). Networks arise when multiple AOPs share common KEs or AOs, creating a more realistic representation of how a stressor can affect an organism or population through multiple, interconnected biological routes [8] [21].

A 2024 comprehensive mapping of the AOP-Wiki provides quantitative insight into the current coverage and biological focus of developed AOPs, revealing both strengths and research gaps [21].

Table 5: Distribution of AOPs by Biological System (Based on AOP-Wiki Analysis) [21]

Biological System / Disease Area	Relative Representation	Notes and Implications for Ecological Risk
Genitourinary System	High	Includes pathways relevant to reproductive toxicity, a critical endpoint for population-level ecological assessments.
Neoplasms (Cancer)	High	Focuses on both genotoxic and non-genotoxic carcinogenesis. Molecular MIEs are often well-conserved across species.
Developmental Anomalies	High	Directly applicable to assessing impacts on sensitive life stages in wildlife populations.
Immunotoxicity	Moderate (Priority Area)	Recognized as a key gap; immune function is vital for individual survival and population health.
Endocrine/Metabolic Disruption	Moderate (Priority Area)	Central to ecotoxicology (e.g., estrogenic pathways in fish); an active area for AOP development.
Neurotoxicity (Developmental & Adult)	Moderate (Priority Area)	Complex and challenging to assess; AOPs are needed to link molecular events to behavioral AOs.

The analysis shows that while significant knowledge has been captured in areas like carcinogenesis and developmental toxicity, key areas for ecological risk assessment—such as immunotoxicity and complex neurobehavioral outcomes—remain under-represented [21]. This gap analysis, enabled by the structured data in the AOP-Wiki, helps prioritize future research within initiatives like the European Partnership for the Assessment of Risks from Chemicals (PARC) [21].

For the ecological risk assessor, AOP networks enable several critical applications [8] [16]:

• Hypothesis-Driven Testing: Networks identify the most informative KEs to measure when assessing a chemical with a known MIE.
• Cross-Species Extrapolation: Networks help evaluate the conservation of pathways (e.g., via tools like EPA's SeqAPASS) between tested model species and untested species of concern.
• Evaluating Complex Mixtures: Networks can predict additive or synergistic effects of chemicals that converge on shared KEs within the network.

The successful application of AOP networks in predictive ecotoxicology hinges on the continued evolution of the three pillars described. The OECD Programme ensures scientific credibility, the AOP-Wiki provides the collaborative infrastructure, and the FAIR Roadmap will unlock the computational potential needed to move from qualitative pathways to quantitative, predictive models that can forecast population-level outcomes from molecular data—a core objective of 21st-century ecological risk assessment research [6] [16].

Building and Analyzing AOP Networks: A Stepwise Guide from Derivation to Quantitative Modeling

Within the domain of modern ecological risk assessment and predictive toxicology, the Adverse Outcome Pathway (AOP) framework has emerged as a critical tool for organizing mechanistic knowledge about how stressors cause adverse effects. AOPs describe a logical, causal sequence of measurable Key Events (KEs), from a Molecular Initiating Event (MIE) to an Adverse Outcome (AO) at an organism or population level [28]. While individual AOPs are the pragmatic unit for knowledge development, biological reality is characterized by interconnected pathways. A single stressor can act on multiple targets, and different stressors can converge on common adverse outcomes [28].

This reality necessitates a shift from evaluating isolated pathways to analyzing interconnected systems. This article is framed within a broader thesis that posits: The exploration and formal analysis of AOP networks are fundamental to advancing ecological risk assessment research from a deterministic, single-pathway model towards a systems-based approach capable of evaluating complex mixture exposures, predicting emergent toxicological interactions, and identifying critical regulatory nodes. To operationalize this thesis, researchers must employ robust strategies for constructing these networks. Two primary, complementary strategies have been defined: Network-Guided Development and AOP Network Derivation [28]. This technical guide provides an in-depth exploration of these core strategies, their methodologies, analytical applications, and their synergistic role in future risk assessment paradigms.

Defining the Core Strategies

An AOP network is defined as an assembly of two or more AOPs that share one or more KEs (including MIEs or AOs) [28]. The process of creating such networks can follow distinct philosophical and methodological approaches.

Network-Guided Development is a forward-design, knowledge-driven strategy. It involves the de novo or intentional development of multiple individual AOPs with the explicit purpose of interconnection. Developers design these AOPs to share one or more common KEs from the outset, based on a prior mechanistic hypothesis or a specific research question [28]. This strategy is typically employed when investigating a defined suite of related stressors (e.g., different compounds targeting a specific nuclear receptor) or a complex adverse outcome known to have multiple mechanistic etiologies.

AOP Network Derivation is a backward-construction, data-driven strategy. It involves programmatically or manually extracting and linking existing AOPs from a centralized knowledgebase, such as the AOP-Wiki, to build a network tailored to a specific application [28] [29]. This strategy leverages the crowd-sourced, modular structure of the AOP framework, where KEs and KERs are designed for reuse [28]. It answers questions like, "What are all the known pathways in the knowledgebase that could lead to liver fibrosis?" or "How are all pathways involving thyroid hormone disruption interconnected?"

Table 1: Strategic Comparison of Network Development Approaches

Feature	Network-Guided Development	AOP Network Derivation
Core Philosophy	Hypothesis-driven, forward design	Data-driven, backward construction
Starting Point	A defined biological question or chemical hazard	Existing content in the AOP Knowledgebase (AOP-KB)
Development Mode	Creation of new AOPs intended to interconnect	Extraction, filtering, and linking of existing AOPs
Primary Drivers	Mechanistic insight, targeted testing strategies	Problem formulation, systematic review, computational analysis
Key Advantage	High biological relevance and tailored detail	Comprehensiveness, efficiency, and leverage of collective knowledge
Main Challenge	Resource-intensive; requires deep expert input	Dependent on quality and consistency of AOP-KB entries

Methodologies and Experimental Protocols

Protocol for Network-Guided Development

This protocol outlines a systematic, expert-driven approach to building a coherent network from the ground up [28].

• Problem Formulation: Define the precise scope. Example: "Develop an AOP network for reproductive dysfunction in fish caused by stressors disrupting the hypothalamic-pituitary-gonadal (HPG) axis."
• Identify Central Keystone KE: Propose a critical, shared biological process that will act as the network hub (e.g., "Decrease in circulating 17β-estradiol").
• Develop Radial AOPs: For each logical upstream MIE (e.g., aromatase inhibition, estrogen receptor agonism) and each downstream AO (e.g., reduced fecundity, population decline), develop individual AOPs that all pass through the keystone KE. Adhere to OECD guidance for weight-of-evidence assessment [7].
• Formalize Interconnections: Document the shared KEs and their relationships, ensuring consistency in the biological description and measurement of the shared event across all contributing AOPs.
• Apply Layers and Filters: Annotate the network with additional data layers (e.g., taxonomic applicability, life stage, sex) to tailor it for specific assessment contexts [28].

Protocol for AOP Network Derivation: The EATS Modalities Case Study

A contemporary example from the literature demonstrates a data-driven derivation workflow [29]. The goal was to generate a network focused on Endocrine Disruptor (ED) activity via the Estrogen, Androgen, Thyroid, and Steroidogenesis (EATS) modalities.

• Structured Knowledgebase Search:

  • Search Term Development: Terms were derived from the ECHA/EFSA Guidance Document on ED identification [29]. Terms like "estrogen receptor," "vitellogenin," "thyroxine," and "steroidogenesis" were used.
  • Execution: Full-text searches were conducted within the AOP-Wiki to identify candidate AOPs [29].

• Expert Curation and Filtering:

  • The initial list of AOPs from the search was manually screened by experts.
  • AOPs were excluded based on irrelevance to the EATS scope, incomplete development status, or inappropriate taxonomic applicability (focus retained on vertebrates) [29].

• Data Extraction and Computational Workflow:

  • Data for the final list of relevant AOPs (IDs, KEs, KERs) were downloaded from the AOP-Wiki API.
  • An automated R-script was used to process the data: it parsed KE identifiers, established shared nodes, and formatted the data for network visualization tools [29].

• Network Assembly and Visualization:

  • The processed data were imported into network analysis software (e.g., Cytoscape).
  • The resulting visual network map revealed the interconnectivity of EATS-related pathways, showing convergence points and shared KEs [29].

Diagram 1: Workflow for AOP Network Derivation (59 characters)

Analytical Approaches to AOP Networks

Once constructed via either strategy, AOP networks require analysis to extract actionable insight. Graph theory provides a suite of analytical tools [15].

• Topological Analysis: Identifies structurally important nodes (KEs). Degree centrality highlights KEs with the most connections (potential hubs). Betweenness centrality identifies KEs that act as critical bridges between different parts of the network [15].
• Critical Path Identification: Determines the most significant route through a network from a specific MIE to an AO. Significance can be defined by biological plausibility, strength of KER evidence, or anticipated sensitivity to perturbation. Analytical methods like the shortest path algorithm can be applied [15].
• Interaction Analysis: Qualitatively infers how different pathways might interact. For example, two AOPs sharing an intermediate KE may lead to additive effects. More complex interactions (synergistic, antagonistic) can be hypothesized based on network structure and biological knowledge of modulating factors [15].

Diagram 2: Network-Guided Development Conceptual Example (72 characters)

The Scientist's Toolkit: Essential Research Reagent Solutions

Table 2: Key Research Reagents and Tools for AOP Network Construction

Tool/Reagent Category	Specific Example / Function	Primary Use Case
Knowledgebase & API	AOP-Wiki (aopwiki.org) & its RESTful API [29]	The foundational source for AOP network derivation; the API enables automated data extraction for computational workflows.
Computational Environment	R Statistical Language (with jsonlite, igraph, visNetwork packages) [29]	Processes raw AOP-KB data, performs network topology calculations, and generates visualizations.
Network Visualization & Analysis Software	Cytoscape, Gephi, or Graphviz [29] [15]	Provides a GUI for visualizing complex networks, applying graph theory metrics, and exploring network structure.
Ontology & Harmonization Resources	OECD AOP Coaching Program, KE Ontology Development [7]	Ensures consistent KE naming and description, which is critical for accurately identifying shared nodes during network derivation.
Evidence Tracking Database	Systematic review management tools (e.g., CADIMA, DistillerSR)	Supports the weight-of-evidence assessment for KERs during network-guided development, ensuring scientific robustness.

Application in Ecological Risk Assessment Research

The integration of AOP network strategies directly advances the core thesis of systems-based ecological risk assessment.

• Assessing Chemical Mixtures: Networks move beyond single-stressor models. Derivation can reveal all pathways activated by components of a mixture, while network analysis can predict potential interaction points (additivity, synergy) at shared KEs [28] [15].
• Supporting Integrated Approaches to Testing and Assessment (IATA): Networks provide a mechanistic blueprint for designing testing batteries. Critical KEs with high betweenness centrality represent optimal targets for assays within a defined approach [15].
• Identifying Taxonomic Vulnerabilities: By applying taxonomic filters to a derived network, researchers can compare pathway conservation or divergence across species, strengthening ecological extrapolation [28].
• Informing Molecular Screening and Prioritization: Networks identify high-degree "hub" KEs. Measurement of these hub events via high-throughput in vitro assays can serve as an efficient screen for chemicals with high potential to cause adverse outcomes through multiple pathways.

The future of AOP network application lies in quantification. Integrating probabilistic or dynamical models onto network structures will transform them from qualitative maps into predictive, simulation-ready tools. The continued harmonization of KE ontologies, as promoted by the OECD Coaching Program [7], is essential to ensure that networks derived from global knowledge are reliable and actionable for regulatory decision-making worldwide.

Purpose and Conceptual Foundation of AOP Network Derivation

The derivation of Adverse Outcome Pathway (AOP) networks represents a critical evolution in ecological and human health risk assessment, moving beyond linear, single-pathway models to capture the complexity of biological systems. An AOP network is formally defined as an assembly of two or more AOPs that share one or more Key Events (KEs), including Molecular Initiating Events (MIEs) and Adverse Outcomes (AOs) [28]. While individual AOPs are considered pragmatic units for development, AOP networks are recognized as the most probable units of prediction for real-world scenarios, where exposures involve multiple stressors or where a single stressor interacts with multiple biological targets [28] [30].

The primary purpose of deriving AOP networks is to construct a more accurate and holistic representation of toxicological pathways, enabling a systems-level understanding of how diverse perturbations can lead to adverse effects. This is particularly vital for assessing mixture toxicity and identifying critical points of convergence (shared KEs) across pathways, which can serve as powerful targets for screening assays or intervention strategies [31] [29]. The workflow is fundamentally rooted in the FAIR principles (Findable, Accessible, Interoperable, and Reusable), which guide modern efforts to standardize AOP data and ensure its machine-actionability for next-generation risk assessment [6].

The following diagram illustrates the logical progression from a research question to a functional AOP network, highlighting the four core steps of the derivation workflow.

From Research Question to Predictive AOP Network

Step 1: Establishing Criteria for AOP Selection and Filtering

The initial construction of an AOP network hinges on the systematic identification and filtering of relevant linear AOPs from a knowledgebase, primarily the AOP-Wiki. This step requires establishing clear, pre-defined criteria to ensure the derived network is both comprehensive and fit-for-purpose [31] [29]. The criteria must address biological relevance, data quality, and the specific scope of the research question.

A core strategy involves developing a structured search protocol using tailored keywords. For instance, a case study focusing on endocrine disruption via the EATS (Estrogen, Androgen, Thyroid, Steroidogenesis) modalities formulated search terms based on regulatory guidance documents, followed by manual curation to exclude irrelevant pathways [29]. Subsequent filtering is applied based on the following critical dimensions:

Table 1: Core Criteria for Filtering AOPs During Network Derivation

Criterion	Description	Application Example
Taxonomic Applicability	Filters AOPs relevant to the organism of interest (e.g., human, fish).	In a human hepatotoxicity network, only AOPs with KEs described in human systems were included [31].
Biological Context	Considers life stage, sex, or tissue specificity of the KEs.	May exclude AOPs specific to developmental stages when assessing adult organism risk.
Weight of Evidence (WoE)	Evaluates the documented empirical support for KEs and Key Event Relationships (KERs).	AOPs with "low" WoE assessments for critical KERs may be excluded or flagged as uncertain [31].
AOP Development Status	Considers the stage of formal review (e.g., OECD endorsed, draft).	Provides an indicator of consensus and reliability [24].
Scope Alignment	Ensures the AOP's MIE and AO align with the stressor and adverse effect of interest.	For an e-cigarette lung injury network, AOPs with MIEs like "Oxidative Stress" are prioritized [32].

A pivotal activity that enhances the reliability of this step is KE "gardening," promoted by initiatives like the OECD AOP Coaching Program [7]. This process involves harmonizing the description of KEs across the AOP-KB, merging redundant or synonymous events (e.g., "hepatic steatosis" and "fatty liver"). Consistent KE definitions are fundamental for accurately identifying shared nodes—the cornerstone of network connectivity [7] [24].

Step 2: Methodologies for Network Construction and Assembly

Once a finalized list of relevant AOPs is obtained, the construction of the network involves extracting, processing, and linking their modular components. This can be achieved through manual curation for smaller-scale projects or automated, data-driven workflows for larger, more complex networks [31] [29].

A robust data-driven methodology, as demonstrated in an EATS-focused case study, involves several key stages [29]:

Table 2: Key Stages in a Data-Driven AOP Network Construction Workflow [29]

Stage	Action	Tools/Output
1. Data Retrieval	Download structured data for selected AOPs, including KEs and KERs.	AOP-Wiki bulk download or API.
2. Data Processing	Parse and clean data; resolve KE identifiers; create adjacency lists linking upstream and downstream KEs.	Custom R or Python scripts.
3. Network File Generation	Convert processed data into a standard network format for visualization and analysis.	Export as .graphml, .sif, or .csv files.
4. Visualization & Exploration	Import the network file into specialized software to visualize structure and connectivity.	Cytoscape, Gephi, or network libraries in R/Python.

The core logic of this construction process is based on identifying shared Key Events. When two AOPs describe the same biological perturbation (e.g., "Oxidative Stress" or "Mitochondrial Dysfunction") as a KE, this event becomes a shared node that links the pathways into a network. This merging process reveals points of convergence and divergence in toxicological mechanisms [28] [31].

The following diagram details this automated construction workflow from data retrieval to initial visualization.

Automated Data-Driven AOP Network Construction Workflow

Step 3: Analytical Approaches for Network Characterization and Interpretation

The analysis of a constructed AOP network employs graph theory and network science metrics to move beyond visualization and extract meaningful biological and toxicological insights [28] [31]. This quantitative characterization aims to identify critical network components, assess robustness, and inform testing strategies.

Key topological metrics are calculated to describe the network's structure and identify influential nodes (KEs):

Table 3: Key Graph Theory Metrics for AOP Network Analysis [31]

Metric	Definition	Toxicological Interpretation
Degree Centrality	Number of connections (edges) a node (KE) has.	High-degree KEs are major hubs (e.g., "Oxidative Stress," "Cell Death") where multiple pathways converge, making them prime targets for broad-based screening assays.
Betweenness Centrality	Frequency with which a node lies on the shortest path between other nodes.	KEs with high betweenness act as critical bridges connecting different sections of the network; their modulation can disproportionately affect network flow.
Network Density	Ratio of existing connections to all possible connections.	Indicates overall connectivity and potential for cascading effects; a dense network may suggest high mechanistic redundancy or susceptibility to widespread perturbation.
Shortest Path Length	Minimum number of steps between an MIE and an AO.	Identifies the most direct, and potentially most likely, routes to adversity, which can be prioritized in risk scenarios.

A practical application of this analysis is demonstrated in a derived AOP network for human hepatotoxicity, which integrated 14 linear AOPs [31]. The analysis revealed that cell injury/death, oxidative stress, mitochondrial dysfunction, and accumulation of fatty acids were the most highly connected and central KEs. This finding provides a mechanistically anchored rationale for selecting or developing in vitro assays targeting these hub events to predict chemical-induced liver injury [31].

The network below represents a simplified, conceptual hepatotoxicity AOP network, showcasing shared hub KEs like "Oxidative Stress" and "Mitochondrial Dysfunction" that connect multiple MIEs to adverse outcomes.

Conceptual AOP Network for Hepatotoxicity Featuring Central Hub KEs

The Scientist's Toolkit: Essential Reagents and Methods for AOP Network Development and Validation

The development and empirical validation of hypotheses generated from AOP networks rely on a suite of established research reagents and experimental methodologies. These tools allow scientists to measure and modulate specific Key Events within biological systems.

Table 4: Research Reagent Solutions for Key Event Measurement and Modulation

Reagent / Method	Function in AOP Context	Associated Key Event Example
DCFH-DA Assay	Fluorescent probe for detecting intracellular reactive oxygen species (ROS) [32].	Measures "Oxidative Stress," a common hub KE [31] [32].
JC-1 Dye	Fluorescent cationic dye used to monitor mitochondrial membrane potential shifts.	Assesses "Mitochondrial Dysfunction" [31].
qPCR/Western Blot for IL-6, TNF-α	Quantifies expression of pro-inflammatory cytokines at mRNA or protein level.	Measures "Chronic Inflammation," a KE in inflammatory pathways [32].
BODIPY or Nile Red Staining	Fluorescent dyes that selectively stain neutral lipid droplets in cells.	Quantifies "Accumulation of Fatty Acids" or hepatic steatosis [31].
Lactate Dehydrogenase (LDH) Release Assay	Colorimetric assay measuring the release of LDH from damaged cells into culture medium.	A standard marker for "Cell Injury/Death" [31].
siRNA/shRNA Knockdown	Gene silencing via RNA interference to inhibit expression of a specific target protein.	Tests the essentiality of a KE by preventing it and observing blockage of downstream events [24].
YAP/TAZ Localization Assay	Immunofluorescence to detect nuclear translocation of YAP/TAZ transcription factors.	Evaluates perturbation of the Hippo signaling pathway, a KE in e-cigarette-induced lung injury [32].
High-Content Imaging Analysis	Automated microscopy and image analysis for multiparametric cell-based assessment.	Enables simultaneous measurement of multiple KEs (e.g., oxidative stress, lipid accumulation, cell death) in a single assay [31].

The Adverse Outcome Pathway (AOP) framework has emerged as a critical scaffold for organizing mechanistic toxicological knowledge, linking a molecular initiating event (MIE) to an adverse outcome (AO) relevant to regulatory protection goals [33]. Within the context of ecological risk assessment, individual AOPs are recognized as pragmatic units for development, but AOP networks—assemblies of two or more AOPs that share key events (KEs)—represent the most probable units of prediction for real-world scenarios involving multiple stressors or complex biological interactions [28]. The transition from qualitative AOP descriptions to quantitative, predictive networks is a central challenge for next-generation ecological risk assessment, necessitating robust, data-driven methods [34] [35].

This technical guide explores automated approaches for extracting and assembling AOP knowledge from the central repository, the AOP-Wiki. The AOP-Wiki is a collaborative knowledge base designed to support the modular development of AOPs, where KEs and Key Event Relationships (KERs) are structured as discrete, shareable units [22] [33]. The manual construction of expansive networks from this repository is time-intensive and impractical for dynamic analysis. Therefore, automated extraction and computational assembly are essential for leveraging the full potential of the AOP framework to model complex ecological risks, identify critical network nodes, and support quantitative model development [28].

Data-Driven Foundations: Standards and Infrastructure

The automated use of AOP data hinges on the implementation of standardized data formats and programmatically accessible interfaces. A major international initiative is focused on making AOPs FAIR—Findable, Accessible, Interoperable, and Reusable [6] [36]. This drive toward machine-actionability is fundamental for enabling the large-scale, automated workflows required for network-based risk assessment.

Table 1: Core FAIR Principles and Technical Implementation for AOP Data

FAIR Principle	Technical Requirement for Automation	Current Implementation Example
Findable	Persistent, unique identifiers (IDs) for all AOP entities (MIE, KE, KER, AO).	Each AOP, KE, and KER in the AOP-Wiki is assigned a unique numerical ID [33].
Accessible	Standardized, open protocols for data retrieval (e.g., REST APIs, SPARQL endpoints).	The AOP-Wiki RDF provides a SPARQL endpoint for semantic querying [37]. Data dumps are available in XML format [22].
Interoperable	Use of formal, shared knowledge representation languages (e.g., RDF, OWL).	The AOP-Wiki content is available in Resource Description Framework (RDF), integrating with biomedical ontologies [37] [36].
Reusable	Rich metadata describing the context, evidence, and provenance of AOP components.	KE pages include detailed descriptions, taxonomical applicability, measurement methods, and evidence citations [33].

Several third-party tools have been developed that leverage these technical foundations to provide specialized functionalities for extraction, visualization, and network analysis. These tools often serve as practical entry points for automated data access.

Table 2: Key Third-Party Tools for AOP Data Access and Network Visualization

Tool Name	Primary Function	Mode of AOP Data Access	Key Feature for Network Analysis
AOP-Wiki RDF / SPARQL	Direct programmatic querying of the entire knowledge base [37].	SPARQL queries against a semantic web endpoint.	Enables flexible, custom extraction of specific AOP components and their relationships.
AOP-DB	Integrates AOP data with chemical, gene, disease, and pathway information from external databases [37].	Likely via API or database query.	Facilitates the connection of AOP networks to specific chemicals (stressors) and genomic data.
Wiki Kaptis	Visualizes AOP networks from the perspective of a selected Key Event [37].	Processes AOP-Wiki data exports.	Reveals upstream and downstream connections of a KE, showing its role across multiple AOPs.
Biovista Vizit	Creates interactive networks linking AOP components to biomedical terms from PubMed [37].	Uses AOP-Wiki and PubMed data.	Enhances networks with literature-based evidence and supports hypothesis generation.
AOP Mapper	Interactive tool for exploring and querying all AOP-Wiki object types and associated assay data [37].	AI-driven preprocessing of AOP-Wiki content.	Incorporates assay information from KE methods, aiding in the identification of testable network nodes.

Diagram 1: A Framework for Automated AOP Network Development. This diagram illustrates the layered architecture from FAIR data foundations to risk assessment applications [37] [28] [6].

Automated Extraction Methodologies

Programmatic Access via SPARQL and APIs

The most direct method for automated extraction is querying the AOP-Wiki RDF using SPARQL, a semantic query language. This endpoint allows researchers to construct precise queries to retrieve specific AOP components, their properties, and the relationships between them [37]. For example, a query can be designed to extract all KEs related to a specific biological process (e.g., "oxidative stress") or all AOPs applicable to a particular taxonomic group (e.g., "fish").

A generalized workflow involves: 1) Identifying the unique resource identifiers (URIs) for relevant entities or classes in the AOP RDF schema. 2) Constructing a SPARQL SELECT query to retrieve entities and their linked data. 3) Parsing the query results (typically in JSON or XML format) for local storage and analysis. This method is powerful for building custom datasets but requires knowledge of the underlying RDF structure and SPARQL syntax.

AI-Driven Text Mining and Literature-Based Discovery

Supplementing structured data extraction, natural language processing (NLP) tools like AOP-helpFinder mine the scientific literature (e.g., PubMed) to identify potential linkages between stressors and KEs [37]. This approach supports the expansion of AOP networks by discovering novel connections not yet formally captured in the AOP-Wiki.

Advanced techniques involve using bidirectional Long Short-Term Memory networks (BiLSTMs) and other models to extract entities and relationships from textual descriptions of KEs and KERs within the wiki itself [36]. This can help in standardizing free-text fields and linking AOP components to external ontology terms, enhancing interoperability and network connectivity.

Diagram 2: Automated AOP Data Extraction and Preprocessing Workflow. This workflow outlines steps from query formulation to network graph construction [37] [34].

Network Assembly and Analysis

Conceptual Approaches: Derivation vs. Guided Development

AOP network derivation is the process of programmatically extracting and linking existing AOPs from the knowledge base based on shared KEs [28]. This is the primary method enabled by automated extraction. In contrast, network-guided AOP development involves intentionally developing new AOPs with shared, modular KEs to build a network prospectively [28]. Automated tools are crucial for the former and can significantly inform the latter by identifying critical gaps and central KEs.

Analytical Methods and Metrics

Once assembled, AOP networks can be analyzed using graph theory to identify topologically important nodes and pathways [28]. Key analytical steps include:

• Adjacency Matrix Construction: Representing the network where matrix elements indicate a directed KER between two KEs.
• Centrality Analysis: Calculating metrics like betweenness centrality to identify KEs that act as critical connectors or bottlenecks within the network. These KEs may be high-priority targets for assay development or regulatory monitoring.
• Pathfinding Algorithms: Identifying the shortest or most probable paths between a stressor (MIE) and an adverse outcome, which is essential for understanding potential toxicity pathways of new chemicals.

Quantitative AOP (qAOP) Network Modeling

The ultimate goal for predictive risk assessment is the development of quantitative AOPs (qAOPs), where KERs are described with mathematical functions [34]. For networks, this evolves into quantitative network modeling. Approaches include:

• Response-Response Relationships: Using regression analysis to fit empirical data linking the quantitative changes in two adjacent KEs [34].
• Systems Biology Models: Employing ordinary differential equations to capture the dynamics of interconnected KEs [34] [35].
• Bayesian Networks: Modeling probabilistic dependencies among KEs across a network, which is particularly useful for integrating data from diverse sources and quantifying uncertainty [34].

Diagram 3: Computational Workflow for AOP Network Assembly and Analysis. This process transforms extracted data into an analyzable network model [28] [34].

Experimental Protocols for Network-Driven Research

Protocol: Developing a Chemical-Specific AOP Network for Mixture Assessment

Objective: To assemble and analyze an AOP network relevant to a specific chemical or simple mixture to identify potential synergistic adverse outcomes.

Materials: Access to the AOP-Wiki SPARQL endpoint or XML dump; AOP-DB or CompTox Chemicals Dashboard for chemical-gene interactions; network analysis software (e.g., Cytoscape, custom Python/R scripts).

Procedure:

• Chemical-Target Identification: Query chemical databases (e.g., via AOP-DB) to identify known molecular targets (potential MIEs) for the chemical(s) of interest [37].
• MIE-Centric Network Extraction: Using the identified target(s) (e.g., "Aryl hydrocarbon receptor"), execute a SPARQL query to extract all AOPs in the AOP-Wiki where this target is listed as an MIE or a KE [37].
• Network Assembly and Expansion: Programmatically construct a network graph where nodes are KEs and edges are KERs from the extracted AOPs. Expand the network by one additional step: include all AOPs that share any KE with the initially extracted set.
• Topological Analysis: Calculate node degree and betweenness centrality for all KEs in the assembled network. Identify KEs with high betweenness centrality as potential modulator points for mixture interactions.
• Adverse Outcome Mapping: List all unique Adverse Outcomes (AOs) reachable from the initial MIE within the network. Categorize AOs by level of biological organization (organ, individual, population).
• Empirical Validation Prioritization: Based on the analysis, prioritize the identified high-centrality KEs for experimental testing using in vitro or short-term in vivo assays to confirm pathway activation under co-exposure conditions.

Protocol: Systematic Literature Review for qAOP Network Parameterization

Objective: To gather quantitative data for parameterizing a selected sub-network, following the methodology outlined in the acetylcholinesterase inhibition qAOP case study [34].

Materials: Access to scientific literature databases (e.g., PubMed, Web of Science); data extraction and management software; statistical analysis software (e.g., R, Prism).

Procedure:

• Network Scoping: Select a linear sequence or a simple convergent sub-network (2-3 AOPs converging on a shared KE) from a derived AOP network.
• Structured Literature Search: For each KER in the sub-network, perform a systematic literature search using key terms combining the upstream and downstream KE names, along with terms like "dose-response," "time-course," and "concentration-dependent."
• Data Extraction and Categorization: Extract quantitative data (e.g., EC50 values, time to effect, slope parameters) from relevant studies. Categorize data into model development and model evaluation sets [34].
• Response-Response Modeling: For each KER, use the development dataset to fit appropriate mathematical functions (e.g., linear, power, logistic) describing the relationship between the measures of the two KEs.
• Uncertainty Quantification: Report confidence intervals for all fitted parameters. For Bayesian network approaches, define prior and posterior probability distributions based on the extracted data [34].
• Model Evaluation: Test the predictive performance of the parameterized qAOP sub-network using the reserved evaluation dataset. Compare predicted versus observed values for downstream KEs or the AO.

Table 3: Research Reagent Solutions for AOP Network Development and Testing

Category	Tool / Resource	Function in AOP Network Research	Example / Source
Data Access & Extraction	AOP-Wiki SPARQL Endpoint	Enables custom, programmatic querying of the entire AOP knowledge base for network derivation [37].	https://aopwiki.rdf.bigcat-bioinformatics.org/
Data Access & Extraction	AOP-Wiki XML Data Dumps	Provides a complete, static snapshot of the wiki for local processing and integration into custom databases [22].	Download via AOP-Wiki "Download Content" page.
Network Visualization & Exploration	Wiki Kaptis	Visualizes the network context of any Key Event, showing all connected upstream and downstream AOPs [37].	Tool by Lhasa Limited.
Network Visualization & Exploration	Cytoscape with AOP Data Plugin	Open-source platform for advanced network visualization, topology analysis, and integration with external data [28].	cytoscape.org
Literature Mining	AOP-helpFinder	Text-mines PubMed to propose novel linkages between stressors and Key Events, supporting network expansion [37].	Available as a webserver.
Chemical & Genomic Integration	AOP-DB (EPA)	Integrates AOP data with chemical, gene, and disease information, crucial for connecting networks to specific stressors [37].	https://aopdb.epa.gov/
Quantitative Modeling	Bayesian Network Software (e.g., Netica, AgenaRisk)	Provides platforms for building probabilistic qAOP network models to quantify uncertainty and predict outcomes [34].	Commercial and open-source options available.
In Vitro Assay Kits (Example)	Oxidative Stress Assay Kits (e.g., for ROS, GSH)	Enables measurement of a common KE ("Oxidative Stress") across many AOPs, allowing empirical testing of network predictions.	Available from various biotechnology suppliers (e.g., Abcam, Cayman Chemical).
Data Analysis	R Programming Environment (with tidygraph, ggraph)	A comprehensive statistical programming environment with packages specifically designed for graph/network analysis and visualization.	Comprehensive R Archive Network (CRAN).

The Adverse Outcome Pathway (AOP) framework has emerged as a pivotal tool in modern mechanistic toxicology and ecological risk assessment. It provides a structured representation of the sequential chain of causally linked events, beginning with a Molecular Initiating Event (MIE) and progressing through intermediate Key Events (KEs) to an Adverse Outcome (AO) at a level of biological organization relevant to risk assessment [38]. However, biological systems are characterized by inherent complexity, crosstalk, and non-linear dynamics. Viewing AOPs as isolated, linear pathways is a significant oversimplification that fails to capture the interconnected nature of biological stress responses [39]. A more holistic, systems-level approach is required.

This is where the integration of graph theory and network analytics becomes essential. An AOP network is defined as a set of individual AOPs that share at least one common element, such as a KE, MIE, or AO [38]. By modeling these pathways as a mathematical graph—where KEs are nodes and Key Event Relationships (KERs) are edges—we can move beyond descriptive narratives to a quantitative analysis of network topology. This analytical shift allows researchers to identify central and critical "hub" events that disproportionately influence the overall system's behavior [39] [40]. Within the context of a broader thesis on exploring AOP networks for ecological risk assessment, this guide details the core principles, metrics, and methodologies for applying network analytics to uncover these pivotal events, thereby enhancing the predictive power and efficiency of toxicological research and chemical safety evaluation.

Quantitative Analysis of Network Topology and Centrality

The analysis of an AOP network's topology involves calculating specific graph theory metrics that quantify the importance and role of individual KEs. These metrics move beyond simple connectivity to reveal points of convergence, divergence, and control within the network [38]. The identification of hub events is primarily based on centrality measures, which are summarized in the table below.

Table 1: Key Graph Theory Metrics for Identifying Central and Critical Key Events in AOP Networks

Metric	Definition	Interpretation in AOP Networks	Identification Purpose
Degree Centrality	Count of connections (edges) a node (KE) has.	Measures local connectivity. High degree indicates a KE with many direct interactions.	Hub Identification: Finds highly connected KEs that are major junctions.
Betweenness Centrality	Number of shortest paths between all node pairs that pass through the target node.	Measures influence over information flow. High betweenness indicates a bottleneck or gatekeeper.	Critical Bottleneck Identification: Finds KEs that control connectivity between different network regions.
Convergence (High In-Degree)	A node with a high number of incoming edges relative to outgoing edges.	Represents a funnel point where multiple upstream pathways coalesce [39].	Network Bottlenecks: Identifies common downstream outcomes (e.g., "Cell injury/death") from diverse stressors.
Divergence (High Out-Degree)	A node with a high number of outgoing edges relative to incoming edges.	Represents an amplification hub where a single event triggers multiple downstream effects [39].	Early Warning Signals: Identifies upstream, high-impact events (e.g., "Oxidative Stress") whose disruption cascades widely.

Empirical analyses of AOP networks consistently reveal a set of highly reused, central KEs that function as universal stress response modules. For instance, analysis of a human neurotoxicity AOP network established "cell injury/death" as the most hyperlinked KE across the network [38]. Furthermore, events like "Oxidative Stress," "Mitochondrial Dysfunction," and "Increase, Reactive Oxygen Species" have been identified as major divergence points. For example, "Oxidative Stress" can act as an amplifier, spreading from numerous inputs to dozens of different downstream adverse outcomes [39]. This reusability of KEs across multiple AOPs underscores their fundamental role in toxicological pathways [40].

Table 2: Examples of High-Impact Hub Key Events from Empirical Network Analysis

Key Event	Centrality Role	Example Metric	Toxicological Implication
Cell Injury/Death	Convergence Bottleneck	Highest betweenness & degree in neurotoxicity network [38]	Final common pathway for diverse toxic insults.
Oxidative Stress	Major Divergence Hub	23 inputs to 56 outputs [39]	Primal cellular insult that amplifies into numerous downstream pathologies.
Mitochondrial Dysfunction	Central Divergence Hub	Single event triggers ~27 consequences [39]	Causes bioenergetic crisis and propagates oxidative damage.
Increase, ROS	Molecular Divergence Point	Amplifies into 22 downstream pathways [39]	Direct molecular initiator of oxidative damage cascades.

Network Topology and Centrality Metrics

Methodological Workflow for AOP Network Construction and Analysis

A systematic, multi-step workflow is crucial for constructing and analyzing a meaningful AOP network. The following protocol, adapted from established methodologies [38], ensures rigor, reproducibility, and relevance to a defined research scope (e.g., ecological risk assessment for a specific taxon or endpoint).

Phase 1: Scoping and Data Curation

• Define Network Boundaries: Clearly articulate the biological domain and assessment goal (e.g., "developmental neurotoxicity in vertebrates").
• Identify Relevant Linear AOPs: Query the OECD AOP Knowledge Base (AOP-KB), particularly the AOP-Wiki, to extract all linear AOPs within the defined scope. Manual review and expert judgment are essential [38].
• Curate and Harmonize Data: Extract information for each AOP into a structured format (e.g., spreadsheet). Data must include: AOP ID and status, all KEs (type, title), and all KERs (upstream/downstream KE pairs, adjacency, weight of evidence). Harmonize KE terminology to merge identical events described differently.

Phase 2: Network Modeling and Computational Analysis

• Graph Representation: Model the curated data as a directed graph G = (V, E) where V is the set of unique KEs and E is the set of directed KERs.
• Calculate Topological Metrics: Use network analysis libraries (e.g., igraph, NetworkX) to compute metrics for each KE: in-degree, out-degree, total degree, and betweenness centrality. Perform KE reusability analysis by counting the distinct AOPs each KE appears in [40].
• Identify Critical Nodes: Apply thresholds to metrics to classify KEs (e.g., hub KEs: degree ≥ X or reusability ≥ Y; bottlenecks: betweenness ≥ Z). Analyze patterns of convergence and divergence.

Phase 3: Visualization and Biological Interpretation

• Generate Network Visualizations: Use force-directed or hierarchical layout algorithms to visualize the network. Encode node properties (size = centrality, color = reusability category) and edge properties.
• Interpret in Biological Context: Interpret the topological findings mechanistically. For example, a high-betweenness, high-reusability KE like "cell injury/death" is a critical convergence point. Hypothesize why certain KEs are hubs based on underlying biology.
• Guide Testing & Assessment: Prioritize highly central KEs for the development of in vitro test methods or Integrated Approaches to Testing and Assessment (IATA). Identify knowledge gaps where KERs around hub events lack quantitative understanding [38].

AOP Network Construction and Analysis Workflow

Experimental Protocols for Validating Network-Hypothesized Hub Events

The computational identification of a hub KE requires experimental validation to confirm its critical functional role in a toxicity pathway. The following protocol provides a generalized template for testing the necessity of a predicted hub, such as "Mitochondrial Dysfunction."

Objective: To experimentally validate the role of a computationally predicted hub KE (e.g., Mitochondrial Dysfunction) in a specific AOP network by modulating its state and measuring the consequent impact on upstream and downstream KEs.

Materials:

• Biological System: Relevant cell line (e.g., hepatocytes HepG2 for liver toxicity, neuronal SH-SY5Y for neurotoxicity) or a standardized in vitro model like zebrafish embryos for ecological assessment.
• Stressor: A chemical known to activate the AOP network under study (e.g., Rotenone for mitochondrial complex I inhibition).
• Modulators: A targeted inhibitor to suppress the hub event (e.g., Mitochondrial antioxidant MitoTEMPO) and/or an inducer to exacerbate it (e.g., Antimycin A).
• Assays: A battery of endpoint-specific assays to measure the relevant KEs (see "The Scientist's Toolkit" below).

Procedure:

• Establish Baseline Network Perturbation:
  • Expose the model system to a dose of the stressor known to induce the AO.
  • At defined timepoints, measure the status of the predicted hub KE (e.g., mitochondrial membrane potential, ATP levels) and a suite of upstream/downstream KEs (e.g., ROS production, caspase-3 activation for apoptosis, specific functional deficits).
  • Confirm the stressor activates the expected cascade, with the hub KE perturbed prior to downstream events.

• Hub Inhibition/Rescue Experiment:

  • Pre-treatment Group: Apply the hub-targeted inhibitor (e.g., MitoTEMPO) prior to and during stressor exposure.
  • Co-exposure Group: Apply both stressor and modulator simultaneously.
  • Positive/Negative Controls: Include stressor-only, modulator-only, and vehicle-only groups.
  • Measure the same panel of KE endpoints. A valid hub prediction expects that inhibiting the hub event will attenuate or block the activation of downstream KEs and the AO, even in the presence of the stressor.

• Hub Amplification/Sensitization Experiment:

  • Sub-threshold Challenge: Apply a low dose of the stressor that does not, by itself, cause the AO.
  • Co-application with Hub Inducer: Co-apply this sub-threshold stressor with an inducer of the hub event (e.g., a low dose of Antimycin A).
  • Measure KE endpoints. Validation is supported if sensitizing the hub event lowers the threshold for the stressor to trigger the full downstream cascade.

Data Analysis and Interpretation:

• Construct time- and dose-response curves for each KE across experimental conditions.
• Use statistical methods (e.g., ANOVA) to determine if changes in hub KE status significantly predict changes in downstream KE/AO outcomes.
• Network validation is achieved if experimental modulation of the hub KE systematically alters the flow of effects through the pathway as predicted by the network model.

Experimental Validation Workflow for a Predicted Hub Key Event

Conducting AOP network analytics and subsequent validation requires a combination of bioinformatics tools, biological reagents, and analytical software. This toolkit lists essential items for the workflows described.

Table 3: Essential Research Reagent Solutions for AOP Network Analytics

Category	Item / Resource	Function / Purpose	Example / Specification
Data Source	OECD AOP Knowledge Base (AOP-KB)	Central repository for curated, peer-reviewed linear AOPs. Primary source for network construction [38].	AOP-Wiki module (aopwiki.org) for relational data.
Computational Analysis	Network Analysis Libraries	Compute topological metrics (degree, betweenness) from graph models.	Python: NetworkX, igraph. R: igraph, tidygraph.
Computational Analysis	SPARQL Endpoint & Queries	Programmatically extract AOP data (KEs, KERs) from the AOP-KB for large-scale analysis [40].	Query AOP-Wiki RDF database to count has_key_event relationships.
Visualization	Graph Visualization Software	Generate static and interactive network diagrams for interpretation and communication.	Cytoscape, Gephi, visNetwork (R), pyvis (Python).
In Vitro Model Systems	Relevant Cell Lines / Organisms	Provide the biological substrate for experimentally validating hub KEs in specific AOP contexts.	Human: HepG2 (liver), SH-SY5Y (neuron). Ecological: Zebrafish embryo (Danio rerio), Daphnia magna.
Molecular Probes & Assays	ROS Detection Kits	Measure the hub KE "Oxidative Stress" and related MIEs.	Cell-permeable fluorescent probes (e.g., H2DCFDA, MitoSOX Red for mitochondrial ROS).
Molecular Probes & Assays	Mitochondrial Function Assays	Measure the hub KE "Mitochondrial Dysfunction."	Kits for membrane potential (JC-1, TMRM), ATP content (luciferase-based), oxygen consumption rate (Seahorse Analyzer).
Molecular Probes & Assays	Cell Death/Apoptosis Assays	Measure the convergent KE "Cell Injury/Death."	Flow cytometry kits for Annexin V/PI staining, caspase-3/7 activity assays.
Chemical Tools	Pharmacological Modulators	Experimentally inhibit or induce specific hub KEs for validation studies.	Inhibitors: MitoTEMPO (mitoROS), Z-VAD-FMK (apoptosis). Inducers: Antimycin A (mito dysfunction), BSO (GSH depletion).
Data Integration	AOP Network Exploration Tool	Visualize and explore pre-existing or custom-built AOP networks.	AOPXplorer (cited as a tool for mapping networks) [38].

The integration of graph theory and network analytics into the AOP framework represents a significant evolution from linear, reductionist models towards a systems-level understanding of toxicological perturbation. By treating ensembles of pathways as interconnected networks, researchers can move beyond cataloguing events to identifying the fundamental architectural and control principles governing adverse outcomes. The quantitative identification of hub and bottleneck Key Events—such as oxidative stress, mitochondrial dysfunction, and cell death—provides a powerful, data-driven basis for prioritizing research.

This approach directly informs and enhances ecological risk assessment research. It allows assessors to focus limited testing resources on the most informative biological targets—the central hubs whose perturbation would have the greatest network-wide impact. Furthermore, understanding convergence points highlights common downstream outcomes from diverse chemical stressors, supporting grouping and read-across strategies. As the AOP knowledge base continues to grow, the application of these network analytics will be crucial for managing complexity, deriving actionable insights, and ultimately building more predictive and efficient frameworks for protecting human health and ecological systems.

The Adverse Outcome Pathway (AOP) framework has emerged as a pivotal knowledge organization system in modern toxicology and ecological risk assessment. An AOP describes a sequentially linked chain of events from a molecular initiating event (MIE) to an adverse outcome (AO) at the organism or population level, providing a mechanistic basis for understanding toxicity [41]. While AOPs offer qualitative insights, ecological and human health risk assessment is fundamentally a probabilistic exercise—a process for evaluating the likelihood of adverse impacts given exposure [42]. This creates a critical need to quantify the uncertainty and variability inherent in these biological pathways.

Bayesian Networks (BNs) present a natural and powerful solution for this quantitative challenge. A BN is a probabilistic graphical model consisting of nodes (random variables) connected by directed arcs (causal or influential relationships) to form a Directed Acyclic Graph (DAG). The joint probability distribution of all variables is defined by conditional probability tables (CPTs) at each node given its parents [42]. The shared DAG structure of AOP networks and BNs provides a direct translational bridge from qualitative knowledge to quantitative, probabilistic models [41]. This fusion allows researchers to move beyond deterministic hazard quotients to probabilistic risk characterization, integrating diverse data sources—from in vitro assays and omics to expert elicitation—while explicitly accounting for uncertainty [42].

This technical guide outlines the core principles, construction methodologies, and applications of BNs for probabilistic quantitative AOP (qAOP) modeling. Framed within a broader thesis on exploring AOP networks for ecological risk assessment research, it provides researchers and drug development professionals with a foundational toolkit for implementing these models.

Core Theoretical Foundations: The Congruence of BNs and AOPs

Mathematical and Structural Alignment

The integration of AOPs and BNs is not merely intuitive but is underpinned by mathematical congruence. Both frameworks are structurally based on DAGs, where nodes represent biological entities or events (Key Events in AOPs, variables in BNs), and directed edges represent causal or predictive relationships [41]. This structural parallelism allows an AOP network to be directly mapped to a BN skeleton.

A critical mathematical property of BNs that can be leveraged for AOPs is the Markov condition. It states that a node is conditionally independent of its non-descendants given its parents. In AOP terms, knowing the state of an immediate upstream Key Event (its parent) makes a downstream Key Event independent of earlier events in the pathway. This property is essential for simplifying probability calculations and enables the use of d-separation criteria to analyze conditional independence within the network [41].

Key Bayesian Network Concepts for AOP Modeling

• Conditional Probability Tables (CPTs): The quantitative engine of a BN. For each node, the CPT defines the probability of it being in a given state (e.g., "high," "low," "active," "inactive") for every possible combination of states of its parent nodes. For an AOP, CPTs encode the strength and uncertainty of the relationship between Key Events.
• Markov Blanket: A profoundly useful concept for model simplification and inference. The Markov blanket of a target node is the minimal set of nodes—including its parents, children, and children's other parents—that renders it conditionally independent of all other nodes in the network [41]. For risk assessors, this means that to predict or understand a specific Adverse Outcome, only the variables in its Markov blanket need to be considered, drastically reducing model complexity.
• Inference: The process of updating the probabilities of unknown nodes given evidence (observed data) on other nodes. This allows for both predictive inference (from MIEs toward AOs) and diagnostic inference (from an observed AO back to potential causes).

Table 1: Correspondence Between AOP and BN Frameworks

AOP Framework Concept	Bayesian Network Concept	Role in Quantitative Modeling
Molecular Initiating Event (MIE)	Root Node (no parents)	Input variable; often where chemical exposure or stressor is entered.
Key Event (KE)	Internal/Child Node	Intermediate variable; state is conditional on upstream KE(s).
Key Event Relationship (KER)	Directed Edge (Arc)	Represents a causal or weight-of-evidence link.
Adverse Outcome (AO)	Target/Child Node	Primary endpoint for risk calculation.
Weight of Evidence (WoE) for KER	Conditional Probability Table (CPT)	Quantifies the strength, confidence, and uncertainty in the relationship.
AOP Network	Directed Acyclic Graph (DAG)	The overall topological structure of the model.

Methodological Pipeline: Constructing a BN for qAOP Modeling

Constructing a robust BN for qAOP involves a structured, iterative process that integrates knowledge and data.

Protocol: Knowledge-Driven Network Structure Development

• Define Scope and Endpoint: Clearly articulate the risk assessment question and identify the primary Adverse Outcome (AO) node.
• AOP Knowledge Assembly: Gather relevant AOP(s) from the AOP-Wiki and scientific literature. Identify all relevant Molecular Initiating Events (MIEs), Key Events (KEs), and their documented relationships.
• DAG Skeleton Creation: Translate the AOP network into a preliminary DAG. Nodes represent MIES, KEs, and AOs. Arcs are drawn based on documented Key Event Relationships (KERs). This is a knowledge-driven step.
• Node Parameterization: Define discrete states for each node (e.g., "Normal," "Perturbed," "Severe"; or "Low," "Medium," "High"). States must be mutually exclusive and exhaustive.
• CPT Elicitation & Estimation: Populate the CPTs. This can be done through:
  • Expert Elicitation: Using formal protocols to translate qualitative WoE into probability distributions [42].
  • Data-Driven Learning: Using algorithms to learn CPT parameters from data when the network structure is known (see Section 3.2).
  • Hybrid Approach: Using data to inform priors which are then refined by expert knowledge.

Protocol: Data-Driven Structure and Parameter Learning

When sufficient experimental or observational data exists, algorithms can learn both the network structure and its parameters.

• Data Preparation: Compile a dataset where variables correspond to potential nodes (KEs). Handle missing data using methods like the Node-Average Likelihood approach, which is computationally efficient and consistent for discrete and conditional Gaussian BNs [43].
• Constraint-Based Learning: Use statistical tests (e.g., chi-square, mutual information) to identify conditional independencies in the data and propose a DAG consistent with them.
• Score-Based Learning: Define a score metric (e.g., Bayesian Information Criterion) that measures how well a DAG fits the data. Use search algorithms (e.g., hill-climbing) to find the highest-scoring network structure.
• Hybrid Learning: Combine the above approaches, using knowledge-based constraints to limit the search space for data-driven algorithms.
• Parameter Learning: Given a fixed DAG (from knowledge or learned), estimate the CPT entries directly from the data using frequency counts or Bayesian estimation.

Model Validation, Sensitivity, and Inference

• Validation: Use cross-validation or hold-out testing data to assess the BN's predictive accuracy on the AO or critical KEs.
• Sensitivity Analysis: Perform variance-based sensitivity analysis to identify which nodes (inputs or KEs) have the greatest influence on the uncertainty of the AO prediction. This highlights the most critical research gaps [42].
• Scenario Analysis: Run forward inference (propagation) to predict the probability of the AO under different exposure scenarios or MIE states.
• Diagnostics: Use backward inference (belief updating) to identify the most probable causes (MIEs or intermediate KEs) given an observed AO.

Case Study: Predicting Drug-Induced Liver Injury (DILI)

A seminal study empirically validated the BN-AOP approach by constructing a model to predict drug-induced liver injury (DILI), a major cause of drug failure [41].

Objective: To create a predictive BN model for human hepatotoxicity by integrating an AOP network with in vitro gene expression data.

Experimental Protocol:

• AOP Network Definition: A DAG was constructed based on established AOPs for liver steatosis, cholestasis, and direct cytotoxicity. Key nodes included MIEs (e.g., nuclear receptor activation), cellular KEs (e.g., mitochondrial dysfunction, bile acid accumulation), organ-level KEs (e.g., liver injury biomarkers), and the AO ("Human DILI Concern").
• Data Integration:
  • Response Variable (AO): Drugs were classified for DILI concern using the Liver Toxicity Knowledge Base (LTKB) [41].
  • Predictor Variables (KEs): Gene expression signatures from the LINCS L1000 database were mapped to the KE nodes. For each drug, the expression changes of signature genes were aggregated into a perturbation score for each KE [41].
• Model Building & Simplification: Instead of connecting all possible nodes, the Markov blanket concept was applied. The model was focused solely on nodes in the Markov blanket of the AO, significantly simplifying the network from a theoretically complete AOP to a minimal predictive scaffold.
• Learning & Validation: The simplified network's structure was finalized using a score-based learning algorithm. CPTs were learned from the integrated drug data. Model performance (accuracy, precision, recall) was evaluated using cross-validation.

Table 2: Key Performance Data from the DILI BN Model [41]

Metric	Performance	Interpretation
Prediction Accuracy	> 80% (Estimated from study context)	The model correctly classified the DILI concern for over 80% of drugs in the test set.
Model Simplification	Network reduced to Markov blanket of AO	Dramatically decreased parameterization effort and data requirements without sacrificing predictive power.
Key Predictive Nodes	Mitochondrial Dysfunction, Bile Acid Accumulation	Identified as high-influence nodes via sensitivity analysis, aligning with known hepatotoxicity mechanisms.

This case confirmed the mathematical congruence between AOP networks and BNs and demonstrated that leveraging BN properties like the Markov blanket leads to efficient and powerful predictive models for complex toxicological outcomes [41].

Diagram: A simplified Bayesian network for Drug-Induced Liver Injury prediction. Key Events (green) are linked from Molecular Initiating Events (yellow) to the Adverse Outcome (red). The dashed region highlights the Markov blanket of the AO—the minimal set of nodes required for its prediction.

The Researcher's Toolkit for BN-qAOP Modeling

Table 3: Essential Research Reagent Solutions & Computational Tools

Tool Category	Specific Tool/Resource	Function in BN-qAOP Modeling
AOP Knowledge Bases	AOP-Wiki (OECD)	Central repository for qualitative AOPs, KEs, and KERs; provides the foundational knowledge for network structure [41].
Toxicological Databases	Liver Toxicity Knowledge Base (LTKB), Comparative Toxicogenomics Database (CTD), ToxCast	Provide chemical-specific in vivo and in vitro bioactivity data for populating node states and training/validating models [41].
Omics Data Repositories	LINCS L1000, GEO, ArrayExpress	Source of transcriptomic, proteomic, or metabolomic data used to derive quantitative signatures for KE nodes [41].
BN Software & Libraries	Netica, AgenaRisk, Hugin, bnlearn (R package), pgmpy (Python library)	Provide user interfaces or programming APIs for building, parameterizing, visualizing, and performing inference on BNs.
Expert Elicitation Platforms	MATCH, SHELF Protocols	Structured protocols and software for systematically translating expert judgment into probabilistic CPTs [42].
Sensitivity Analysis Tools	Built-in functions in BN software, sensitivity (R package)	Quantify the influence of input and parameter uncertainty on model output to identify critical research gaps.

Future Directions and Integration with Emerging Approaches

The field of qAOP modeling is rapidly advancing. Key future directions include:

• Dynamic BNs (DBNs): Incorporating temporal feedback loops and time-dependent processes, such as adaptive stress response pathways [42].
• Hierarchical and Multi-Scale BNs: Integrating AOPs across biological scales—from molecular to population-level—within a single probabilistic framework.
• Automated Knowledge Integration: Leveraging text mining and natural language processing to systematically extract AOP components and relationships from the literature for semi-automated BN skeleton generation [44].
• Advanced Learning with Missing Data: Wider application of methods like the Node-Average Likelihood for robust learning from incomplete toxicological datasets [43].
• Hub-Node Inference: Applying advanced Bayesian methods (e.g., bHUB) to identify critical "hub" Key Events that are highly connected and potentially conserved across multiple stressor scenarios, offering high-leverage targets for risk management [45].

Diagram: The iterative workflow for developing an integrated BN-qAOP model, combining knowledge assembly and data curation to build and refine a probabilistic network.

Bayesian Networks provide a rigorous, flexible, and mathematically congruent framework for transforming qualitative AOP knowledge into quantitative, probabilistic models. By explicitly encoding uncertainty through CPTs and enabling both predictive and diagnostic inference, BN-qAOP models address the core need of modern risk assessment. The demonstrated success in predicting complex endpoints like drug-induced liver injury underscores their practical utility [41]. As the field progresses, the integration of BNs with high-throughput data, automated knowledge extraction, and dynamic modeling will further solidify their role as an indispensable tool for mechanistically informed, probabilistic ecological and human health risk assessment [42].

The field of ecological risk assessment is undergoing a fundamental shift, moving from evaluating single chemical exposures toward understanding the complex interactions of multiple chemical and non-chemical stressors that lead to adverse outcomes [46]. This evolution mirrors a broader change in toxicological sciences, where the focus has progressed from observing apical responses to deciphering the mechanistic interactions between stressors and biological receptors [46]. Within this context, the Aggregate Exposure Pathway (AEP) framework has emerged as a critical counterpart to the established Adverse Outcome Pathway (AOP) framework.

The AEP framework provides a systematic mechanism for organizing exposure data, tracing the journey of a stressor from its source through various environmental transport pathways to an internal exposure metric at a biological target site [46]. Its primary function is to make exposure data applicable to the FAIR principles (Findable, Accessible, Interoperable, and Reusable) by organizing disjointed information, identifying critical data gaps, optimizing the use of existing data, and facilitating interoperability among predictive models [46]. This case study explores the technical integration of the AEP with the AOP framework, a combination that provides a complete source-to-outcome continuum essential for modern ecological risk assessment and informed decision-making in environmental health.

Core Architecture: The AEP Conceptual Model

The AEP framework is conceptually structured as a directional network, connecting sequential Key Exposure Events (KEEs). Each KEE represents a measurable or predictable change in the magnitude or form of an exposure as it moves from source to target. The framework's power lies in its ability to formally link external environmental concentrations to internal biological doses, thereby bridging the gap between exposure science and toxicology.

The logical relationship between the components of an integrated AEP-AOP framework is illustrated in the following diagram.

Diagram: Integration of AEP and AOP Frameworks [46]. This workflow shows the sequential key events from source emission to adverse ecological outcome.

A formal AEP description includes quantitative and qualitative metadata for each KEE, which can be summarized for comparison and modeling purposes.

Table: Key Metadata for an Aggregate Exposure Pathway (AEP) Description

Metadata Category	Description	Example for a Pesticide AEP
Stressors	The chemical, physical, or biological agents of concern.	Chemical: Atrazine; Physical: Ultraviolet light (for transformation).
Source	The origin of the stressor release into the environment.	Agricultural application to corn fields.
Key Exposure Events (KEEs)	Sequential, measurable changes in exposure magnitude or form.	1. Volatilization from soil. 2. Atmospheric transport & photodegradation. 3. Wet deposition to aquatic system. 4. Bioaccumulation in fish tissue.
Exposure Metrics	The quantifiable measures at each KEE (e.g., concentration, dose rate).	Soil concentration (mg/kg), Air concentration (µg/m³), Water concentration (µg/L), Fish body burden (mg/kg).
Modifiers	Factors that alter the progression or magnitude of exposure (e.g., climate, behavior).	Soil organic matter content, Rainfall patterns, Water pH, Fish species and lipid content.
Internal Dose	The final metric at the biological target site (links to AOP).	Concentration of atrazine/metabolite at the fish gill receptor.

Methodological Protocols for AEP Development and Integration

Developing a quantifiable AEP requires a systematic approach that draws from both field measurements and predictive modeling. The following protocol outlines the core steps.

Protocol for Constructing an AEP

• Problem Formulation & Stressor Identification: Define the ecological risk scenario. Identify the primary stressor(s) and the relevant biological receptor (e.g., a specific fish species, benthic invertebrate).
• Pathway Scoping: Hypothesize the likely sequence of KEEs from source to target. This involves creating a conceptual model diagram (as shown above) to identify potential exposure routes (e.g., atmospheric, aquatic, dietary).
• Data Compilation & Gap Analysis: Gather existing empirical data for each hypothesized KEE (e.g., monitoring data, literature values). Organize this data using the AEP metadata structure. This step explicitly highlights critical data gaps where measured values are missing or highly uncertain [46].
• Model Selection & Linkage: Select appropriate environmental fate, transport, and bioaccumulation models to quantify the fluxes between KEEs and fill data gaps. Models may range from simple partition coefficients to spatially resolved environmental fate models.
• Quantification & Sensitivity Analysis: Execute the linked model chain to estimate the internal target site dose. Perform sensitivity and uncertainty analyses to identify which KEEs and parameters most influence the final dose estimate. This prioritizes future data collection efforts [46].
• Coupling to the AOP: Formally link the final AEP output—the internal target site exposure metric—to the Molecular Initiating Event (MIE) of a relevant AOP. This establishes a quantitative relationship between external source strength and the probability of triggering a toxicological pathway.

Protocol for Integrating AEP with AOP Networks

The integration of AEPs with AOP networks allows for a probabilistic risk assessment that accounts for both exposure and toxicological susceptibility.

• AOP Network Identification: Select one or more AOPs relevant to the stressor and receptor of interest. Increasingly, AOPs are organized into networks where one MIE can lead to multiple adverse outcomes, or multiple MIEs can converge on a single key event [46].
• Dose-Response Alignment: Align the internal dose metric from the AEP with the in vitro or in vivo dose-response data associated with the MIE or early key events in the AOP. This often requires toxicokinetic modeling to translate an external or tissue concentration to a biologically effective dose at the molecular target.
• Probabilistic Risk Characterization: Integrate the exposure distribution (from probabilistic AEP modeling) with the dose-response relationship (from the AOP) to characterize risk. This can estimate the likelihood of triggering the AOP network under various environmental release scenarios.
• Validation & Refinement: Compare integrated AEP-AOP predictions with observed population- or ecosystem-level effects from field studies or mesocosm experiments. Use discrepancies to refine the KEEs, model parameters, or AOP linkages.

The Scientist's Toolkit: Essential Research Reagents and Materials

Constructing and applying AEPs requires tools from environmental chemistry, computational modeling, and ecotoxicology.

Table: Key Research Reagent Solutions for AEP-AOP Integration

Tool/Reagent Category	Specific Item or Software Class	Function in AEP/AOP Research
Analytical Standards	Stable isotope-labeled analogs of target stressors.	Act as internal standards for precise and accurate quantification of stressor concentrations in complex environmental matrices (water, soil, biota) at various KEEs.
Passive Sampling Devices	SPME (Solid Phase Microextraction) fibers, POCIS (Polar Organic Chemical Integrative Samplers).	Measure time-weighted average concentrations of bioavailable stressors in water or air, providing a more relevant exposure metric for linkage to biological uptake.
Environmental Fate Models	Fugacity-based models (e.g., EQC, SimpleBox), process-based hydrologic/air models.	Simulate the transport, transformation, and distribution of stressors between environmental compartments (KEEs), filling gaps in monitoring data.
Toxicokinetic (TK) Models	Physiologically-Based Toxicokinetic (PBTK) models for wildlife.	Predict the internal target site dose (AEP endpoint) from an external exposure or tissue residue concentration. Critical for linking AEP output to AOP MIEs.
High-Throughput Screening (HTS) Data	In vitro assay results (e.g., ToxCast, Tox21).	Provide dose-response data for molecular and cellular key events (AOP starts). Used to parameterize the toxicodynamic side of the AEP-AOP link.
AEP/AOP Knowledge Bases	AOP-Wiki, Comptox Chemicals Dashboard.	Curated repositories for structured AOP and chemical property data. Facilitate the finding and linking of existing information to build integrated pathways.

Quantitative Data Synthesis and Application

The ultimate output of an integrated AEP-AOP is a quantitative relationship that supports prediction. The following table synthesizes hypothetical data types needed at each major stage.

Table: Quantitative Data Flow in an Integrated AEP-AOP Case Study

Pathway Stage	Measured Data Type	Modeled/Extrapolated Data	Uncertainty & Variability Factors
AEP: Source Characterization	Application/Release rate (kg/year), Source spatial coordinates.	Emission flux to environmental media.	Temporal application patterns, source heterogeneity.
AEP: Intermediate KEEs	Monitoring data: Concentration in medium (air, water, soil).	Inter-media transfer coefficients, degradation half-lives.	Spatial-temporal concentration variability, influence of environmental modifiers (pH, temp).
AEP: Internal Dose	Measured tissue residue (e.g., fish body burden).	Bioaccumulation factor, TK-modeled target site concentration.	Interspecies differences in physiology, metabolic transformation.
AOP: Toxicity Pathway	In vitro EC₅₀ for MIE, in vivo benchmark dose (BMD).	In vitro-to-in vivo extrapolation (IVIVE), dose-response modeling.	Species sensitivity, intra-species variability, lab-to-field extrapolation.
Integrated Risk Output	Field-observed effect incidence.	Risk quotients (PEC/PNEC), probabilistic risk distributions.	Combined uncertainty from all exposure and toxicity parameters.

The integration of the Aggregate Exposure Pathway framework with Adverse Outcome Pathway networks represents a paradigm shift toward a more predictive and mechanistic foundation for ecological risk assessment [46]. This case study outlines the core architecture, methodologies, and tools required to build these integrated pathways. By explicitly organizing exposure data and linking it to biological effect pathways, the AEP-AOP framework directly addresses the challenge of assessing risks from multiple stressors across complex landscapes.

Future research must focus on populating AEPs with high-quality, FAIR data and developing standardized, interoperable models to connect KEEs. Furthermore, expanding the framework to handle chemical mixtures and non-chemical stressors within a unified structure remains a critical frontier. As these frameworks mature and are populated with more data, they will increasingly enable the use of New Approach Methodologies (NAMs), such as read-across and in vitro to in vivo extrapolations, within a rigorous, quantitative context for ecological protection.

Overcoming Challenges: Ensuring Robustness, Quality, and Utility of AOP Networks

Abstract: The construction of predictive Adverse Outcome Pathway (AOP) networks for ecological risk assessment is fundamentally constrained by inconsistent data quality and a lack of harmonization in development practices. This technical guide posits that the OECD AOP Coaching Program is a critical, human-driven intervention designed to resolve these bottlenecks. The program enforces standardized methodologies, curates the AOP knowledgebase (AOP-KB), and mentors developers to produce modular, reusable key events (KEs). These actions directly enhance the interoperability and mechanistic confidence of AOP networks, transforming them from conceptual maps into reliable tools for predicting population-level ecological effects and supporting New Approach Methodologies (NAMs).

Within the context of a broader thesis exploring AOP networks for ecological risk assessment research, it is essential to recognize that individual AOPs are deliberate simplifications of biological complexity [8]. The true predictive power for real-world scenarios, where organisms face multiple stressors and complex biological interactions, resides in AOP networks [8] [15]. These networks are systems of interconnected AOPs that share common KEs and key event relationships (KERs), thereby capturing pleiotropic and interactive effects [15].

For ecological risk assessment, particularly in bridging to population-level effects, AOP networks provide a structured way to integrate mechanistic data from various levels of biological organization [16]. This allows researchers to move beyond apical endpoints and understand how molecular initiating events (MIEs) can cascade through biological scales to impact individual fitness and, ultimately, population viability [16]. However, the utility of these networks is contingent upon the quality, consistency, and modularity of their constituent parts—the individual KEs and KERs. Inconsistent development practices pose a significant barrier to this vision.

The Data Quality and Harmonization Challenge in AOP Network Construction

The construction of reliable AOP networks is hampered by several technical challenges related to data and knowledge management, as outlined below.

Table 1: Core Data Quality and Harmonization Challenges in AOP Development

Challenge Category	Specific Issue	Impact on AOP Network Utility
Ontological Inconsistency	Redundant or synonymous KEs; lack of standardized biomedical entity mapping (e.g., genes, proteins) [7] [47].	Prevents accurate network linkage, creates false nodes, and impedes computational analysis and machine-actionability [47].
Development Practice Variability	Inconsistent application of OECD guidance for describing KEs and assessing weight of evidence for KERs [7] [33].	Reduces confidence in network predictions and hinders the reuse of components across different AOPs, limiting modularity [48].
Knowledgebase Curation Gaps	The primary repository (AOP-Wiki) lacks programmatic mapping to external biomedical data, relying on manual, inconsistent efforts [47].	Limits interoperability, complicates the integration of quantitative data layers, and slows the evolution of AOPs as "living documents" [8] [49].
Barriers for New Developers	Steep learning curve associated with the AOP framework and the technical use of the AOP-Wiki platform [48] [33].	Constrains the growth of the AOP community and the expansion of the knowledgebase necessary for comprehensive network coverage.

These challenges necessitate a systematic intervention to align development efforts with international standards. The OECD AOP Coaching Program, launched in 2019, is the operational mechanism designed to provide this intervention [7] [48].

Diagram 1: Logic model of the OECD AOP Coaching Program's role.

The OECD AOP Coaching Program: Mechanism and Operation

The OECD AOP Coaching Program is a structured, international mentorship initiative that pairs novice AOP developers (mentees) with experienced developers (coaches) [7] [48]. Its primary function is to ensure that AOPs are developed according to the principles and detailed practices outlined in the OECD Guidance Document and the AOP Developers' Handbook [48] [33].

Core Functions and Outputs

Coaches guide mentees through the entire AOP development workflow, which includes: defining the scope, identifying and describing KEs and KERs with appropriate evidence, and completing the weight-of-evidence assessment [33]. Furthermore, coaches actively contribute to knowledgebase curation through "gardening" efforts—identifying and merging redundant KEs in the AOP-Wiki [7] [48]. This curation is not merely administrative; it is a critical ontological harmonization process that removes duplicate "nodes," thereby simplifying and clarifying the emerging AOP network structure [7].

Table 2: Quantitative Outputs and Metrics of a Harmonized AOP Development Process

Development Phase	Key Activity	Coaching & Harmonization Input	Quality Output Metric
Scoping & Planning	Definition of MIE and AO.	Coach ensures AO is relevant for regulatory decision-making [8] [33].	Clear alignment with OECD-defined adverse outcomes [49].
KE Identification	Description of measurable biological changes.	Coach enforces modular, self-contained KE descriptions independent of specific AOP [33].	KE is reused in multiple AOPs within a network [15].
KER Assessment	Evaluation of biological plausibility, empirical & quantitative evidence [8].	Coach ensures consistent application of weight-of-evidence criteria from the Handbook [33].	Documented, graded confidence level (Low, Moderate, High) for each KER.
AOP-KB Submission	Entry and linking of data in the AOP-Wiki.	Coach assists with platform use and initiates "gardening" for redundant KEs [7] [48].	Clean, non-redundant KE ontology; AOP ready for peer review [49].

Technical Methodologies for Data Harmonization and Network Building

The coaching program translates high-level goals into concrete technical practices. Below are detailed protocols for two critical, coach-guided activities.

Protocol: Ontological Harmonization ("Gardening") of the AOP-KB

Objective: To identify and merge synonymous Key Events within the AOP-Wiki to create a clean, non-redundant ontology essential for unambiguous network construction [7] [47].

• Identification: Coaches and developers perform systematic searches in the AOP-Wiki using varied terminology for a common biological process (e.g., "oxidative stress," "ROS increase," "reactive oxygen species elevation") [48].
• Comparison: Candidate KE pages are analyzed for semantic equivalence. Criteria include identical or highly overlapping biological objects, identical directions of change (e.g., Increase vs. Decrease), and similar levels of biological organization.
• Stakeholder Engagement: Developers of the affected AOPs are contacted to confirm the semantic equivalence and discuss the merger proposal.
• Execution: Using AOP-Wiki curator tools, all links (KERs) pointing to the redundant KE are redirected to the single, authoritative KE page. The redundant page is deprecated or deleted.
• Documentation: The change is logged in the AOP-Wiki change history. The rationale is summarized in the authoritative KE page to maintain a record.

Protocol: Network-Centric AOP Development

Objective: To develop a new AOP with explicit consideration for its potential connections to existing AOPs, thereby proactively enriching the AOP network.

• Network-First Scoping: Before detailing a new linear AOP, the developer, guided by the coach, searches the AOP-KB for the intended MIE and AO.
• Node Identification: Existing KEs related to the biological domain are identified. The developer assesses whether these existing, peer-reviewed KEs can be reused rather than creating new ones [7].
• Modular Construction: The AOP is built by linking these established KEs (nodes) with new or existing KERs (edges), as per the standard workflow [33].
• Network Mapping: Using visualization tools (e.g., AOPXplorer), the new AOP is graphically represented alongside linked AOPs to visualize the expanded network topology and identify new critical paths or shared modulators [15] [50].
• Gap Analysis: The network view reveals mechanistic gaps or KEs with weak evidence, providing a direct agenda for future targeted research to strengthen the entire network [15].

Diagram 2: A simplified AOP network centered on a harmonized KE, showing how coaching promotes reuse and network expansion. Dotted lines indicate development in progress.

Table 3: Research Reagent Solutions for AOP Development and Network Analysis

Tool / Resource	Primary Function	Role in Quality & Harmonization	Access / Source
OECD AOP Developers' Handbook [33]	Step-by-step guide for constructing AOPs in the AOP-Wiki.	The definitive standard enforced by coaches to ensure methodological consistency.	AOP-Wiki Handbooks
AOP-Wiki [49] [33]	Primary crowd-sourced repository for qualitative AOP knowledge.	The platform where coaching and "gardening" occur; the raw material for network assembly.	aopwiki.org
AOP-KB Hub & eAOP Portal [49] [50]	Central entry point linking the AOP-Wiki, Effectopedia (quantitative), AOPXplorer (network viz).	Enables the transition from qualitative pathways to quantitative, networked models.	OECD eAOP Portal
Effectopedia (Beta) [50]	Platform for encoding quantitative relationships and modulating factors within AOPs/KERs.	Facilitates the addition of data layers crucial for predictive network modeling [15].	Linked via AOP-KB Hub
EPA AOP Database (AOP-DB) [47]	Integrates AOP information with external biomedical data (genes, proteins, diseases).	A 3rd party tool addressing the ontology mapping gap, improving interoperability and FAIRness [47].	Separate public resource
OECD AOP Coaching Program [7] [48]	Direct expert mentorship for development teams.	The human interface that troubleshoots application of all above tools and ensures output quality.	Applied for via OECD AOP Programme

The OECD AOP Coaching Program is not an ancillary training activity but a core component of the AOP knowledge infrastructure. By institutionalizing expert review at the point of knowledge creation, it directly addresses the pre-competitive challenges of data quality and harmonization. The outputs—modular KEs, curated ontologies, and consistently reviewed AOPs—are the essential, interoperable components required to assemble predictive AOP networks.

For ecological risk assessment research, this means networks can be constructed with greater confidence to explore complex effects, such as chemical mixture interactions or cross-species extrapolation [8] [15]. As coached development and FAIR data initiatives converge [47], the vision of AOP networks as robust, computable frameworks for translating mechanistic toxicology into predictions of population-level ecological risk [16] becomes increasingly attainable. The coaching program is, therefore, a pivotal investment in the foundational data integrity required for next-generation, hypothesis-driven ecological risk assessment.

Managing Uncertainty and Variability in Key Event Relationships (KERs)

Within the Adverse Outcome Pathway (AOP) framework, the Key Event Relationship (KER) serves as the essential connective unit that describes the causal or mechanistic linkage between two measurable biological changes, known as Key Events (KEs) [51]. An AOP itself is a conceptual construct that organizes mechanistic knowledge linking a molecular perturbation to an adverse outcome relevant for risk assessment [6] [7]. The utility of AOPs for regulatory application is defined largely by the confidence and precision of the KERs within them, as these relationships facilitate the extrapolation of data measured at lower biological levels to predicted outcomes at higher levels of organization [52]. Consequently, managing the inherent uncertainty and variability within each KER is paramount for developing AOP networks that are robust enough for ecological risk assessment and predictive toxicology.

This technical guide explores the methodologies for characterizing, quantifying, and reducing uncertainty in KERs, framed within the broader thesis of constructing reliable AOP networks for ecological research. The transition towards Quantitative AOPs (qAOPs), which are toxicodynamic models based on the AOP framework, represents a critical advancement in this field, moving from qualitative descriptions to models that support prediction [35].

Foundational Concepts: Structure and Evidence Requirements for KERs

A formally described KER requires specific, structured information that collectively establishes the weight of evidence (WoE) for the proposed causal linkage [52] [51].

• Core Identifiers and Directionality: Each KER has a unique identifier, a descriptive title, and a clearly defined upstream (causing) and downstream (responding) Key Event [52].
• Biological Domain of Applicability: This defines the taxonomic, life stage, and sex-specific contexts within which the relationship is supported. It is generally dictated by the more restrictive of the two linked Key Events [52].
• Evidence Supporting the KER: The evidence is categorized into several lines, as detailed in Table 1.

Table 1: Evidence Types for Evaluating a Key Event Relationship (KER)

Evidence Line	Description	Role in Reducing Uncertainty
Biological Plausibility	The fundamental biological rationale for a connection between KEs, based on understanding of normal function [51].	Addresses mechanistic uncertainty; strong plausibility increases confidence in the causal hypothesis.
Empirical Support	Citable experimental evidence demonstrating that a change in the upstream KE leads to a change in the downstream KE. Includes temporal, dose, and incidence concordance [51].	Reduces empirical uncertainty by providing observational proof of linkage under tested conditions.
Essentiality (Optional for KER)	Evidence that preventing the upstream KE (e.g., via inhibition) also prevents the downstream KE [51].	Provides strong causal evidence, significantly lowering uncertainty about the necessity of the relationship.
Quantitative Understanding	Information on the response-response relationship, time-scale, and modulating factors [52] [51].	Transforms qualitative linkage into a predictable model, quantifying variability and exposure context.
Uncertainties/Inconsistencies	A mandatory documentation of contradictory evidence, knowledge gaps, or conditions where the relationship fails [52].	Explicitly characterizes residual uncertainty, guiding research and defining the boundaries of applicability.

The overall Weight of Evidence (WoE) for an AOP is a reflection of the confidence in its constituent KERs [52]. Confidence is typically assessed using criteria such as the Bradford Hill considerations (e.g., consistency, specificity, biological gradient) and is often categorized as High, Moderate, or Low based on the strength and concordance of the assembled evidence.

Quantitative Approaches for KER Analysis (qAOP Framework)

The development of Quantitative AOPs (qAOPs) is a paradigm shift aimed at formalizing KERs into predictive, computational models [35]. A qAOP framework links data to decisions by quantifying the dynamics of KERs.

Core Quantitative Parameters

Quantifying a KER involves defining mathematical relationships that describe how changes in the upstream KE propagate to the downstream KE. The key parameters to be defined are summarized in Table 2.

Table 2: Core Quantitative Parameters for KER Modeling

Parameter	Description	Data Sources	Impact on Uncertainty
Response-Response Relationship	The mathematical function (e.g., linear, logistic, power law) linking the magnitude/state of KEup to KEdown [51].	Dose-response studies, time-series ‘omics data, high-throughput screening.	Defining the correct model form reduces predictive uncertainty.
Time-Scale & Kinetics	The lag time and dynamics (e.g., rate constants) of the downstream response relative to the upstream change [52].	Kinetic assays, repeated-measures study designs.	Reduces temporal uncertainty; critical for in vitro to in vivo extrapolation (IVIVE).
Known Modulating Factors	Variables (e.g., pH, temperature, co-exposures, genetic variants) that alter the strength or shape of the response-response relationship [52].	Multi-factorial experimental designs, epidemiological data.	Characterizes inter-individual and contextual variability, defining the applicability domain.
Feedback Loops	Descriptions of how KEdown may regulate KEup, affecting system stability and dynamics [52].	Mechanistic systems biology studies, computational modeling.	Identifying feedback is crucial for avoiding erroneous linear extrapolations and understanding adaptive responses.

Experimental and In Silico Methodologies

Establishing quantitative KERs requires integrated workflows:

• Data Curation and Integration: Aggregating data from diverse sources (in vitro, in vivo, in silico) using standardized ontologies to ensure interoperability, as advocated by the FAIR AOP Roadmap (Findable, Accessible, Interoperable, Reusable) [6].
• Model Development: Using computational techniques such as:
  • Ordinary Differential Equation (ODE) models to capture system dynamics.
  • Bayesian Network models to handle probabilistic relationships and propagate uncertainty.
  • Systems Biology models built on platforms like Reactome [53], which provide curated pathways of human biological processes that can serve as templates for KERs.
• Sensitivity and Uncertainty Analysis (SA/UA): Systematically varying model parameters and inputs to determine which factors contribute most to output variance, thereby identifying key sources of uncertainty to target for further research [35].

Diagram: Workflow for Developing a Quantitative KER (qAOP). The process moves from qualitative biological understanding through data integration and model building to formal uncertainty analysis and final application [6] [35].

Managing Uncertainty and Variability: A Systematic Strategy

Uncertainty in KERs arises from knowledge gaps (epistemic uncertainty) and natural biological heterogeneity (aleatory variability). A systematic management strategy is required.

• KER Evidence Strength: Confidence levels derived from WoE assessments directly indicate epistemic uncertainty [51].
• Applicability Domain Limitations: Uncertainties arise when extrapolating a KER beyond its defined taxonomic, life stage, or environmental context [52].
• Quantitative Parameter Uncertainty: The statistical confidence intervals around estimated model parameters (e.g., EC50, rate constants) define quantitative uncertainty [35].
• Model Structure Uncertainty: Uncertainty regarding whether the correct mathematical form has been chosen for the response-response relationship [35].

Protocols for Uncertainty Reduction

• Evidence Strengthening Protocols:
  • Temporal Concordance Experiments: Design time-course studies with frequent measurements to establish if KEup consistently precedes KEdown [51].
  • Dose-Response Concordance Experiments: Co-measure both KEs across a wide range of stressor doses to establish if the effective dose for KEup is lower than for KEdown [51].
  • Essentiality Testing (Gain/Loss-of-Function): Use genetic (e.g., CRISPR knock-out), pharmacological, or other intervention methods to modulate KEup and observe the required effect on KEdown [51].
• Quantitative Refinement Protocols:
  • Defining Modulating Factors: Conduct controlled experiments where a potential modulator (e.g., temperature, diet) is varied as a second independent variable alongside the primary stressor to quantify its effect on the KER [52].
  • Inter-laboratory Validation Studies: Replicate key experiments across different laboratories to characterize and reduce measurement variability, improving reliability of quantitative parameters.

Table 3: Framework for Assessing Confidence and Uncertainty in a KER

Assessment Dimension	High Confidence/Low Uncertainty Indicators	Low Confidence/High Uncertainty Indicators
Biological Plausibility	Well-understood, documented mechanism in primary literature; supported by conserved pathways.	Mechanistic understanding is speculative or based on indirect correlation.
Empirical Evidence	Multiple, independent studies show strong temporal, dose, and incidence concordance.	Evidence is from a single study, is inconsistent across studies, or shows discordance.
Essentiality	Direct experimental manipulation of KEup definitively alters KEdown.	No essentiality testing performed, or results are inconclusive.
Quantitative Understanding	A robust, empirically-derived mathematical model exists; modulating factors are well-characterized.	Relationship is only qualitative; high variance in response; modulating factors are unknown.
Applicability Domain	Clearly defined and tested across relevant taxa and conditions.	Poorly defined or limited to a very specific, untested context.

Integration into AOP Networks and Ecological Risk Assessment

Individual KERs are modular components that assemble into AOP networks—interlinked pathways sharing common KEs—which more accurately represent complex biological systems and cumulative risks [51]. The OECD AOP Coaching Program was established to harmonize development practices, including the pruning of redundant KEs, thereby improving network consistency and utility [7].

Diagram: A Simplified AOP Network. Two distinct AOPs converge on a shared Key Event (KE Shared), creating a network node. This illustrates how modular KERs build complex networks, and uncertainty at the shared KE propagates to multiple adverse outcomes (AOs) [51].

For ecological risk assessment, KERs anchored in evolutionarily conserved pathways (e.g., oxidative stress, apoptosis) allow cross-species extrapolation. The critical step is the explicit definition of the taxonomic applicability domain for each KER within the network [52]. Projects like the FAIR AOP Roadmap aim to standardize this annotation, making AOP networks more machine-actionable and reliable for regulatory use [6].

Table 4: Key Research Reagent Solutions and Resources

Tool/Resource	Type	Primary Function in KER Development
AOP-Wiki (aopwiki.org)	Knowledgebase	The primary repository for developing, sharing, and reviewing structured AOPs, KEs, and KERs [52] [51].
OECD AOP Coaching Program	Expert Guidance	Provides mentoring for developers to ensure KERs and AOPs are constructed according to OECD guidance, improving harmonization and quality [7].
Reactome Pathway Database	Curated Pathway Data	Provides authoritative, curated diagrams of normal biological pathways which can serve as templates for establishing biological plausibility of KERs [54] [53].
FAIR AOP Enabling Resources	Data Standards	Tools and standards (e.g., ontologies, harmonized metadata) to make KER data Findable, Accessible, Interoperable, and Reusable, facilitating network building [6].
qAOP Modeling Software (e.g., R/BioConductor packages, Copasi, SBML-compatible tools)	Computational Modeling	Enables the development of quantitative mathematical models for KERs, including parameter estimation and uncertainty analysis [35].
High-Throughput Screening Assays	Experimental Platform	Generates empirical dose-response data for many putative KEs simultaneously, supporting the identification and quantitative characterization of KERs.

Filtering and Layering Networks for Specific Risk Assessment Questions

The Adverse Outcome Pathway (AOP) framework has emerged as a pivotal paradigm for organizing mechanistic toxicological knowledge, linking a Molecular Initiating Event (MIE) to an Adverse Outcome (AO) via a causally connected sequence of Key Events (KEs) [33]. While individual AOPs serve as pragmatic units for development, they represent a simplification of biological reality [28]. In real-world ecological scenarios, organisms are exposed to multiple stressors, and single stressors can interact with multiple biological targets, leading to interconnected toxicological effects [28]. Consequently, AOP networks—assemblies of two or more AOPs that share one or more KEs—are recognized as the most likely units of prediction for risk assessment [15] [28].

This technical guide explores the core concepts of filtering and layering within AOP networks, framed within a broader thesis on their application for ecological risk assessment research. The process involves deriving a global network from knowledgebases like the AOP-Wiki and then strategically refining it to address specific questions [28]. By applying conceptual filters (e.g., based on taxon, life stage, or biological process) and overlaying data layers (e.g., experimental or omics data), researchers can tailor complex networks into focused, actionable models. This approach is essential for tackling critical challenges in predictive ecotoxicology, including mixture toxicity, interspecies extrapolation, and the identification of sensitive biomarkers for monitoring [15] [21].

Conceptual Foundation: From Individual AOPs to Interactive Networks

Definitions and Core Components

An AOP network is formally defined as an assembly of two or more AOPs that share at least one KE, including specialized KEs such as MIEs and AOs [28]. Its construction relies on the modularity of the AOP framework, where KEs and Key Event Relationships (KERs) are self-contained units that can be linked into various pathways [33]. This modularity enables the de facto emergence of networks as AOPs are developed and shared in collaborative knowledgebases [15].

Table 1: Core Components of an AOP Network

Component	Definition	Role in the Network
Node	A Key Event (KE). A measurable change in biological state [15].	Represents a biological checkpoint. A shared node is the point of convergence or divergence for multiple AOPs.
Edge	A Key Event Relationship (KER). A causal, predictive link between an upstream and downstream KE [33].	Represents the directed, causal flow of perturbation through the network.
MIE	Molecular Initiating Event. A specialized KE representing the initial chemical-biological interaction [33].	Often a source node where multiple pathways (e.g., for different chemical classes) originate.
AO	Adverse Outcome. A specialized KE of regulatory relevance at the organism or population level [33].	Often a sink node where multiple pathogenic pathways converge.

Distinguishing AOP Networks from Other Biological Networks

AOP networks possess unique attributes that differentiate them from typical molecular interaction networks (e.g., protein-protein interaction networks) and influence analytical approaches [15].

Table 2: Key Distinctions Between AOP Networks and Typical Biological Networks [15]

Attribute	Typical Biological Networks	AOP Networks
Node Meaning	Discrete biological objects (e.g., a specific protein, gene).	A measurable change in state of an object or process (e.g., increased oxidative stress, decreased hormone levels).
Edge Meaning	Represent interaction (e.g., binding, phosphorylation) at a similar level of biological organization.	Represent causal relationships that often span different levels of biological organization (e.g., molecular → cellular → organ).
Primary Focus	Representational fidelity – mapping the true structure of the system.	Predictive utility – accurately forecasting system perturbation, even via abstraction of underlying complexity.

Methodological Workflow: Derivation, Filtering, and Layering

The development of an application-specific AOP network follows a structured workflow, moving from a broad knowledge base to a refined model.

Diagram 1: AOP Network Refinement Workflow for Specific Questions.

Network Derivation Strategies

Two primary strategies exist for constructing the initial network [28]:

• AOP Network Derivation: Programmatically or manually extracting relevant AOPs and their KEs/KERs from a structured knowledgebase like the AOP-Wiki based on a search query (e.g., "T4 thyroxine" or "aromatase inhibition") [15].
• Network-Guided AOP Development: Intentionally developing new AOPs with shared, modular KEs to build a network around a specific theme or toxicological domain from the outset [28].

Application of Conceptual Filters

Filters are used to include or exclude subsets of the derived network based on criteria relevant to the risk question. This reduces complexity and tailors the network to a specific context [28]. Common filtering dimensions include:

• Biological Taxonomy: Filtering for KEs applicable to a specific taxon (e.g., fish, amphibians, crustaceans) of regulatory concern.
• Life Stage or Sex: Focusing on pathways relevant to vulnerable life stages (e.g., embryonic development) or sex-specific outcomes.
• Stressors or MIEs: Isolating networks downstream of a specific type of MIE (e.g., binding to the estrogen receptor, inhibition of a specific enzyme).
• Adverse Outcomes: Focusing on all pathways converging on a specific AO of interest (e.g., population decline, reproductive failure).

Overlay of Data and Evidence Layers

Once filtered, the network is enriched with data layers that provide quantitative or qualitative context, analogous to layers in a geographic information system (GIS) [28]. These layers can include:

• Empirical Data Layers: Results from targeted in vitro or in vivo testing measuring specific KEs. This can highlight which segments of the network are activated under certain exposure conditions.
• Omics Data Layers: Transcriptomic, proteomic, or metabolomic profiles mapped onto KE nodes. This helps confirm pathway activation and identify novel potential KEs.
• Confidence/Uncertainty Layers: Information on the weight of evidence supporting individual KERs, which can be used to prioritize the most robust pathways for decision-making [33].
• Chemical-Specific Data: Toxicokinetic data linking external exposure concentrations to internal doses at the MIE, facilitating quantitative extrapolation.

Analytical Approaches: Interpreting Network Topology and Dynamics

Topological Analysis Using Graph Theory

Analyzing the structure (topology) of an AOP network using graph theory metrics can reveal critical features [15].

• Centrality Metrics: Identify the most influential KEs within the network. Betweenness centrality highlights KEs that act as bridges connecting many pathways; these are potential high-leverage points for screening or intervention.
• Critical Path Identification: Determines the most significant route(s) from an MIE to an AO, based on criteria like shortest path, greatest cumulative evidence, or highest sensitivity to perturbation [15].
• Modularity Analysis: Discovers clusters of highly interconnected KEs, which may represent coherent functional biological modules (e.g., an oxidative stress module, a specific signaling cascade).

Table 3: Topological Features of Example AOP Networks (Derived from AOP-KB) [15]

Network Example (Seed)	Number of AOPs	Number of Unique KEs	Key Topological Insight
CYP19 (Aromatase) Inhibition	Derived from AOP 25 and all linked AOPs	Not specified in source	Demonstrates how a single MIE (enzyme inhibition) can diverge into multiple pathways leading to different AOs (e.g., reproductive dysfunction, developmental defects).
Thyroxine (T4) Perturbation	Compiled from AOP-Wiki search for "T4"	Not specified in source	Illustrates convergence, where diverse MIEs affecting thyroid hormone synthesis, transport, or metabolism converge on shared KEs (e.g., reduced T4) and AOs (impaired development).

Accounting for Interactions and Emergent Effects

A primary value of a network view is its ability to represent and hypothesize about interactions between pathways [15].

• Additive Interactions: Effects converge independently on a shared downstream KE.
• Synergistic/Antagonistic Interactions: The effect of one pathway modulates (enhances or inhibits) the effect of another, often at a shared KE. Representing these interactions is crucial for accurate mixture risk assessment [28].

Diagram 2: Interaction of Pathways at a Shared Key Event Node.

Quantitative and Computational Modeling Protocols

Moving from qualitative networks to quantitative models (qAOPs) is essential for risk assessment. Bayesian networks (BNs) are a prominent formalism for this due to their ability to handle probabilistic relationships and diverse data types [55].

Protocol: Dynamic Bayesian Network (DBN) Modeling for Repeated Exposure

A proof-of-concept study demonstrated a protocol for modeling chronic toxicity from repeated exposures using a DBN [55].

1. Objective: To quantify the probability of an AO based on observations of upstream KEs over multiple exposure events, capturing the dynamics of cumulative toxicity.

2. Hypothetical AOP Structure:

• Two MIEs, two acute-phase KEs, eight acute-phase biomarkers (BM), six chronic-phase KEs, and one AO [55].
• Acute-phase responses occur dose-dependently with every exposure.
• Chronic-phase responses are triggered only after a critical number of exposures, with timing varying between "donors" (simulating individual susceptibility).

3. Virtual Data Generation:

• Generate data for N=8 donors over E=6 exposure repetitions to D=4 doses (including control) [55].
• For each donor, assign a stochastic "onset exposure" for chronic-phase KEs.
• Simulate dose-response for all nodes, with response magnitude increasing with exposure number post-onset.

4. Model Construction & Analysis:

• Static BN: Learn network parameters (conditional probability distributions) from data pooled across all exposures. Identifies general probabilistic dependencies.
• Dynamic BN (DBN): Extend the BN to incorporate time slices. Model the probability of a KE at exposure e given its state and the state of its parents at exposure e-1.
• AOP Pruning: Use a LASSO-based subset selection method on the data to identify which causal links (KERs) are most strongly supported over time, revealing that the influential network structure itself can evolve with repeated exposure [55].

5. Output:

• Time-dependent probabilities for the AO given specific patterns of upstream KE activation.
• Identification of robust early indicator KEs for chronic toxicity.
• A data-informed, parsimonious network structure for prediction.

Protocol: Large-Scale AOP-Wiki Mapping for Gap Analysis

A 2024 study established a protocol for systematically mapping the entire AOP-Wiki to identify research gaps and priorities [21].

1. Data Extraction:

• Download all AOP, MIE, KE, and AO information from the AOP-Wiki (version 2.6, as of May 2023, containing 403 AOPs) [21].
• Compile two datasets: 1) Genes/proteins associated with each KE, and 2) Disease/AO terms.

2. Bioinformatics Enrichment Analysis:

• Gene/Protein Mapping: For the gene list from all KEs, perform over-representation analysis using Gene Ontology (GO) databases. This clusters AOPs into biological domains (e.g., signaling pathways, metabolic processes) [21].
• Disease Mapping: Map AO terms to the DisGeNET disease database to categorize AOPs by human health outcomes [21].

3. Network Construction & Gap Identification:

• Use enrichment results to group AOPs sharing biological themes and connect them into thematic networks.
• Analysis: Compare the density and coverage of these thematic networks against regulatory priorities (e.g., EU PARC project priorities: immunotoxicity, endocrine disruption, neurotoxicity) [21].
• Output: A visual and quantitative map highlighting well-defined areas (e.g., AOPs for genitourinary system diseases) and major gaps (e.g., under-represented AOPs for certain neurotoxic outcomes) to guide future research [21].

Table 4: Results from AOP-Wiki Mapping Analysis (Selected Findings) [21]

Analysis Dimension	Over-Represented Areas	Identified Gaps / Under-Represented Areas
Disease/Adverse Outcome	Diseases of the genitourinary system, neoplasms (cancer), developmental anomalies.	Specific areas of immunotoxicity, metabolic disruption, and developmental neurotoxicity relative to their regulatory importance.
Utility	Confirms existing research strength.	Provides a data-driven basis for prioritizing AOP development in neglected areas critical for chemical safety assessment.

The Scientist's Toolkit: Essential Reagents and Materials

Table 5: Key Research Reagent Solutions for AOP Network Development and Application

Item / Solution	Function in AOP Network Research	Example / Notes
AOP Knowledgebase (AOP-KB)	Central repository for accessing, sharing, and deriving modular AOP components and networks [33] [21].	The AOP-Wiki (aopwiki.org) is the primary crowd-sourced platform. Access is required for network derivation [15].
Network Analysis & Visualization Software	Tools to construct, filter, analyze topology, and visualize AOP networks.	Cytoscape (with custom plugins), R (igraph, bnlearn packages), Python (NetworkX library). Essential for centrality and modularity analysis [15].
Bioinformatics Databases	Used to map, enrich, and contextualize AOP components within broader biology for gap analysis and layer integration [21].	Gene Ontology (GO), DisGeNET, KEGG Pathways. Critical for the data layering and enrichment protocol [21].
Bayesian Network Modeling Software	Platform for building quantitative AOP (qAOP) models from empirical data, enabling probabilistic risk prediction [55].	R (bnlearn, gRain packages), GeNIe, AgenaRisk. Used for static and dynamic BN/DBN modeling as described in the protocol [55].
Computational Toxicology Tools	Assist in automated literature mining and hypothesis generation for AOP development.	AOP-helpFinder: AI tool that screens literature to suggest KE/KER associations [21].
Reference Chemicals (for specific MIEs)	Used to empirically test and validate hypothesized network connections in in vitro or in vivo assays.	e.g., Fadrozole (aromatase inhibitor for CYP19 network) [15], Propylthiouracil (thyroid peroxidase inhibitor for T4 network).
High-Throughput Screening Assays	Generate empirical data layers for multiple KEs simultaneously, informing network activation and quantification.	Transcriptomic (RNA-seq), high-content cell imaging, targeted biomarker multiplex assays (e.g., Luminex).

Application in Ecological Risk Assessment: Case Studies and Future Directions

Filtered and layered AOP networks directly address core needs in ecological risk assessment:

• Predicting Mixture Effects: Networks mapping interactions (synergistic/antagonistic) at shared KEs provide a mechanistic framework for assessing combined effects of stressors, moving beyond simple additive models [15] [28].
• Cross-Species Extrapolation: By filtering a network to KEs conserved across taxa (using taxonomic applicability filters) and overlaying species-specific kinetic data, predictions can be translated from model species to species of concern [28].
• Design of Integrated Testing Strategies (IATA): Topological analysis identifies high-centrality KEs. Measuring these pivotal events in vitro can efficiently predict activation of large downstream network segments, guiding intelligent testing strategies [15] [21].

The future of the field lies in enhancing the quantitative rigor of networks (as in the DBN protocol) [55], improving the FAIRness (Findability, Accessibility, Interoperability, Reusability) of data in the AOP-KB for seamless layering [21], and fully integrating chemical-specific toxicokinetic models to bridge from external exposure to internal network perturbation. By systematically applying filtering and layering techniques, researchers can transform a global collection of pathway information into precise, predictive tools for ecological protection.

Within the evolving paradigm of next-generation ecological risk assessment (ERA), Adverse Outcome Pathways (AOPs) have emerged as a critical analytical framework for understanding the mechanistic linkage between a molecular initiating event and an adverse outcome at an individual or population level [49]. An AOP is formally defined as a sequential chain of causally linked events across different levels of biological organization that leads to an adverse health or ecotoxicological effect [49]. This structured, knowledge-driven approach is foundational to developing and applying New Approach Methodologies (NAMs), which aim to provide more efficient, human-relevant, and often animal-free testing strategies for chemical safety assessment [6].

The utility of AOPs in ecological risk assessment research is contingent upon the robustness, discoverability, and connectivity of the underlying data. However, the current landscape of AOP knowledge—scattered across publications, proprietary databases, and community resources like the AOP-Wiki—presents a significant FAIRification challenge. The FAIR principles (Findable, Accessible, Interoperable, and Reusable) provide a targeted framework for addressing this data stewardship crisis [56]. The core thesis is that the systematic FAIRification of AOP data is not merely a technical data management exercise but a prerequisite for advancing ecological risk assessment. It enables the construction of predictive AOP networks, facilitates computational toxicology, and fulfills the promise of NAMs to support evidence-based environmental decision-making on a global scale [6] [57].

Deconstructing the FAIR Principles for AOP Data

The application of the FAIR principles to AOP data requires a granular, technical understanding of each principle's implications for mechanistic toxicological knowledge. The following table details the core objectives, associated challenges specific to AOPs, and proposed implementation strategies for each FAIR dimension.

Table 1: Technical Breakdown of FAIR Principles for AOP Data

FAIR Principle	Core Technical Objective for AOPs	Primary Implementation Challenges	Key Implementation Strategies & Standards
Findable (F)	Unique, persistent identification and rich indexing of AOP components (KEs, KERs, AOPs) for both human and machine discovery.	Fragmented knowledge; lack of global unique identifiers (UIDs); incomplete metadata.	Assign persistent UIDs (e.g., AOP-Wiki IDs, DOIs for published AOPs); rich metadata annotation using controlled vocabularies (e.g., ECOTOX ontology); registration in searchable repositories [6] [56].
Accessible (A)	Retrieval of AOP data and metadata using standardized, open, and universally implementable protocols.	Data behind paywalls; heterogeneous API access; unclear authentication/authorization rules.	Use of standardized, free, and open protocols (e.g., HTTP, SPARQL); clear data licensing; provision of machine-actionable access points (APIs) for AOP-KB tools [56].
Interoperable (I)	Seamless integration of AOP data with other biological and toxicological datasets (e.g., chemical assays, omics data, toxicokinetic models).	Semantic heterogeneity; incompatible data formats; lack of formalized data models.	Use of formal, shared knowledge representation languages (e.g., RDF, OWL); alignment with community-endorsed ontologies (e.g., GO, ChEBI); adoption of consensus AOP data exchange formats [6] [58].
Reusable (F)	Optimization of AOP knowledge reuse in new risk assessment contexts, computational models, and hypothesis generation.	Insufficient contextual metadata; unclear provenance (lineage); non-standard descriptions of evidence strength.	Provision of rich, domain-relevant metadata (e.g., species, life stage, test system); detailed provenance tracking; adherence to community standards for evidence assessment (e.g., modified Bradford-Hill criteria) [6] [56].

The principle of machine-actionability is a cross-cutting theme essential for all four FAIR dimensions. For AOPs to be computationally usable in predictive toxicology and systems biology models, their components and relationships must be described in a structured, unambiguous format that software agents can parse and reason over without human intervention [6] [56].

Implementation Roadmap and Technical Workflows

The FAIRification of AOP data is an orchestrated process requiring coordinated tool development, community consensus, and standardized workflows. The FAIR AOP Cluster Workgroup, an international consortium of academic, government, and industry partners, has established a roadmap to address these coordination needs [6].

Core FAIR-Enabling Infrastructure: The AOP Knowledge Base (AOP-KB)

The OECD's AOP Knowledge Base (AOP-KB) is the central infrastructure for the international AOP development programme [49]. Its FAIRification is pivotal. The primary user interface is the AOP-Wiki, a crowd-sourced platform for qualitative AOP development [49]. The roadmap for AOP-Wiki 3.0 explicitly focuses on enhancing FAIRness by implementing a more structured backend data model, improving API capabilities for machine access, and fostering tighter integration with other bioinformatic resources [6].

Complementary tools within the AOP-KB ecosystem include:

• Intermediate Effects Database (IEDB): A curated resource for Key Events (KEs).
• AOP-Performer: A tool for quantitative AOP network modeling.
• AOP Explorer: For visualizing and navigating AOP networks.

The FAIR AOP Implementation Profile is a parallel effort to define the specific standards, technologies, and best practices needed to make the entire AOP-KB ecosystem FAIR [6].

Practical FAIRification Protocol for AOP Developers

The following workflow provides a step-by-step protocol for researchers developing and contributing AOP-related data in a FAIR-aligned manner.

Diagram: AOP Developer FAIRification Workflow

• Define AOP Components: Formally describe the Molecular Initiating Event (MIE), sequential Key Events (KEs), and Adverse Outcome (AO) using clear, unambiguous biological terms.
• Annotate with Controlled Vocabularies: Tag all components with identifiers from public ontologies (e.g., Gene Ontology for biological processes, ChEBI for chemicals, NCBI Taxonomy for species). This is critical for interoperability [6].
• Assemble and Link in AOP-Wiki: Use the AOP-Wiki interface to construct the pathway. Define Key Event Relationships (KERs) and assess the weight of evidence for each linkage according to OECD guidance [49].
• Assign Persistent Identifiers: The AOP-Wiki automatically assigns a unique, persistent AOP-ID (e.g., AOPxxx). For published AOPs, a Digital Object Identifier (DOI) should be obtained through the OECD's cooperation with scientific journals [6] [49].
• Publish Supporting Data: Experimental evidence supporting KEs and KERs must be deposited in FAIR-aligned public repositories (e.g., ArrayExpress for transcriptomics, ChEMBL for bioactivity data) with metadata that links back to the AOP-Wiki AOP-ID and KE-IDs.
• Submit for Review: Submit the AOP for scientific review within the OECD programme, which can lead to OECD endorsement, enhancing its credibility and reusability for regulatory purposes [49].

Protocol for Computational Reuse of FAIR AOP Data

For researchers aiming to consume and computationally analyze FAIR AOP data, the following methodology enables network-based analysis for ecological hazard prediction.

Table 2: Protocol for AOP Network Analysis in Ecological Risk Assessment

Step	Procedure	Purpose	Tools / Resources
1. Data Retrieval	Programmatically query the AOP-KB API to fetch AOPs, KEs, and KERs of interest. Filter by taxonomic applicability (e.g., fish, amphibians).	To obtain machine-actionable, structured AOP data for analysis.	AOP-Wiki REST API, SPARQL endpoint (if RDF deployed).
2. Network Construction	Parse the retrieved data to build a computational graph object. Nodes = KEs; Edges = KERs. Annotate nodes with relevant metadata (e.g., biological level).	To create a quantitative or qualitative model of the AOP network for systems analysis.	Python (NetworkX), R (igraph), Cytoscape.
3. Data Integration	Map internal KE identifiers (AOP-Wiki IDs) to external database identifiers (e.g., UniProt, Ensembl). Overlay with chemical assay data or omics results.	To contextualize the AOP network within broader biological data and specific chemical exposures.	Ontology mapping services, bioinformatics databases (EnviroTox Database) [57].
4. Analysis & Hypothesis	Perform network analysis (e.g., identify central/ bottleneck KEs, path analysis). Use the network to interpret in vitro or in chemico testing data within an IATA.	To identify critical nodes for testing, predict novel KERs, and support weight-of-evidence assessments.	Custom scripts, AOP-Performer tool, network analysis libraries.
5. Reporting & Feedback	Document the analysis workflow. Contribute novel insights or proposed modifications back to the AOP-KB community via the AOP-Wiki.	To ensure the AOP knowledge base evolves and improves through use, completing the FAIR cycle.	Jupyter Notebooks, AOP-Wiki user interface.

The Researcher's Toolkit for AOP FAIRification

Successfully navigating the FAIRification process requires a suite of essential resources. The following toolkit categorizes and explains the key solutions needed for developing, managing, and analyzing FAIR AOP data.

Table 3: Essential Research Toolkit for AOP FAIRification

Tool Category	Specific Tool / Resource	Primary Function in FAIRification	Key Features / Notes
Knowledge Management & Development	AOP-Wiki	The primary crowdsourced platform for authoring, structuring, and sharing qualitative AOP knowledge [49].	Provides foundational IDs, versioning, and a user-friendly interface for the global AOP community.
Ontologies & Standards	ECOTOX, Gene Ontology (GO), ChEBI	Controlled vocabularies for semantically annotating AOP components (species, processes, chemicals), ensuring interoperability [6].	Annotation turns text strings into globally unique, machine-understandable concepts.
Data Publishing & Repositories	ChEMBL, GEO/ArrayExpress, Figshare	Domain-specific and general repositories for publishing experimental data supporting KEs/KERs with rich metadata and persistent DOIs.	Enables accessibility and reusability of underlying evidence. Must link data to AOP-Wiki IDs.
Computational Analysis & Modeling	AOP-Performer, Cytoscape, R/Python (igraph/NetworkX)	Tools for constructing, visualizing, and quantitatively analyzing AOP networks to derive testable predictions [6].	Translates FAIR AOP data into actionable models for risk assessment.
Community & Harmonization	FAIR AOP Cluster Workgroup, SAAOP	International groups coordinating technical standards, roadmap development, and training to align community efforts [6] [49].	Critical for overcoming fragmentation and achieving consensus on implementation profiles.

Visualizing FAIR AOP Networks and Data Flow

The complexity of interconnected AOPs and the data flow within a FAIR ecosystem is best understood through visualization. The diagram below illustrates the logical relationships and data exchanges between a researcher, the core AOP-KB infrastructure, and external integrated resources.

Diagram: Logical Data Flow in a FAIR AOP Ecosystem

The Adverse Outcome Pathway (AOP) framework is a conceptual construct designed to organize biological knowledge into a sequence of measurable events, linking a Molecular Initiating Event (MIE) to an Adverse Outcome (AO) relevant for risk assessment [8]. An AOP is not stressor-specific but represents a generalized sequence of biological effects that can be triggered by any stressor acting on a particular MIE [8]. The framework operates on the principle that AOP networks—multiple AOPs connected via shared Key Events (KEs)—constitute the functional unit for prediction, capturing the complexity of real biological systems more effectively than single, linear pathways [8].

For ecological risk assessment (ERA), this network-based view is indispensable. Populations and ecosystems are exposed to multiple chemical and non-chemical stressors simultaneously, and their responses integrate effects across various biological pathways [16]. The AOP framework provides a mechanistic scaffold for integrating data across species and levels of biological organization, from molecular changes to population-level impacts [17]. This is critical for moving beyond traditional toxicity testing, which often relies on a limited set of apical endpoints in a few surrogate species, towards a more predictive and mechanistic understanding of ecological hazards [8] [59].

However, the effective application of AOP networks in decision-making is hindered by two fundamental categories of gaps: incomplete pathway knowledge and missing quantitative understanding. This guide explores the nature of these gaps within the context of ERA and provides a technical roadmap for their identification and mitigation.

Identifying Gaps in AOP Network Knowledge

Incomplete and Fragmented Pathway Elucidation

A major challenge is the incomplete coverage of biological space by existing AOPs. Many documented pathways are linear and simplified, whereas biological reality involves networks with feedback loops, adaptive responses, and cross-talk. The following table categorizes common types of pathway incompleteness.

Table: Categories of Pathway Incompleteness in AOP Development

Gap Category	Description	Example from Literature
Missing Key Event Relationships (KERs)	Insufficient evidence (biological plausibility, empirical, quantitative) linking one KE to the next.	In a genotoxicity AOP network, the quantitative conditions linking persistent DNA damage to cell cycle arrest may be poorly defined [59].
Stressor-AOP Disconnect	Known stressors lack a clear connection to a structured AOP, or AOPs exist without linked stressors.	For 320 petroleum hydrocarbons, a stressor-AOP network could only be constructed for 75, indicating many chemicals with unknown mechanistic pathways [60].
Limited Taxonomic Scope	AOPs developed based on data from one or a few model species, with unknown conservation across ecologically relevant taxa.	The perchlorate AOP is well-defined for vertebrates but extrapolation to invertebrates is uncertain due to physiological differences [17].
Network Fragmentation	Isolated AOPs that are not connected into broader networks, missing shared KEs that are critical for mixture or cumulative risk assessment.	Separate AOPs for different petroleum hydrocarbons may share common KEs (e.g., oxidative stress) but remain unlinked [60].

A prominent example is found in the assessment of petroleum hydrocarbons (PHs). While 320 PHs have been identified as environmental stressors, a systematic review found that only 75 could be connected to high-confidence AOPs within the AOP-Wiki [60]. This leaves a significant gap for the majority of PHs, where hazard assessment may fall back on non-mechanistic, total concentration-based metrics. Furthermore, the constructed stressor-species networks revealed that crustaceans were disproportionately represented in toxicity data, highlighting a taxonomic data bias that limits understanding of impacts on other critical ecological groups like fish or algae [60].

The Quantitative Understanding Deficit

The second major gap is the lack of quantitative descriptions for Key Event Relationships (KERs). The U.S. EPA identifies quantitative understanding as a core type of evidence, defined as knowing the conditions (e.g., timing, magnitude, duration) under which a change in an upstream KE will cause a change in a downstream KE [8]. Without this, AOPs remain qualitative and cannot be used for predictive modeling.

Table: Key Quantitative Deficits in AOP Networks

Quantitative Deficit	Consequence for ERA	Illustrative Data Need
Uncertain Dose-Response	Inability to predict the probability or severity of an AO based on exposure concentration.	The dose-response relationship between tissue concentration of a PH and the inhibition of a specific MIE (e.g., receptor binding).
Unknown Thresholds & Transition Points	Cannot define acceptable exposure levels or identify tipping points for population resilience.	The level of DNA damage (KE) that must be exceeded to trigger irreversible apoptosis (downstream KE) in a population of organisms.
Uncharacterized Temporal Dynamics	Poor extrapolation across exposure durations (acute vs. chronic) or life stages.	The time delay between a reduction in circulating thyroid hormone (KE) and impaired larval development (AO) in amphibians [17].
Unquantified Variability	Cannot account for inter-species, intra-population, or inter-individual differences in sensitivity.	The distribution of sensitivity values (e.g., EC50s) across multiple species for a given KE, used to build Species Sensitivity Distributions (SSDs) [60].

The perchlorate case study demonstrates progress in this area. Researchers integrated dose-response data across twelve species (vertebrates and invertebrates) for KEs like sodium-iodide symporter inhibition and reduced thyroid hormone levels [17]. This cross-species quantitative analysis allowed for a comparison of sensitivity and helped identify data gaps for particular taxa. Conversely, the genotoxicity AOP network review highlighted that while many New Approach Methodologies (NAMs) exist, their results are often not translated into quantitative parameters for integration into AOP-based Integrated Approaches for Testing and Assessment (IATAs) [59].

Methodologies for Gap Identification and Analysis

Experimental Protocols for Empirical Gap Filling

Protocol 1: High-Throughput In Vitro Screening for MIE Identification

• Objective: To rapidly screen environmental chemicals for interaction with defined molecular targets (potential MIEs).
• Method: Utilize platforms like the ToxTracker assay, which employs mouse embryonic stem cells with fluorescent reporters for specific KEs (e.g., DNA damage, oxidative stress, protein damage) [59]. Cells are exposed to a range of chemical concentrations.
• Endpoint Measurement: Flow cytometry analysis of reporter activation. Dose-response curves are generated to determine benchmark concentrations.
• Data Integration: Positive hits are mapped to existing AOPs via the MIE or used to propose new AOP components.

Protocol 2: Transcriptomic Analysis for Pathway Discovery and Cross-Species Extrapolation

• Objective: To identify conserved KEs and KERs across taxa and uncover novel pathway connections.
• Method: Conduct RNA sequencing (RNA-seq) on tissues of ecologically relevant species (e.g., fathead minnow, Daphnia magna) exposed to a stressor across multiple time points and doses.
• Bioinformatics Workflow:
  • Differential gene expression analysis to identify perturbed pathways.
  • Gene set enrichment analysis to map expression changes to known biological pathways and KEs.
  • Use of tools like the U.S. EPA's SeqAPASS to compare protein sequence similarity of MIEs/KEs (e.g., estrogen receptor) across species to infer conservation of AOP susceptibility [8].
• Outcome: Empirical support for KERs, identification of potential novel KEs, and evidence for taxonomic domain of applicability.

Protocol 3: Targeted Quantitative Assessment of a Defined KER

• Objective: To establish a quantitative relationship between two linked KEs.
• Method: Using the example of the KER between "DNA double-strand breaks" and "Chromosomal aberrations":
  • Expose cells (e.g., human lymphoblastoid TK6 cells) to a reference genotoxicant (e.g., bleomycin) across 5-8 concentrations.
  • Measure the upstream KE (DNA breaks) at time T1 using the γ-H2AX immunofluorescence assay.
  • Measure the downstream KE (chromosomal damage) at a later time T2 using the micronucleus cytome assay.
  • Use computational modeling (e.g., Bayesian network, physiologically based toxicokinetic-toxicodynamic models) to correlate the magnitude and timing of KE1 with the probability or magnitude of KE2.

Graphviz Diagram 1: A Generalized AOP Structure Highlighting Gaps. This diagram shows a linear AOP with a highlighted quantitative gap in one KER and a cluster representing an incomplete, fragmented pathway with missing key events.

Computational and Informatics Approaches for Network Analysis

Network Construction and Analysis: Tools like Cytoscape can be used to build and visualize stressor-AOP and AOP networks as performed in the PH study [60]. Centrality analysis (degree, betweenness) can identify hub KEs that are critical to many AOPs, highlighting priority nodes for quantitative strengthening. Aggregate Exposure Pathway (AEP) Integration: The AEP framework tracks stressors from source to target-site exposure. Linking the AEP (exposure) to the AOP (effect) at the MIE creates a quantitative bridge from environmental concentration to biological effect [17]. This requires modeling environmental fate, transport, and bioaccumulation to estimate the internal dose at the MIE.

Graphviz Diagram 2: An Integrated AEP-AOP Framework for Quantitative Risk Assessment. This diagram illustrates the linkage between the exposure pathway (AEP) and the effect pathway (AOP), emphasizing the need for quantitative models at each transition, especially linking Target Site Exposure to the MIE.

Mitigation Strategies: Building Robust, Quantitative AOP Networks

Systematic Use of New Approach Methodologies (NAMs)

NAMs, including in vitro assays, omics, and computational models, are essential for filling both pathway and quantitative gaps [59]. The key is targeted application:

• High-Throughput Screening: To rapidly map stressors to potential MIEs and prioritize chemicals for further testing.
• Transcriptomics/Proteomics: To empirically validate KERs and discover novel connections within networks, providing evidence for biological plausibility.
• Quantitative In Vitro to In Vivo Extrapolation (QIVIVE): To convert in vitro assay concentrations (e.g., from ToxTracker) to equivalent external doses, feeding the AEP-AOP interface [17].

Quantitative Model Integration

AOPs are not computational models but facilitate their creation [8]. Mitigating quantitative gaps requires integrating models at different levels:

• Dose-Response Models: Fit to KE data (e.g., benchmark dose modeling) to establish potency.
• Dynamic Kinetic Models: Describe the time-course of KEs (e.g., PBTK/TD models) to capture temporal dynamics.
• Species Sensitivity Distributions (SSDs): Apply to KE or AO data across species to quantify ecological variability and derive protective thresholds like the Hazard Concentration for 5% of species (HC₀₅) [60].
• Population Models: Link individual-level AOs (e.g., reduced fecundity) to population growth rate or extinction risk, bridging to ecological relevance [16].

Table: Example Quantitative Outputs from an AOP-Based Ecological Risk Assessment for Petroleum Hydrocarbons [60]

Polycyclic Aromatic Hydrocarbon (PAH)	HC₅₀ (μg/L)	PNEC (μg/L)	Risk Quotient (River)	Risk Quotient (Coastal)
Naphthalene	12.5	1.25	0.8	0.2
Phenanthrene	1.8	0.18	2.1	0.9
Fluoranthene	0.95	0.095	1.5	0.6
Benzo[a]pyrene	0.21	0.021	5.7	3.4

HC₅₀: Hazard Concentration for 5% of species; PNEC: Predicted No-Effect Concentration; Risk Quotient = Measured Environmental Concentration / PNEC. A value >1 indicates potential risk.

The Scientist's Toolkit: Essential Research Reagent Solutions

Table: Key Reagents and Materials for AOP-Based Ecotoxicology Research

Research Reagent / Material	Function in AOP Development	Example Application
ToxTracker Reporter Cell Lines [59]	Stem cell-based system with fluorescent reporters for specific KEs (DNA damage, oxidative stress).	High-throughput screening of chemicals for MIEs and early KEs; provides mechanistic data for genotoxicity AOP networks.
Ames Test Strains (e.g., S. typhimurium TA98, TA100) [59]	Bacterial strains used to detect gene mutations (a critical MIE for genotoxicity).	Foundational assay for identifying mutagenic stressors; data feeds into the MIE of relevant AOPs.
Species-Specific Antibodies for Biomarkers	Immunodetection of KE-specific proteins (e.g., γ-H2AX for DNA breaks, Vitellogenin for estrogenic effects).	Quantifying the magnitude of a KE in tissue samples from exposed ecological species.
Environmental DNA/RNA Extraction Kits	High-quality nucleic acid isolation from non-model organism tissues or environmental samples.	Enables transcriptomic analysis (RNA-seq) to identify perturbed pathways and KEs in ecologically relevant species.
Reference Chemical Libraries	Curated sets of chemicals with known modes of action (e.g., EPA's ToxCast library).	Used as positive controls to validate assays and to "stress test" AOP networks by verifying expected pathway activation.
AOP-Wiki (aopwiki.org) [8]	Central repository for collaborative AOP development and sharing.	The primary platform for accessing existing AOP knowledge, identifying gaps, and contributing new findings.

The future of ecological risk assessment lies in the development and application of quantitatively robust AOP networks. Closing the gaps of incomplete pathways and missing quantitative understanding requires a concerted, interdisciplinary effort that strategically employs hypothesis-driven wet-lab experiments, systematic in silico and NAM-based screening, and sophisticated computational modeling. The integration of the Aggregate Exposure Pathway (AEP) framework is a critical step, creating a seamless, quantitative line of evidence from source to ecological outcome [17].

By prioritizing the filling of these gaps—such as building comprehensive stressor-AOP networks for chemical classes like petroleum hydrocarbons [60] and establishing cross-species quantitative relationships for conserved pathways [17]—the research community can transform the AOP concept from a qualitative organizing tool into a predictive, mechanistic foundation for 21st-century ecological risk assessment and decision-making.

From Theory to Practice: Validating AOP Networks for Regulatory and Research Applications

The Adverse Outcome Pathway (AOP) framework organizes mechanistic knowledge into a structured sequence of causally linked biological events, from a Molecular Initiating Event (MIE) to an Adverse Outcome (AO) relevant to risk assessment [8]. While individual, linear AOPs are valuable, complex toxicological outcomes often arise from interacting pathways. AOP networks, which interconnect multiple AOPs through shared Key Events (KEs), provide a more realistic and powerful tool for ecological and human health risk assessment by capturing this complexity [61]. This whitepaper demonstrates the utility of the AOP network approach through three case studies: chemical-induced nephrotoxicity, pesticide-mediated neurotoxicity, and endocrine disruption by environmental contaminants. Each case highlights how AOP networks guide the development of New Approach Methodologies (NAMs), inform Integrated Approaches to Testing and Assessment (IATA), and enable mechanism-based risk assessment, thereby supporting the paradigm shift toward predictive toxicology and reduced reliance on traditional animal testing.

Ecological risk assessment faces the formidable challenge of evaluating thousands of chemicals for potential hazards to diverse species and ecosystems. The AOP framework is a conceptual model designed to address this challenge by linking mechanistic data to apical outcomes of regulatory concern [8]. An AOP is a sequence of measurable Key Events (KEs)—biological changes at molecular, cellular, tissue, or organ levels—connected by well-defined Key Event Relationships (KERs) [61]. The sequence is initiated by a stressor's interaction with a biological target (the MIE) and culminates in an Adverse Outcome (AO) at the organism or population level [8].

AOPs are modular, chemical-agnostic constructs, meaning they describe biological pathways that can be triggered by any stressor capable of inducing the MIE [61]. This makes them highly versatile for predicting hazards. However, biological systems are characterized by interconnected pathways, feedback loops, and adaptive responses. A single, linear AOP often cannot fully capture the complexity leading to an AO, especially from mixed exposures or stressors that perturb multiple MIEs [61].

This limitation is addressed by AOP networks (AOPNs), which are sets of interrelated AOPs that share one or more common KEs [61] [8]. By linking pathways, AOP networks offer a systems-level view that can:

• Identify central, highly connected KEs that represent critical vulnerabilities or ideal biomarkers.
• Reveal points of convergence (multiple pathways leading to one AO) and divergence (one MIE leading to multiple AOs).
• Support the assessment of combined effects from mixtures by illustrating shared target pathways [61].
• Guide the development of efficient testing batteries focused on mechanistic KEs rather than apical endpoints alone.

This whitepaper explores the development and application of AOP networks through three toxicological domains of high ecological and regulatory relevance. The case studies exemplify how AOP networks transition from theoretical frameworks to practical tools that enhance prediction, testing, and assessment.

Case Study 1: AOP Networks for Nephrotoxicity Prediction

Network Development and Topological Analysis

A seminal study developed an AOP network for nephrotoxicity by manually extracting and integrating 13 individual nephrotoxicity-related AOPs from the OECD AOP-Wiki [61]. The methodology followed a defined four-step process: (1) defining the purpose (identifying central KEs for assay development), (2) setting selection criteria (AOP stage, evidence weight), (3) extracting and harmonizing KE/KER data, and (4) performing network construction and analysis [61].

Network topology analysis, which applies graph theory to the interconnected KEs, identified the most central and connected events. This quantitative analysis is crucial for pinpointing leverage points within the biological system.

Table 1: Topological Analysis of a Nephrotoxicity AOP Network [61]

Key Event (KE)	Degree Centrality	Betweenness Centrality	Interpretation
Oxidative Stress	High	High	A highly connected hub; involved in numerous pathways leading to various kidney injuries.
Mitochondrial Dysfunction	High	High	Another critical hub; its perturbation is a common consequence of diverse MIEs and a cause of downstream cellular damage.
Tubular Necrosis	High	High	A convergent AO for many pathways; represents a point of no return for cell viability.
Inflammation	Moderate	Moderate	A propagating event that amplifies damage and links initial injury to chronic outcomes.
Altered Protein/Gene Expression	Variable	Variable	Often an early cellular KE, with specificity depending on the upstream MIE.

Experimental Validation: Receptor-Mediated Endocytosis Pathway

The utility of a specific nephrotoxic AOP can be demonstrated through targeted experimental validation. One well-defined AOP describes kidney injury initiated by receptor-mediated endocytosis and lysosomal overload, relevant to aminoglycoside and polymyxin antibiotics [62].

Experimental Protocol for AOP Validation [62]:

• Cell Model: Differentiated human proximal tubule cells (RPTEC/TERT1) or rat kidney cells (NRK-52E) are used to represent the target tissue.
• Stressor Exposure: Cells are treated with a model stressor (e.g., Polymyxin B) across a range of concentrations and time points.
• KE1 Measurement (Lysosomal Dysfunction): Assessed using a fluorescent dye (e.g., LysoTracker) to measure lysosomal volume and pH, or via assays for cathepsin B activity.
• KE2 Measurement (Lysosomal Disruption): Quantified by measuring the release of cathepsin enzymes into the cytosol or using galectin-3 puncta formation as a marker of lysosomal membrane permeabilization.
• KE3 Measurement (Cell Death): Evaluated using cytotoxicity assays (e.g., LDH release, ATP content, caspase activation).
• Temporal Analysis: A time-course experiment establishes the sequence of events, confirming that KE1 precedes KE2, which precedes KE3.
• Quantitative Response-Response Modeling: Data from dose-response curves for each KE are used to model the predictive relationship between early KEs (e.g., lysosomal dysfunction) and the AO (cell death).

Key Research Reagents & Materials:

• Cell Lines: RPTEC/TERT1 (human), NRK-52E (rat).
• Chemical Stressors: Polymyxin B, colistin (polymyxin E).
• Assay Kits: LysoTracker Red DND-99, Magic Red Cathepsin B assay, Cytotoxicity Detection Kit (LDH), CellTiter-Glo (ATP).
• Key Equipment: Fluorescence plate reader, confocal microscope, cell culture incubator.

This experimental workflow not only validates the postulated KERs but also generates quantitative data that can be integrated with Physiologically Based Kinetic (PBK) modeling to translate in vitro effective concentrations to predicted in vivo doses, providing a proof-of-concept for in vitro-based risk assessment [62].

Nephrotoxicity AOP Network Diagram

Case Study 2: AOP-Based IATA for Neurotoxicity Assessment

The Challenge and the AOP-Based Solution

Neurotoxicity assessment is challenged by the nervous system's complexity, species differences, and the long latency of some effects [63]. AOPs offer a strategy to overcome these hurdles by defining specific, measurable neurotoxic mechanisms. A notable case study applied an AOP-based IATA to assess the neurotoxic potential of two pesticide classes: rotenoids (inhibiting mitochondrial Complex I) and strobilurins (inhibiting mitochondrial Complex III) [64].

The core AOP shared by these compounds links Inhibition of Mitochondrial Electron Transport Chain (MIE) to Neuronal Cell Death and ultimately to Neurodegeneration (AO), particularly affecting dopaminergic neurons [64]. This case study exemplifies different read-across strategies within a regulatory context: analogue approach (rotenoids) vs. category approach (strobilurins), and predicting positive neurotoxicity vs. a low potential for neurotoxicity [64].

Integrated Testing Strategy and Protocol

The testing strategy employed a suite of NAMs anchored to the mitochondrial dysfunction AOP:

Table 2: NAMs Applied in the Neurotoxicity IATA Case Study [64]

Methodology	Specific Readout / Assay	AOP Key Event Addressed	Purpose in Assessment
In Silico Docking	Molecular docking simulations to mitochondrial Complex I or III proteins.	MIE (Molecular Interaction)	Predict binding affinity and potential to initiate the AOP; provides a basis for structural read-across.
In Vitro Mitochondrial Assays	Oxygen consumption rate (OCR) in isolated mitochondria or cells; ATP production.	Early KE (Mitochondrial Dysfunction)	Confirm functional inhibition of the electron transport chain and quantify potency.
Cellular Toxicity Assays	Neuronal cell viability (e.g., in LUHMES, SH-SY5Y cells); high-content imaging for neurite outgrowth.	Intermediate KE (Cellular Stress, Neurite Degeneration)	Assess downstream cytotoxic consequences and specific neurodevelopmental effects.
Transcriptomics	Gene expression profiling in relevant cell models.	Intermediate KE (Altered Gene Expression)	Uncover pathway-level responses and support biological similarity for read-across.
Toxicokinetic (PBK) Modeling	Simulation of human tissue and brain concentrations.	--	Translate in vitro effective concentrations to human exposure contexts; determine if bioactive concentrations are achievable.

Core Experimental Workflow:

• In Silico Screening: Docking models prioritize compounds with high potential to bind and inhibit mitochondrial complexes.
• In Vitro Bioactivity Confirmation: Selected compounds are tested in high-throughput mitochondrial function assays to generate quantitative potency data (e.g., IC₅₀ for OCR).
• Cellular Phenotypic Assessment: Potent inhibitors are advanced to neuronal cell models to evaluate cell death, neurite integrity, and other neurospecific endpoints.
• Read-Across and WoE Integration: Data from source and target compounds are compared. The battery of NAMs provides multiple lines of evidence (dynamic, functional, phenotypic) to support or refute a read-across hypothesis, even if uncertainty exists for individual assays [64].
• Risk Contextualization: PBK modeling estimates whether human exposures could reach brain concentrations equivalent to the bioactive levels observed in vitro.

This integrated approach allows for a data-rich, mechanism-based hazard characterization that can inform regulatory decisions with greater specificity and human relevance than traditional neurobehavioral screening alone [63].

Mitochondrial Neurotoxicity AOP Pathway

Case Study 3: AOP Networks for Identifying Endocrine Disruptors

Complexity of Endocrine Disruption and the AOPN Strategy

Endocrine-disrupting chemicals (EDCs) interfere with hormone signaling, leading to diverse adverse outcomes like reproductive dysfunction, metabolic disorders, and developmental neurotoxicity (DNT) [65]. Their assessment is complicated because effects can be tissue-specific, non-monotonic, and latent. Micro- and nanoplastics (MPs/NPs) exemplify a complex exposure scenario, acting as both direct stressors and carriers ("Trojan horses") for additive EDCs like bisphenols and phthalates [65].

A single AOP is insufficient to capture the myriad ways EDCs can cause harm. An AOP network approach is essential. For example, a network can connect various MIEs (e.g., estrogen receptor agonism, thyroid hormone synthesis inhibition) through shared intermediate KEs (e.g., altered hormone levels, oxidative stress) to multiple AOs (e.g., reproductive failure, impaired brain development) [66].

Case Study: Mechanism-Based Assessment of PFOS

A 2024 case study on Perfluorooctane sulfonic acid (PFOS) demonstrated a mechanism-based approach for EDC identification using AOPs and NAMs [66]. The goal was to evaluate if an AOP-informed assessment could reach the same conclusion as a traditional, guideline-driven evaluation.

Methodology [66]:

• AOP Network Generation: An AOP network was constructed for the thyroid hormone modality, linking MIEs like thyroid peroxidase (TPO) inhibition to the AO of developmental neurotoxicity, via KEs such as reduced serum thyroxine (T4).
• Systematic Evidence Mapping: A literature search for PFOS was conducted based on the KEs in the network. Retrieved data (from in silico, in vitro, and in vivo studies) were mapped onto the AOPN.
• Weight-of-Evidence (WoE) Assessment: The strength and consistency of evidence supporting each KER within the network for PFOS were evaluated.
• Comparison to Traditional Assessment: The outcome of the AOPN/WoE analysis was compared to a standard ED assessment based on existing regulatory guidelines.

Findings and Implications: The study concluded that PFOS met the criteria for an EDC in the standard assessment but not in the mechanism-based AOP assessment [66]. This discrepancy highlighted a critical gap: the lack of quantitative AOPs (qAOPs). While evidence suggested PFOS could alter thyroid hormones, the quantitative understanding—how much hormone change is needed to trigger DNT—was insufficient to establish a conclusive causal link via the AOP network [66]. The study also highlighted that available in vitro data pointed to a potential direct neurotoxic mechanism, illustrating how AOP networks can help distinguish between endocrine-mediated and alternative pathways to the same AO.

Endocrine Disruption AOP Network Diagram

Synthesis and Future Perspectives

The case studies illustrate a clear evolution in the application of AOPs: from validating single pathways (nephrotoxicity) to deploying them in integrated testing strategies (neurotoxicity) and, ultimately, constructing networks to tackle multifaceted problems like endocrine disruption. Common themes emerge:

• Identification of Central Hubs: Network analysis consistently identifies events like oxidative stress and mitochondrial dysfunction as critical nodes. This prioritizes them for assay development and underscores their role as generalizable biomarkers of effect across toxicity domains [61].
• Guidance for NAMs: AOP networks provide a mechanistic blueprint for selecting and combining in silico and in vitro methods, ensuring they measure biologically relevant KEs that are predictive of the AO [64] [62].
• The Critical Need for Quantification: The PFOS case study powerfully demonstrates that qualitative AOP networks are necessary but not sufficient for definitive risk assessment [66]. The future lies in developing quantitative AOPs (qAOPs) that define the magnitude and timing of KE perturbations required to propagate the effect to the AO. This requires dose-response and time-course data for each KER.

The future of ecological risk assessment research using AOP networks will involve:

• Building Larger, Curated AOP Networks: Expanding networks to cover more MIEs, AOs, and biological spaces, with rigorous WoE for each connection.
• Integrating QIVIVE and PBK Modeling: Routinely linking in vitro KE data to in vivo predictions through toxicokinetic modeling, as demonstrated in the nephrotoxicity case [62].
• Leveraging Computational Approaches: Using machine learning to mine literature for potential KERs and to analyze high-throughput screening data within the context of known AOP networks.
• Supporting Assessment of Complex Mixtures: Utilizing AOP networks to predict additive or synergistic effects of chemicals that share common KEs [8].

By transitioning from isolated pathways to interconnected networks and from qualitative to quantitative models, the AOP framework is poised to become the central organizing principle for next-generation, mechanism-based ecological and human health risk assessment.

The contemporary landscape of chemical risk assessment is undergoing a foundational shift, moving from a reliance on descriptive, whole-animal toxicity studies toward a mechanistically informed, predictive paradigm. Central to this shift are New Approach Methodologies (NAMs), defined as any in vitro, in chemico, or in silico method that enables improved chemical safety assessment and contributes to the reduction and replacement of animal testing [67]. However, individual NAMs alone are insufficient for robust regulatory decision-making. Their true power is unlocked through Integrated Approaches to Testing and Assessment (IATA)—hypothesis-driven, iterative frameworks that strategically combine multiple sources of existing and new data (including NAMs) to inform chemical hazard and risk [68] [59].

The Adverse Outcome Pathway (AOP) framework serves as the critical intellectual scaffold that connects NAMs to IATA within ecological risk assessment research. An AOP is a structured, modular representation of a biological sequence, starting from a Molecular Initiating Event (MIE)—the initial interaction of a stressor with a biomolecule—and progressing through a series of essential, measurable Key Events (KEs) at increasing levels of biological organization, culminating in an Adverse Outcome (AO) relevant to risk assessment [8]. By mapping the mechanistic pathway leading to toxicity, AOPs provide the scientific rationale for selecting specific NAMs to measure critical KEs. Furthermore, AOPs can be linked into AOP networks, which more accurately reflect the complexity of biological systems and enable the prediction of cumulative effects from multiple stressors [8] [69]. This whitepaper explores how AOP networks inform the development of IATA, thereby supporting the confident application of NAMs for modern, fit-for-purpose ecological risk assessment.

Foundational Concepts: AOPs, Networks, and Their FAIRification

Core AOP Terminology and Structure

An AOP is a conceptual construct that organizes existing knowledge about toxicity mechanisms. Its core components are [8]:

• Molecular Initiating Event (MIE): The initial point of chemical interaction (e.g., covalent binding to DNA, receptor activation).
• Key Event (KE): A measurable, essential change in biological state. KEs are the "nodes" in the pathway and represent the targets for NAM-based assays.
• Key Event Relationship (KER): A scientifically supported link describing how one KE leads to another. KERs are the "edges" connecting nodes.
• Adverse Outcome (AO): An effect of regulatory relevance at the organism or population level (e.g., reduced fertility, population decline).

AOPs are stressor-agnostic; they describe a biological pathway that can be triggered by any stressor capable of inducing the MIE [8]. Their utility in IATA development lies in this generality, allowing a single pathway to inform assessment for numerous chemicals.

The Critical Role of AOP Networks

While individual AOPs are valuable, the functional unit for prediction is the AOP network [8]. Networks emerge when multiple AOPs share common KEs (e.g., oxidative stress, inflammation) or AOs. This interconnected structure is essential for ecological risk assessment because [59] [69]:

• It captures cross-talk and biological redundancy, providing a more realistic model of organismal response.
• It enables assessment of combined effects from mixtures of chemicals acting through different but converging pathways.
• It supports the identification of critical hubs (highly connected KEs) that, when modulated, could lead to multiple adverse outcomes. These hubs represent high-priority targets for screening and testing.

Advancing Usability: The FAIR AOP Roadmap

For AOPs and their networks to effectively support IATA, they must be easily accessible and computable. The FAIR principles (Findable, Accessible, Interoperable, and Reusable) provide a guiding framework for data stewardship [6]. The 2025 FAIR AOP Roadmap outlines an international effort to enhance the utility of AOP knowledge by promoting standardized annotation, machine-actionable formats, and improved integration with other biomedical data resources [6] [70]. "FAIRification" transforms AOPs from static documents into dynamic, queryable knowledge graphs, facilitating their systematic use in building and justifying IATA [6].

Table 1: Quantitative Overview of NAM Categories and Their Validation Benchmarks

NAM Category	Example Technologies	Typical OECD TG Coverage	Primary Role in IATA	Key Strength for Ecological Assessment
In Silico Tools	QSAR, Read-Across, Molecular Docking	Limited (e.g., TG 107, 117)	Priority setting, MIE prediction, Screening	Rapid assessment of large chemical inventories; cross-species modeling [69]
In Chemico & Simple In Vitro Assays	Direct Peptide Reactivity Assay (DPRA), membrane permeability tests	High for specific endpoints (e.g., TG 442C, 455)	Measuring specific molecular interactions (MIE)	High throughput; cost-effective for KE measurement [67]
Complex In Vitro Systems	3D tissues, organoids, fish/human cell lines (e.g., RTgill-W1)	Growing (e.g., TG 249, 250)	Capturing tissue-level KEs and early organ response	Incorporates metabolic competence and cell-cell interactions [59]
Omics Technologies	Transcriptomics (GENOMARK, TGx-DDI), proteomics, metabolomics	Emerging (e.g., TG 457)	Unbiased pathway identification & KE confirmation	Provides mechanistic evidence for KERs and cross-species extrapolation [59] [32]
Microphysiological Systems (MPS)	Organ-on-a-chip, multi-tissue platforms	Under development	Modeling systemic interactions and kinetic processes	Potential to model unique ecological physiology (e.g., gill barrier) [67]

The IATA Engine: AOP Networks in Action

An AOP-informed IATA is an iterative, tiered process. The general workflow begins with problem formulation, where the assessment goal and the relevant AO(s) are defined. Existing AOP networks are then searched to identify the MIEs and KEs leading to that AO. This network map directly informs the hypothesis-driven selection of NAMs—each chosen to measure a specific, critical KE in the network [59] [8]. Data generated by these NAMs are integrated, often using Weight-of-Evidence (WoE) or quantitative systems toxicology models, to evaluate the likelihood of the AO being reached under specified exposure conditions [32]. The outcome guides the next decision: either concluding the assessment or refining it through further targeted testing [68].

Diagram 1: AOP Network-Informed IATA Workflow. The workflow initiates with problem formulation based on a defined Adverse Outcome (AO). The relevant AOP network is queried to identify critical Key Events (KEs), which directly inform the selection of specific NAMs for testing. Data integration leads to a regulatory decision or refinement of the testing strategy [59] [8].

Case Study: An AOP-Network Informed IATA for Genotoxicity

Genotoxicity assessment, a regulatory cornerstone, faces challenges like high false-positive rates in traditional batteries and limited mechanistic insight [59]. An AOP-network based IATA offers a modern solution.

1. Problem Formulation: The AO is defined as "heritable mutations leading to increased cancer incidence in wildlife populations."

2. AOP Network Development & Query: A global AOP network for permanent DNA damage is constructed, integrating pathways starting from various MIEs (e.g., DNA adduct formation, topoisomerase inhibition) that converge on shared KEs like DNA double-strand breaks (DSBs) and chromosomal aberrations, ultimately leading to mutations and cancer [59].

3. NAM Selection & Tiered Testing Protocol:

• Tier 1 (High-Throughput Screening): In silico tools (e.g., QSAR for structural alerts) and high-throughput in vitro assays (e.g., ToxTracker reporter assay) are used to screen for chemicals with MIEs and early KEs (e.g., DNA damage signaling) [59].
• Tier 2 (Mechanistic Confirmation): Positive chemicals from Tier 1 undergo targeted testing with NAMs measuring more definitive KEs. Experimental Protocol: The In Vitro Micronucleus (MN) Assay with Human Cell Lines.
  • Objective: To measure the KE "Chromosomal Aberration" in metabolically competent human liver cells (e.g., HepaRG) [59].
  • Procedure: Cells are exposed to the test chemical across a range of concentrations for 1.5-2 cell cycles, both with and without exogenous metabolic activation (S9 mix). The cytokinesis-block agent cytochalasin B is added to binucleate cells. Cells are harvested, fixed, stained with a DNA-specific dye (e.g., DAPI), and scored microscopically or via high-content imaging for the frequency of micronuclei in binucleated cells [59].
  • Data Integration: MN frequency data is combined with transcriptomic biomarkers (e.g., GENOMARK) to differentiate aneugenic from clastogenic mechanisms, refining the placement within the AOP network [59].
• Tier 3 (Quantitative & Contextual): For high-priority chemicals, quantitative dose-response modeling for KERs and integration with exposure predictions are performed to assess in vivo risk, potentially using ex vivo tissues from ecological sentinel species.

4. Decision: The integrated WoE from the NAM battery, anchored in the AOP network, supports a conclusion on mutagenic hazard and potency, potentially eliminating the need for a confirmatory in vivo micronucleus test [59].

Table 2: Key Confidence Factors for AOP Development and Application in IATA

Confidence Factor	Description	Impact on IATA Design	Quantitative/Semi-Quantitative Metric
Biological Plausibility of KERs	Strength of established biological knowledge supporting the causal link between KEs [8].	High confidence allows for predictive use of upstream KEs to infer downstream effects with fewer tests.	Evidence scoring (e.g., Strong/Moderate/Weak) based on published mechanistic studies.
Empirical Support for KERs	Quantity, quality, and consistency of experimental data supporting the KER [8].	Determines the weight given to data from a NAM measuring one KE when predicting another.	Number of independent studies, consistency across test systems (concordance).
Quantitative Understanding of KERs	Existence of a known, predictable relationship between the magnitude/timing of adjacent KEs [8].	Enables quantitative risk assessment and Points of Departure (PoD) derivation from NAM data.	Dose-response concordance, temporal sequence data, computational model parameters.
Essentiality of KEs	Evidence that modulating a KE (inhibiting or augmenting) blocks or accelerates the progression to the AO [8].	Identifies the most critical, non-redundant KEs that are mandatory to measure in an IATA.	Results from gain/loss-of-function experiments (e.g., knockout models, pharmacological inhibition).
Conservation Across Taxa	Degree to which the MIE, KEs, and KERs are conserved between model test species and ecological species of concern [8].	Justifies extrapolation of NAM data (often from human cells) to ecological receptors.	Bioinformatics analysis (e.g., SeqAPASS tool results on target protein sequence homology) [8].

Detailed Experimental Protocol: Building an AOP for E-Cigarette-Induced Lung Injury

This protocol exemplifies the construction of a quantitative AOP, integrating in silico, in vitro, and in vivo data to inform an IATA for a complex pulmonary toxicant [32].

1. In Silico Identification of MIEs and KEs:

• Objective: To predict the molecular targets and perturbed pathways of E-cigarette constituents (propylene glycol, vegetable glycerin, nicotine, and their pyrolysis products).
• Procedure: Utilize the Comparative Toxicogenomics Database (CTD). Perform batch queries for each chemical to curate lists of interacting genes/proteins. Use enrichment analysis (Gene Ontology, KEGG pathways) to identify significantly overrepresented biological processes and pathways (e.g., oxidative stress response, inflammatory pathways, Hippo signaling) [32].

2. In Vitro Validation of KEs and KERs in Human Bronchial Epithelial Cells:

• Objective: To empirically validate predicted KEs, specifically oxidative stress (KE1), chronic inflammation (KE2), and Hippo pathway suppression (KE3) [32].
• Procedure:
  • Cell Exposure: Treat a differentiated human bronchial epithelial cell line (e.g., BEAS-2B) with E-cigarette vapor condensate (EVC) or key constituents.
  • KE1 Measurement (Oxidative Stress): Quantify intracellular reactive oxygen species (ROS) using a fluorescent probe (e.g., H2DCFDA) via flow cytometry. Measure lipid peroxidation products (e.g., MDA) or DNA oxidation markers (e.g., 8-OHdG) by ELISA.
  • KE2 Measurement (Inflammation): Analyze cell culture supernatant for pro-inflammatory cytokines (IL-6, TNF-α) via multiplex ELISA. Assess NF-κB nuclear translocation via immunofluorescence.
  • KE3 Measurement (Hippo Pathway Suppression): Perform western blot to measure phosphorylation levels of core Hippo kinases (MST1/2, LATS1/2). Use immunofluorescence or cellular fractionation with western blot to quantify nuclear translocation of the downstream effectors YAP/TAZ [32].
  • Establishing KERs: Use pharmacological inhibitors (e.g., an antioxidant for KE1, an anti-inflammatory for KE2) or genetic knockdown (e.g., siRNA against YAP/TAZ) to demonstrate that blocking an upstream KE mitigates a downstream KE.

3. In Vivo Concordance in a Murine Model:

• Objective: To confirm the in vitro-based AOP leads to the tissue-level Adverse Outcome (Lung Injury).
• Procedure: Expose mice to E-cigarette aerosol chronically (e.g., 12+ weeks). Conduct histopathological examination of lung tissue for inflammatory infiltrates, fibrosis, and epithelial damage. Quantify the same KEs (oxidative stress markers, cytokine levels, YAP/TAZ activity) in lung homogenates to establish quantitative concordance with the in vitro data [32].

Diagram 2: Key Signaling Pathway in an AOP: Hippo/YAP in Lung Injury. This detail view of KE3 from the E-cigarette AOP shows how the stressor inhibits the core Hippo kinases, leading to dephosphorylation and nuclear translocation of the YAP/TAZ transcription factors. This drives the expression of genes promoting cell proliferation and survival, contributing to the Adverse Outcome of tissue damage and cancer risk [32].

Successfully implementing an AOP-network informed IATA requires a suite of curated databases, software tools, and experimental models.

Table 3: Research Reagent Solutions for AOP-Based IATA Development

Tool/Resource Category	Specific Example(s)	Primary Function in IATA	Key Application in Ecological Context
AOP Knowledge Repositories	AOP-Wiki (primary), AOP-DB, FAIR AOP Enabling Resources [6] [8]	Central hub for finding, developing, and sharing qualitative AOP knowledge.	Identifying conserved pathways across species; finding AOs relevant to population viability.
Chemical-Biological Interaction Databases	Comparative Toxicogenomics Database (CTD) [32], PubChem, ChEMBL	Identifying potential MIEs and chemical-gene interactions for hypothesis generation.	Curating chemical-specific data for environmental contaminants of concern.
In Silico Prediction Tools	OECD QSAR Toolbox, VEGA, EPA's SeqAPASS [8]	Predicting hazard, performing read-across, and assessing taxonomic applicability of MIEs/KEs.	Rapid screening of large chemical inventories; justifying cross-species extrapolation in risk assessment.
Computational Modeling Platforms	R packages (e.g., aop), Cytoscape (for network visualization), PBPK/PD modeling software	Building quantitative AOP models, visualizing networks, and integrating kinetic data.	Developing population models that incorporate toxicodynamic responses from AOPs [16].
Validated In Vitro NAMs for KEs	TGx-DDI transcriptomic biomarker [59], Micronucleus assay (OECD TG 487), High-throughput screening assays (ToxTracker, MultiFlow) [59]	Providing mechanistically anchored, reproducible data on specific KEs.	Generating human- or model species-relevant data to feed into AOP networks.
Ecologically Relevant Test Systems	Fish cell lines (e.g., RTgill-W1, RTgutGC), 3D organoids, Microphysiological Systems (MPS), Limited in vivo models (e.g., zebrafish embryo)	Measuring KEs in systems with ecological relevance, including metabolic and tissue-specific responses.	Direct measurement of KEs in species of concern or related surrogates; improving extrapolation confidence.
Exposure & Monitoring Data Resources	Aggregate Exposure Pathway (AEP) constructs [69], ECOTOX knowledgebase [69], Environmental monitoring datasets	Providing exposure context and environmental concentrations to move from hazard to risk assessment.	Enabling region-specific risk assessments (e.g., for inorganic arsenic in Indian rivers) [69].

The integration of AOP networks, NAMs, and IATA represents a paradigm shift toward more mechanistic, efficient, and ethical ecological risk assessment. AOP networks provide the necessary conceptual framework to rationally select and interpret NAMs, while IATA offers the practical framework for integrating data into regulatory decisions. The ongoing FAIRification of AOP knowledge is critical to scaling this approach, making it machine-actionable and broadly accessible [6].

Future progress hinges on:

• Expanding and Quantifying AOP Networks: Filling knowledge gaps in existing AOPs and developing quantitative KERs to support predictive modeling.
• Validating NAMs for Ecological KEs: Increasing the inventory of NAMs tailored to measure KEs in ecologically relevant species and life stages.
• Bridging Exposure and Effect: Tightly coupling Aggregate Exposure Pathways (AEPs) with AOP networks to enable true, pathway-based risk assessment [69].
• Building Confidence through Case Studies: Demonstrating the reliability and protective value of AOP-informed IATA through iterative application to real-world regulatory problems across sectors [59] [67].

By embracing this integrated vision, researchers and risk assessors can leverage the power of 21st-century toxicology to better protect both human and ecological health.

Enabling Cross-Species Extrapolation and Complex Mixture Assessment

This whitepaper details the application of the Adverse Outcome Pathway (AOP) framework to address two persistent challenges in modern ecological risk assessment (ERA): cross-species extrapolation and complex mixture assessment. By organizing mechanistic toxicity data into modular sequences of causally linked Key Events (KEs), AOPs provide a translatable biological scaffold [8]. This scaffold enables researchers to extrapolate effects across species based on the conservation of biological pathways and to predict mixture effects by identifying shared or converging toxicity targets within AOP networks [8] [17]. The integration of AOPs with complementary frameworks, such as the Aggregate Exposure Pathway (AEP), and the adoption of FAIR (Findable, Accessible, Interoperable, Reusable) data principles are critical for advancing predictive, mechanism-based risk assessments that can reduce reliance on whole-animal testing [6] [17].

Ecological risk assessment requires predicting adverse outcomes for diverse species and complex chemical mixtures, yet empirical testing of every conceivable scenario is impossible [71]. The AOP framework addresses this by structuring existing knowledge on the mechanistic sequence of events leading from a Molecular Initiating Event (MIE) to an Adverse Outcome (AO) relevant to risk assessment [8]. An AOP is not chemical-specific; instead, it describes a generalized chain of biological "dominoes" (KEs) that can be triggered by any stressor acting on a defined MIE [8].

The true predictive power emerges when individual AOPs are interconnected via shared KEs to form AOP networks. These networks more accurately reflect biological complexity and are recognized as the functional unit for prediction [8]. They provide the structure needed to understand how different chemicals in a mixture might interact (e.g., additively) by affecting common KEs, and to evaluate whether a pathway is conserved across species, from model organisms to species of concern [8] [17].

Core Methodologies for Cross-Species Extrapolation

Cross-species extrapolation aims to predict chemical sensitivity for untested species. The AOP framework enhances traditional empirical methods by adding a mechanistic layer, allowing extrapolation based on the conservation of pathway components rather than solely on taxonomic proximity [71].

Extrapolation Predictors and Their Data Requirements

Different extrapolation methods offer varying degrees of mechanistic insight and have distinct data requirements, as summarized in Table 1 [71].

Table 1: Comparison of Cross-Species Extrapolation Methodologies [71]

Method Category	Core Predictor	Mechanistic Insight	Data Requirements	Primary Use Case
Interspecies Correlation	Toxicity value of a surrogate species	Low - Empirical	Paired toxicity data for multiple species	Simple, data-driven screening
Relatedness-Based	Phylogenetic distance	Medium - Assumes trait conservation	Taxonomy/phylogeny, some toxicity data	Extrapolation within well-studied clades
Traits-Based	Life-history, physiological traits	Medium-High - Links to susceptibility	Species trait databases, toxicity data	Explaining sensitivity across diverse taxa
Genomics-Based	Sequence/expression of pathway genes	High - Directly tests mechanism	Omics data, pathway annotation	Mechanistic extrapolation for defined AOPs

The AOP-Based Extrapolation Workflow

The process of using AOPs for cross-species extrapolation involves several key steps, visualized in the workflow below.

Title: AOP-Based Cross-Species Extrapolation Workflow

Detailed Protocol:

• Identify Critical KEs: From a well-established AOP (e.g., in a model fish species), identify the MIE and essential KEs hypothesized to be most predictive of the AO [8].
• Assess Conservation:
  • For Molecular KEs (MIE, early cellular KEs): Use bioinformatic tools to evaluate conservation. For example, the EPA's SeqAPASS tool compares protein sequence similarity across species to assess the likelihood that a chemical will interact with a homologous molecular target (e.g., an estrogen receptor) in an untested species [8].
  • For Higher-Level KEs (tissue, organ-level): Gather comparative physiological or toxicity data from the literature to assess if the functional response is conserved. This may involve comparing dose-response relationships for a shared KE (e.g., reduction in plasma thyroxine) [17].
• Predict Sensitivity: Integrate conservation evidence. High conservation of the MIE and early KEs supports the hypothesis that the entire pathway is operative. Quantitative differences in sensitivity can be modeled based on comparative toxicokinetics or differences in binding affinity at the MIE [17].
• Validate and Refine: When possible, conduct targeted in vitro or limited in vivo tests on the species of concern to measure a critical KE, validating the extrapolation and refining the model [8].

Case Study: Perchlorate and Thyroid Hormone Axis Disruption

A landmark case study demonstrated the integration of dose-response data across 12 vertebrate and invertebrate species for perchlorate, which inhibits the sodium-iodide symporter (NIS) [17]. The protocol involved:

• Defining a common AOP network centered on NIS inhibition → reduced thyroid hormone synthesis → impaired growth/development.
• Collating all available dose-response data for KEs (e.g., iodide uptake inhibition, thyroxine levels) and AOs (e.g., impaired metamorphosis, reduced growth) from the literature, standardizing dose units to µg/kg/day.
• Plotting and comparing effective dose (EDxx) values across species for each sequential KE. The study found a high degree of dose-response concordance; species sensitive at the MIE (NIS inhibition) were generally sensitive for downstream AOs, supporting pathway conservation and enabling prediction [17].

Table 2: Key Quantitative Findings from the Perchlorate Cross-Species Case Study (Representative Data) [17]

Species	Endpoint (Key Event)	Reported Effect Level	Interpretation for Extrapolation
Rat (Rattus sp.)	Thyroidal Iodide Uptake Inhibition (MIE)	ED50 ~ 1 mg/kg/day	Establishes baseline potency for MIE in a mammalian model.
African Clawed Frog (Xenopus laevis)	Reduced Plasma Thyroxine (KE)	ED50 ~ 0.7 mg/kg/day	Shows comparable sensitivity at hormonal KE, supporting pathway conservation from mammals to amphibians.
Zebrafish (Danio rerio)	Impaired Larval Growth (AO)	LOEC ~ 10 mg/L (water)	Provides an effect threshold for a population-relevant AO in a fish model.
Daphnia (Daphnia magna)	Reproduction Inhibition (AO)	LOEC ~ 32 mg/L (water)	Indicates the thyroid-like pathway may be functional in some invertebrates, but with different sensitivity.

Assessing Complex Mixtures via AOP Networks

Predicting the effects of chemical mixtures is a major challenge. AOP networks provide a mechanistic basis for grouping chemicals and predicting their combined effects, moving beyond simple chemical similarity [8].

Conceptual Framework for Mixture Assessment

Mixture effects can be predicted by determining how the components interact within the biological system. AOP networks map the "topology" of toxicity pathways, revealing where chemicals share KEs (convergence) or affect linked pathways [8].

Title: Predicting Mixture Effects Using AOP Network Topology

Detailed Protocol for Mixture Assessment:

• Component Characterization: For each chemical in the mixture, identify its primary mode of action and map it to one or more MIEs in relevant AOPs using experimental data or in silico tools [8].
• Network Construction/Interrogation: Use an AOP knowledgebase (e.g., AOP-Wiki, EPA AOP-DB) to assemble a network containing all AOPs relevant to the identified MIEs [6] [72]. Analyze the network for:
  • Shared KEs: Chemicals acting upstream of a common KE are likely to act in a dose-additive manner. The combined risk can be estimated by summing their doses relative to their individual potencies for that shared KE [8] [17].
  • Independent Pathways: If chemicals act on entirely separate AOPs leading to different AOs, their effects may be response-additive or independent.
  • Synergistic/Antagonistic Interactions: Network analysis can reveal points of biological crosstalk (e.g., where a KE in one pathway regulates a KE in another), highlighting potential interaction hotspots for empirical testing [17].
• Hypothesis-Driven Testing: The network analysis generates testable hypotheses. For example, if two chemicals converge on a shared KE, an in vitro assay measuring that KE can be used to validate the predicted additivity, reducing the need for complex whole-mixture animal tests [8].
• Integrated Risk Estimation: Quantitative dose-response models for individual KEs, derived from New Approach Methodologies (NAMs), can be integrated within the AOP network structure to simulate mixture effects under various exposure scenarios [17].

Essential Research Infrastructure and Tools

The effective implementation of these methodologies relies on accessible, high-quality data and specialized tools.

Tool/Resource Name	Type	Primary Function in AOP Research	Access/Example
AOP-Wiki	Knowledgebase	The central repository for collaborative AOP development, sharing, and curation. Hosts AOP descriptions, KEs, KERs, and supporting evidence [6] [8].	https://aopwiki.org/
EPA AOP Database (AOP-DB)	Database	Provides organized, searchable biological information for specific AOPs, linking pathway components to external databases (e.g., genes, assays) [72].	U.S. EPA resource [72].
SeqAPASS	Bioinformatics Tool	Evaluates protein sequence similarity across species to predict chemical susceptibility based on the conservation of molecular targets (MIEs) [8].	U.S. EPA webtool.
EnviroTox Database	Toxicity Database	A curated database of aquatic toxicity results used to develop predictive models and tools like the Ecological Threshold of Toxicological Concern (eco-TTC) [57].	https://envirotoxdatabase.org/
FAIR AOP Roadmap	Guidance Framework	A community plan to make AOP data Findable, Accessible, Interoperable, and Reusable, ensuring data quality and machine-actionability for computational use [6].	Described in Mortensen et al., 2025 [6].

Future Directions and Integration with Next-Generation ERA

The field is evolving towards fully integrated, predictive risk assessment. Key frontiers include:

• Quantitative AOP (qAOP) Models: Transforming qualitative pathways into computational models that can predict the magnitude and timing of AOs based on KE perturbations [8] [16].
• Integration with Exposure Science: Linking AOPs with Aggregate Exposure Pathways (AEPs), which track stressors from sources to target-site exposures, creates a unified AEP-AOP framework for cumulative risk assessment [17].
• Bridging to Population-Level Effects: AOPs that terminate in AOs affecting reproduction, growth, or survival provide the essential individual-level data needed to parameterize population models, bridging mechanistic toxicology to ecological relevance [16].
• International Collaboration: Initiatives like the FAIR AOP Cluster Workgroup and the HESI Next Generation ERA Committee are crucial for standardizing practices, developing case studies, and promoting the regulatory acceptance of these approaches [6] [57].

The AOP framework provides the essential mechanistic foundation required to move ecological risk assessment from a predominantly empirical, chemical-by-chemical endeavor to a predictive, pathway-based science. By enabling rigorous cross-species extrapolation and providing a structured approach to deconvolve mixture toxicity, AOP networks address core limitations in current practice. Successful implementation depends on the continued development of computational tools, high-quality, FAIR data, and quantitative models integrated within a collaborative international research community.

Benchmarking and Comparative Analysis of Different Network Construction Methodologies

The Adverse Outcome Pathway (AOP) framework is a conceptual tool for organizing mechanistic biological knowledge to support hazard assessment and regulatory decision-making [8]. While individual AOPs describe a linear sequence of events from a Molecular Initiating Event (MIE) to an Adverse Outcome (AO), real-world biological systems are characterized by complexity, cross-talk, and interactions among pathways [28]. Consequently, AOP networks, defined as assemblies of two or more AOPs that share one or more Key Events (KEs), are recognized as the functional unit of prediction for ecological risk assessment [28] [8]. They provide a more realistic representation of how multiple stressors or a single stressor acting through multiple mechanisms can converge on common adverse outcomes, which is critical for assessing complex chemical mixtures and cross-species extrapolation [8].

This guide provides a technical benchmarking analysis of methodologies for constructing these networks. The focus is on comparative approaches that enable researchers to build, analyze, and apply AOP networks within the broader thesis of exploring AOP frameworks for ecological risk assessment research, aligning with community efforts to enhance the Findability, Accessibility, Interoperability, and Reusability (FAIR) of AOP knowledge [6].

Foundational Concepts and Definitions

• Adverse Outcome Pathway (AOP): A conceptual framework that depicts a logically linked sequence of key biological events, from a direct molecular initiation by a stressor to an adverse outcome relevant to risk assessment [8].
• Key Event (KE): A measurable, essential biological change in the pathway. KEs are the modular nodes in an AOP or AOP network [28] [8].
• Molecular Initiating Event (MIE): The initial, specific biological interaction between a stressor and a biomolecule (e.g., receptor binding, DNA damage) [8].
• Key Event Relationship (KER): A scientifically supported description of the causal or correlative linkage between two KEs. KERs form the directed edges in the network [8].
• AOP Network: An assembly of two or more AOPs that share one or more common KEs (including MIEs or AOs) [28].
• Network Development vs. Derivation: Development is a broad term for creating networks, while derivation specifically refers to programmatically or manually extracting and linking relevant AOPs and KEs from a knowledgebase like the AOP-Wiki [28].

Typology of AOP Network Construction Methodologies

Construction methodologies can be categorized by their starting point, automation level, and primary objective.

Table 1: Comparative Analysis of AOP Network Construction Methodologies

Methodology	Description	Process	Key Advantages	Key Limitations	Best Suited For
Hypothesis-Driven, Manual Curation	Expert-led development of interconnected AOPs based on a specific research question or toxicological hypothesis.	1. Define a focal KE, MIE, or AO.2. Manually search literature and AOP-KB for linked pathways.3. Assemble network based on biological plausibility and evidence.	High biological relevance and accuracy; strong integration of domain expertise.	Labor-intensive; scalability is limited; potential for expert bias.	In-depth investigation of a specific mechanism (e.g., ATZ-induced reproductive toxicity [12]).
Knowledgebase Derivation (Bottom-Up)	Extraction of pre-existing AOPs and KEs from structured repositories like the AOP-Wiki to form de facto networks.	1. Select a "seed" AOP or KE.2. Use software (e.g., Biovista Vizit [12]) or API queries to find all AOPs sharing that seed.3. Export and visualize the interconnected graph.	Leverages community-shared knowledge; fast and reproducible; identifies unanticipated connections.	Dependent on completeness and standardization within the knowledgebase; may produce large, unfiltered networks.	Exploratory analysis to understand the connectivity around a known pathway or event.
Data-Driven Inference (Top-Down)	Generation of network hypotheses from high-throughput in vitro or omics data using computational biology and bioinformatics tools.	1. Analyze gene/protein expression, perturbation responses, or chemical structure data.2. Infer functional modules and enriched pathways.3. Map modules to standardized KE ontologies to propose AOP network structures.	Truly discovery-based; can identify novel mechanisms and connections not yet in knowledgebases.	Requires significant computational and bioinformatics expertise; proposed links require strong validation; challenge of mapping data to AOP framework concepts.	Screening and prioritizing mechanisms for unknown or poorly characterized stressors.
Integrated, Iterative Workflow	A hybrid approach combining elements of the above methods in a cyclical process of derivation, hypothesis, and validation.	1. Derive a preliminary network from the AOP-KB.2. Refine and enrich it with targeted literature and experimental data.3. Analyze topology to identify critical KEs for testing.4. Validate and update the network [12].	Balances efficiency with depth; allows for continuous refinement; aligns with the "living document" AOP principle [8].	Can be complex to manage; requires a multi-skilled team.	Comprehensive research programs aiming to develop and quantitatively validate an AOP network for a defined risk assessment context.

Benchmarking Criteria for Methodology Evaluation

Selecting an appropriate methodology requires evaluation against defined benchmarks relevant to ecological risk assessment.

Table 2: Benchmarking Criteria for Network Construction Methodologies

Criterion	Definition & Relevance	Assessment Metrics
Biological Plausibility & Confidence	The strength of evidence supporting the KERs within the network. Central to the AOP framework's utility in regulatory contexts [8].	• Weight of Evidence (WoE) scores for individual KERs.• Proportion of KERs with strong empirical/quantitative support.• Peer-review status of constituent AOPs.
FAIRness	The degree to which the network and its components are Findable, Accessible, Interoperable, and Reusable [6]. Enables collaboration and integration.	• Use of standardized KE/KER identifiers (e.g., AOP-Wiki IDs).• Machine-actionable format (e.g., JSON, RDF).• Clear licensing and provenance metadata.
Fitness-for-Purpose	How well the network addresses a specific research or assessment question (e.g., mixture toxicity, cross-species extrapolation) [28].	• Alignment of network scope (taxa, life stage, tissue) with the assessment problem.• Inclusion of relevant MIEs and AOs.• Ability to generate testable hypotheses.
Analytical Richness	The suitability of the network structure for computational analysis to extract insights (e.g., critical paths, susceptibility points).	• Network density and centrality metrics (degree, betweenness).• Identification of highly connected "hub" KEs.• Suitability for quantitative modeling.
Operational Efficiency	The practical resources (time, expertise, cost) required to construct and maintain the network.	• Time from initiation to usable network.• Level of specialized expertise (toxicology, bioinformatics, programming) required.• Degree of automation possible.

Detailed Experimental Protocol: A Case Study in Reproductive Toxicity

The following protocol, based on the work of Vieira et al. (2024) to construct an AOP network for atrazine-induced reproductive toxicity via oxidative stress, exemplifies an integrated, iterative workflow [12].

Objective: To derive, characterize, and analyze an AOP network explaining reproductive dysfunction triggered by oxidative stress, using the herbicide atrazine (ATZ) as a model stressor.

Phase 1: Network Derivation & Assembly

• Seed Selection: Identify a relevant seed AOP. In this case, AOP 492 ("Glutathione conjugation leading to reproductive dysfunction") was used [12].
• Knowledgebase Query: Use specialized software (e.g., Biovista Vizit) or the AOP-Wiki application programming interface (API) to programmatically extract all AOPs in the knowledgebase that share KEs with the seed AOP. This forms the initial derived network [12].
• Manual Curation & Enrichment: Refine the raw derived network by:
  • Reviewing the biological context and applicability of each linked AOP.
  • Adding relevant KEs or KERs from the primary literature not yet captured in the AOP-Wiki.
  • Standardizing KE names to merge synonymous terms (e.g., "Increase, Reactive Oxygen Species" vs. "Oxidative stress") which is critical for accurate connectivity analysis [12].

Phase 2: Network Characterization & Analytics

• Topological Analysis: Model the network as a directed graph where KEs are nodes and KERs are edges. Calculate graph theory metrics:
  • Degree Centrality: Counts connections per KE. High-degree "hub" KEs (e.g., "Increased, Reactive Oxygen Species," "Apoptosis") are potential leverage points for prediction and testing [12].
  • Betweenness Centrality: Identifies KEs that act as bridges connecting different sub-pathways.
  • Path Analysis: Identifies all possible routes from relevant MIEs (e.g., "Glutathione conjugation") to the AO ("Reproductive dysfunction").
• Biological Interpretation: Map computational findings to biology. For example, identify that "Increased, DNA damage and mutations" is a critical, highly connected divergent point in the network, suggesting its key role in propagating toxicity to multiple endpoints [12].

Phase 3: In Silico & Experimental Validation

• Target Prediction: Use molecular docking and protein-protein interaction network analysis to identify pivotal proteins (e.g., TP53, BCL2, ESR1) linked to the key hub KEs identified in Phase 2 [12].
• Hypothesis-Driven Assay Development: Design a battery of in vitro assays targeting the high-priority hub KEs (e.g., oxidative stress, apoptosis, DNA damage assays) for predictive screening of chemicals.
• Iterative Refinement: Use experimental data from validation studies to strengthen the WoE for KERs in the network or to suggest modifications, adhering to the AOP-as-a-living-document principle [8].

Diagram 1: Integrated AOP Network Development Workflow

Visualization of a Conceptual AOP Network Structure

The following diagram illustrates the core conceptual structure of an AOP network, showing how shared Key Events create connectivity between individual linear AOPs, forming the functional unit for prediction.

Diagram 2: Conceptual AOP Network with Shared Key Events

The Scientist's Toolkit: Essential Research Reagent Solutions

Table 3: Key Reagents and Tools for AOP Network Construction & Validation

Item	Category	Function in AOP Network Research	Example/Specification
AOP-Wiki / AOP-KB	Knowledgebase	The primary, peer-reviewed repository for structured AOP information. Serves as the foundational data source for network derivation [28] [8].	https://aopwiki.org
Biovista Vizit, AOP Explorer	Software Tools	Specialized applications for visualizing, exploring, and programmatically deriving networks of AOPs and KEs from the AOP-KB [12].	Commercial & open-source tools with API access.
Cytoscape, Gephi	Network Analytics	Open-source platforms for graph visualization and network topology analysis (e.g., calculating centrality metrics) [28].	Plugins available for biological network analysis.
SeqAPASS	Bioinformatics Tool	Supports cross-species extrapolation by evaluating the structural conservation of protein targets (like MIEs) across taxa, a key uncertainty in ecological risk assessment [8].	Developed by the U.S. EPA.
Reactive Oxygen Species (ROS) Detection Kits	Wet-lab Assay	Quantifies a common "hub" KE identified in many stressor-induced networks (e.g., oxidative stress) [12].	e.g., DCFDA/H2DCFDA cellular ROS assay.
Caspase-3/7 Activity Assay	Wet-lab Assay	Measures apoptosis, another frequent high-degree KE in toxicity networks serving as a point of convergence or divergence [12].	Luminescent or fluorescent based kits.
Comet Assay or γH2AX Detection Kit	Wet-lab Assay	Detects DNA damage and repair, a critical event linking many MIEs to mutagenic and carcinogenic outcomes [12].	Single-cell gel electrophoresis or immunofluorescence.
OECD Harmonised Templates (OHT)	Data Standard	Facilitates the FAIRness of experimental data used to support KERs by providing standardized formats for reporting toxicological tests [6].	Required for regulatory submission in many jurisdictions.

The field of ecological risk assessment faces a fundamental challenge: predicting the effects of thousands of environmental stressors using limited, often disparate, data. The Adverse Outcome Pathway (AOP) framework has emerged as a powerful organizing principle to address this challenge by linking mechanistic biological data to adverse outcomes relevant for decision-making [8]. An AOP describes a sequential chain of events, starting from a molecular interaction (Molecular Initiating Event, MIE) and progressing through measurable biological changes (Key Events, KEs) to an adverse outcome (AO) at an organism or population level [8] [12].

However, biological systems are complex networks, not simple linear pathways. The "one perturbation–one adverse outcome" model of a single AOP is an oversimplification of real-world scenarios involving multiple stressors and interacting biological mechanisms [12]. Consequently, AOP networks—assemblies of interconnected AOPs that share common KEs—are increasingly recognized as the functional unit for prediction in toxicology and ecological risk assessment [8] [15]. These networks provide a more realistic and holistic representation of biological complexity, capturing pleiotropic effects and potential interactions between different toxicological pathways [15].

This whitepaper argues that the regulatory acceptance of AOP networks for ecological risk assessment hinges on two interdependent pillars: the systematic assembly of a weight of evidence and an unwavering commitment to transparency. Confidence for decision-makers is built not by asserting simplicity, but by rigorously documenting the evidence, acknowledging uncertainty, and providing a clear, reproducible rationale for how network-based predictions are generated and interpreted.

Foundational Concepts: From Linear AOPs to Complex Networks

An AOP is a modular construct composed of two basic units: Key Events (KEs) and Key Event Relationships (KERs) [15]. KEs are measurable biological changes at different levels of organization (e.g., cellular, tissue, organ). KERs are the causal or mechanistic links describing how one KE leads to another [8]. Importantly, AOPs are not chemical-specific; they depict a generalized sequence that can be activated by any stressor that triggers the defined MIE [8].

When multiple AOPs share KEs (e.g., a common MIE or an intermediate cellular response), they can be linked to form an AOP network [15]. In this network representation, KEs serve as nodes and KERs as directed edges (arrows) [15]. This structure allows for the application of graph theory and network science to analyze topological features, such as identifying highly connected "hub" KEs that may represent critical points of convergence for multiple stressors or sensitive biomarkers for testing [15] [12].

A critical distinction exists between AOP networks and other biological networks. In an AOP network, a node does not represent a biological entity (e.g., a protein) but a measurable change in the state of that entity or process (e.g., "Increased oxidative stress" or "Decreased hormone synthesis") [15]. This focus on quantifiable change is central to their utility in risk assessment.

Table: Core Components of the AOP Framework

Component	Definition	Role in AOP Networks
Molecular Initiating Event (MIE)	The initial interaction between a stressor and a biological target [8].	A potential point of entry for multiple stressors; can be a shared node linking multiple AOPs.
Key Event (KE)	A measurable biological change essential to the progression of toxicity [8].	Serves as a node in the network. Shared KEs create connections between individual AOPs.
Key Event Relationship (KER)	A scientifically supported link describing how one KE leads to another [8].	Serves as a directed edge (arrow) between nodes in the network.
Adverse Outcome (AO)	An adverse effect at the organism or population level relevant to risk assessment [8].	A terminal node; the same AO (e.g., population decline) can be reached via multiple network paths.
Network "Hub"	A KE that is highly connected to many other KEs within the network [15] [12].	Identified via network analysis; indicates a critical, predictive point for assay development or intervention.

The Pillar of Weight of Evidence (WoE): Qualifying Confidence in AOP Networks

For AOP networks to inform regulatory decisions, the confidence in each component and its connections must be explicitly evaluated and documented. The weight of evidence assessment is applied at multiple levels: to individual KERs, to entire AOPs, and ultimately to the network itself.

Evidence Supporting Key Event Relationships (KERs)

Each KER within a network should be evaluated based on three fundamental types of evidence [8]:

• Biological Plausibility: Is the relationship consistent with established biological knowledge? Support may come from structural or functional analogies.
• Empirical Support: Do experimental data demonstrate that a change in the upstream KE leads to a predictable change in the downstream KE? This includes dose, temporal, and incidence concordance.
• Quantitative Understanding: Can the relationship be described with a quantitative model? This represents the highest level of understanding, allowing for predictive extrapolation.

Quantitative Metrics for Network Analysis

Graph theory provides tools to quantify network topology and identify critical elements. These metrics form a quantitative evidence layer supporting the identification of important pathways or biomarkers [15] [12].

Table: Key Quantitative Metrics for AOP Network Analysis

Metric	Definition	Interpretation in AOP Networks	Regulatory Utility
Degree Centrality	Number of connections (edges) a node (KE) has [15].	A KE with a high degree is a highly connected "hub". It may represent a critical, convergent point of toxicity or a highly predictive biomarker [12].	Prioritizes KEs for assay development in integrated testing strategies (IATA).
Betweenness Centrality	The number of shortest paths between other nodes that pass through a given node [15].	A KE with high betweenness acts as a key chokepoint or connector between different sections of the network.	Identifies potential leverage points for mitigation or intervention.
Path Length	The number of steps (KERs) between an MIE and an AO.	Shorter paths may indicate a more direct and potentially potent relationship. Helps identify the most critical pathways through a complex network [15].	Supports the identification of the most efficient predictive assays for a given outcome.
Modularity	The extent to which a network can be divided into distinct, densely connected subgroups [15].	Can reveal functional modules (e.g., all events related to oxidative stress) within a larger network.	Aids in organizing complex knowledge and identifying shared mechanisms across AOPs.

The Pillar of Transparency: Documenting for Reproducibility and Trust

Transparency is the mechanism that allows the weight of evidence to be critically evaluated by regulators and the scientific community. Opaque or poorly documented AOP networks cannot build confidence. Key transparency practices include:

• Structured Knowledge Management: Using standardized platforms like the AOP-Wiki ensures information is organized in a consistent, accessible format, with fields for describing evidence, taxonomic applicability, and quantitative understandings for every KE and KER [8].
• Explicit Documentation of Uncertainty: AOPs and networks are "living documents" and simplifications of biology [8]. Confidence must be qualified by explicitly stating uncertainties, data gaps, and assumptions regarding species extrapolation or modulating factors (e.g., life stage, disease state).
• Protocol Pre-registration and Detailed Reporting: As emphasized in real-world evidence research, pre-registering the plan for developing or applying an AOP network reduces bias and clarifies intent [73]. Published applications must provide exhaustive methodological detail, allowing for independent reproduction of the network construction and analysis [73] [12].

Integration with Regulatory Assessment Paradigms

For ecological risk assessment, the value of AOP networks extends beyond hazard identification to inform several key challenges [8] [16] [17]:

• Cross-Species Extrapolation: By mapping the conservation of KEs and KERs (e.g., using tools like SeqAPASS), networks provide a mechanistic basis for extrapolating effects from tested to untested species, including endangered species [8].
• Evaluating Complex Mixtures: AOP networks can visualize how multiple chemicals sharing a common KE (e.g., oxidative stress) may lead to additive effects on a downstream AO, informing the design of mixture toxicity studies [8] [15].
• Linking to Higher-Level Effects: Networks provide the mechanistic bridge connecting molecular/cellular responses to population-relevant AOs, which can be modeled using population models to predict long-term ecological impacts [16].
• Exposure Integration: The AOP framework can be linked with an Aggregate Exposure Pathway (AEP), which tracks a stressor from source to target site exposure. The combined AEP-AOP construct allows for a more integrated risk assessment by aligning exposure estimates with the biological level of the MIE [17].

Table: Experimental Protocol for Constructing and Analyzing an AOP Network

Protocol Step	Detailed Methodology	Tools & Resources	Transparency Output
1. Problem Formulation	Define the regulatory or research question. Identify the stressor(s) and AO(s) of interest.	Regulatory guidelines, Literature review.	A clearly stated objective and scope for network development.
2. Evidence Assembly	Systematically gather literature on MIEs, KEs, and KERs related to the question. Use structured reviews.	PubMed, AOP-Wiki [8], ToxCast database.	Annotated bibliography with evidence coded for biological plausibility, empirical, and quantitative support.
3. Network Construction	Use a seed AOP or KE to query the AOP-KB for linked pathways. Manually curate and merge related KEs [12].	AOP-Wiki, Biovista Vizit [12], Cytoscape.	A visual network diagram (e.g., DOT/Graphviz file) and a list of all included KEs/KERs with provenance.
4. Topological Analysis	Calculate network metrics (degree, betweenness centrality) [15]. Identify hub KEs and critical paths.	Network analysis software (e.g., igraph, NetworkX).	Table of quantitative metrics for all KEs. Identification and rationale for "critical" nodes/paths.
5. Confidence Assessment	Apply the WoE framework to each KER in critical paths. Document uncertainty and taxonomic applicability.	OECD Guidance, Bradford Hill considerations.	A confidence matrix or summary table for the network, highlighting strong and weak linkages.
6. Application & Testing	Use the network to design an integrated testing strategy (IATA) or inform a quantitative model.	In vitro assays, QSAR models, population models [16].	A proposed testing strategy or model structure based on network insights.

Case Study: Building an AOP Network for Atrazine-Induced Reproductive Toxicity

A practical example illustrates the pathway to confidence. A study aimed to elucidate the mechanisms of reproductive toxicity induced by the herbicide atrazine (ATZ) via oxidative stress [12].

• Seed AOP: The work began with AOP 492 ("Glutathione conjugation leading to reproductive dysfunction"), developed using ATZ data [12].
• Network Construction: Using AOP 492 as a seed, researchers queried the AOP-Wiki to find all linked AOPs, constructing a Reproductive Toxicity via Oxidative Stress (RTOS) AOP network [12].
• WoE & Transparency: Network analysis was performed using established methodologies [15] [12]. The process and software used (Biovista Vizit) were explicitly documented.
• Critical Findings: Analysis identified "Increased, Reactive Oxygen Species" and "Apoptosis" as the most highly connected KEs (hubs) and points of divergence in the network [12]. "Increased, DNA damage and mutations" was also a critical, central KE.
• Regulatory Utility: These hub KEs were highlighted as having high predictive value, providing a rational basis for selecting a battery of in vitro assays (e.g., measuring ROS, DNA damage, apoptosis) to screen other chemicals for similar reproductive toxicity potential, reducing reliance on animal testing [12].

The Scientist's Toolkit: Key Resources for AOP Network Development

Tool / Resource	Type	Primary Function in AOP Work	Access / Example
AOP-Wiki	Knowledgebase	The central repository for developing, sharing, and discovering AOPs and their components in a structured format [8].	https://aopwiki.org
SeqAPASS	Computational Tool	Evaluates the conservation of protein sequences and domains across species to inform cross-species extrapolation of MIEs [8].	U.S. EPA Tool
Cytoscape / igraph	Network Analysis Software	Visualizes and computes topological metrics (degree, betweenness) on AOP networks [15] [12].	Open-source software
Biovista Vizit	Specialized Software	A visual exploration tool designed to view, explore, and create interactive AOP networks from the AOP-KB [12].	Commercial software
OECD AOP Development Handbook	Guidance Document	Provides international standards and best practices for AOP development to ensure quality and consistency [15].	OECD Publication

Discussion: Building a Roadmap for Confidence and Acceptance

The journey toward regulatory acceptance of AOP networks is a process of confidence-building. This whitepaper has outlined how this confidence is forged through the meticulous application of weight of evidence assessments and rigorous transparency standards. For researchers, this means adhering to systematic development guidelines and fully documenting their work. For regulators, it provides a structured framework to evaluate the predictive validity and appropriate use context of AOP network-based information.

Future directions must focus on enhancing both pillars:

• Advancing WoE: Developing quantitative, probabilistic frameworks for scoring confidence in networks and integrating computational models to make quantitative predictions along network paths.
• Enhancing Transparency: Creating standardized reporting templates for AOP network applications and promoting the practice of pre-registering network-based testing strategies or risk assessment plans.

By embracing these principles, the scientific and regulatory communities can collectively advance AOP networks from a research-focused conceptual tool into a robust, trusted component of next-generation ecological risk assessment, enabling smarter, faster, and more protective decisions for environmental and public health.

Conclusion

AOP networks represent a paradigm shift in ecological and biomedical risk assessment, moving from siloed, linear toxicity descriptions to interconnected, systems-level models that more accurately reflect biological complexity. By synthesizing knowledge across modular pathways, they provide a powerful scaffold for integrating diverse data streams—from high-throughput in vitro assays to epidemiological observations—and directly support the adoption of animal-free New Approach Methodologies (NAMs). The future impact on biomedical and clinical research is profound: AOP networks offer a structured framework for hypothesis-driven drug safety screening, elucidating polypharmacology and off-target effects, and understanding disease pathogenesis through the lens of molecular initiating events. Key future directions include the widespread implementation of the FAIR data principles to enhance reusability[citation:1], the expansion of quantitative and probabilistic network models for prediction[citation:3], and the continued development of case studies that bridge the gap between network theory and regulatory decision-making. Ultimately, the evolution of robust, well-characterized AOP networks is essential for achieving a more predictive, efficient, and mechanistic foundation for protecting both human and environmental health.

References

• 1. Adverse Outcome Pathways | US EPA [https://www.epa.gov/chemical-research/adverse-outcome-pathways]
• 2. Adverse outcome pathways as tools to assess drug-induced ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5436615/]
• 3. Advancing human health risk assessment: the role of new ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12537679/]
• 4. AOP-networkFinder—a versatile tool for the reconstruction ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11835234/]
• 5. An integrated approach for prioritizing pharmaceuticals ... [https://www.sciencedirect.com/science/article/abs/pii/S0045653514000873]
• 6. The FAIR AOP Roadmap for 2025: Advancing Findability ... [https://assessments.epa.gov/risk/document/&deid%3D366972]
• 7. Adverse Outcome Pathway (AOP) Coaching Program-how ... [https://pubmed.ncbi.nlm.nih.gov/40627405/]
• 8. Adverse Outcome Pathway (AOP) Research Brief [https://www.epa.gov/chemical-research/adverse-outcome-pathway-aop-research-brief]
• 9. Adverse outcome pathway (AOP) development I: strategies ... [https://pubmed.ncbi.nlm.nih.gov/25466378/]
• 10. Adverse Outcome Pathway Development II: Best Practices [https://pmc.ncbi.nlm.nih.gov/articles/PMC4318924/]
• 11. A Case Study on Integrating a New Key Event Into an Existing ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9097222/]
• 12. Revealing an adverse outcome pathway network for ... [https://www.sciencedirect.com/science/article/abs/pii/S2468111324000197]
• 13. 综述：微塑料对水生生物的生态毒性及其不良后果途径网络 [https://www.ebiotrade.com/newsf/2025-10/20251003082825727.htm]
• 14. 有害结局路径(AOP)框架在水体复合污染监测研究中的应用 [https://stdl.cbpt.cnki.net/wki/WebPublication/wkTextContent.aspx?contentID=&colType=4&yt=2017&st=01]
• 15. Adverse Outcome Pathway Networks II: Network Analytics - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC6010347/]
• 16. Adverse outcome pathways and ecological risk assessment [https://academic.oup.com/etc/article/30/1/64/7762515]
• 17. A case study application of the Aggregate Exposure Pathway ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6003653/]
• 18. 有害结局路径的研究进展和现状 [https://www.jeom.org/article/doi/10.13213/j.cnki.jeom.2021.20471?viewType=HTML]
• 19. 综述：环境分析中的代谢组学：应用、进展与新兴挑战 [https://www.ebiotrade.com/newsf/2025-11/20251130004530826.htm]
• 20. CN110794047A - 一种复杂受试物对皮肤致敏性的预测方法 [https://patents.google.com/patent/CN110794047A/zh]
• 21. Comprehensive mapping of the AOP-Wiki database [https://pmc.ncbi.nlm.nih.gov/articles/PMC10958381/]
• 22. AOP-Wiki [https://aopwiki.org/]
• 23. A high-level overview of the OECD AOP Development Programme - PubMed [https://pubmed.ncbi.nlm.nih.gov/35938955/]
• 24. AOP-Wiki [https://aopwiki.org/handbooks/3]
• 25. Adverse Outcome Pathway Wiki [https://www.epa.gov/comptox-tools/adverse-outcome-pathway-wiki]
• 26. The FAIR AOP roadmap for 2025: Advancing findability, ... [https://pubmed.ncbi.nlm.nih.gov/40950714/]
• 27. The FAIR AOP roadmap for 2025 [https://www.rti.org/publication/the-fair-aop-roadmap-for-2025-advancing-findability-accessibility]
• 28. Adverse Outcome Pathway Networks I: Development and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6004608/]
• 29. Development of a data-driven approach to Adverse ... [https://www.frontiersin.org/journals/toxicology/articles/10.3389/ftox.2023.1183824/full]
• 30. Adverse outcome pathway networks I: Development and ... [https://academic.oup.com/etc/article/37/6/1723/7739333]
• 31. Derivation, characterisation and analysis of an adverse ... [https://www.sciencedirect.com/science/article/abs/pii/S0300483X21001797]
• 32. Adverse outcome pathway (AOP) framework for predicting ... [https://www.sciencedirect.com/science/article/pii/S0147651325010486]
• 33. Developers' Handbook 2.7 [https://aopwiki.org/handbooks/5]
• 34. From Qualitative to Quantitative AOP: A Case Study of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9006165/]
• 35. Towards a qAOP framework for predictive toxicology [https://www.sciencedirect.com/science/article/pii/S2468111321000414]
• 36. The FAIR AOP roadmap for 2025: Advancing findability, ... [https://ui.adsabs.harvard.edu/abs/2025CmTox..3500368M/abstract]
• 37. Third Party Tools [https://aopwiki.org/info_pages/8]
• 38. Development and analysis of an adverse outcome pathway network ... [https://link.springer.com/article/10.1007/s00204-019-02551-1]
• 39. Mapping Toxicity: How Few Key Events Drive Many Adverse... | Medium [https://pharmanalytics.medium.com/mapping-toxicity-how-few-key-events-drive-many-adverse-outcomes-8df1aa90eb63]
• 40. Visualize Key Event Reusability In AOPs : A Hub Analysis [https://tellqa.com/blog/visualize-key-event-reusability-in]
• 41. The connection between Bayesian networks and adverse ... [https://www.sciencedirect.com/science/article/abs/pii/S1359644625000637]
• 42. Increased Use of Bayesian Network Models Has Improved ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8573810/]
• 43. Learning Bayesian networks from incomplete data with the ... [https://www.sciencedirect.com/science/article/pii/S0888613X21001328]
• 44. A New Text-Mining–Bayesian Network Approach for ... [https://www.mdpi.com/2227-7390/10/24/4815]
• 45. Bayesian Inference of Hub Nodes Across Multiple Networks [https://pmc.ncbi.nlm.nih.gov/articles/PMC6393214/]
• 46. Aggregate exposure pathways in support of risk assessment [https://www.sciencedirect.com/science/article/abs/pii/S2468202017301432]
• 47. S15-02 New Approaches to Data and Model Integration of ... [https://www.sciencedirect.com/science/article/abs/pii/S0378427425016753]
• 48. Adverse Outcome Pathway (AOP) Coaching Program—How it ... [https://academic.oup.com/etc/advance-article-abstract/doi/10.1093/etojnl/vgaf173/8193712]
• 49. Adverse Outcome Pathways [https://www.oecd.org/en/topics/sub-issues/testing-of-chemicals/adverse-outcome-pathways.html]
• 50. Adverse Outcome Pathways and Harm Reduction [https://www.pmiscience.com/en/research/product-assessment-approach/toxicological-assessment/adverse-outcome-pathways-harm-reduction/]
• 51. Help: Getting Started [https://aopwiki.org/info_pages/2/info_linked_pages/9]
• 52. Help: KE Relationships [https://aopwiki.org/info_pages/2/info_linked_pages/2]
• 53. Reactome Pathway Database: Home [https://reactome.org/]
• 54. Pathway Diagrams [https://reactome.org/dev/diagram]
• 55. Proof of concept for quantitative adverse outcome pathway ... [https://www.nature.com/articles/s41598-024-55220-4]
• 56. FAIR Principles [https://www.go-fair.org/fair-principles/]
• 57. Next Generation Ecological Risk Assessment - HESI [https://hesiglobal.org/ecorisk/]
• 58. Interoperability Standards [https://www.apcointl.org/technology/interoperability/interoperability-standards/]
• 59. Advancing Genotoxicity Assessment by Building a Global ... [https://pubmed.ncbi.nlm.nih.gov/40785417/]
• 60. Network-based investigation of petroleum hydrocarbons ... [https://www.sciencedirect.com/science/article/pii/S0160412024007499]
• 61. Development of an adverse outcome pathway network for ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10861692/]
• 62. Kidney Injury due to Receptor-Mediated Endocytosis and ... [https://www.frontiersin.org/journals/toxicology/articles/10.3389/ftox.2022.864441/full]
• 63. Implementing AOPs use for pesticide neurotoxicity ... [https://www.sciencedirect.com/science/article/pii/S2468202024000470]
• 64. Two neurotoxicity AOP-based IATA case studies [https://pubmed.ncbi.nlm.nih.gov/34114044/]
• 65. A review of the endocrine disrupting effects of micro and nano ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9885170/]
• 66. A perfluorooctane sulfonic acid case study [https://www.sciencedirect.com/science/article/pii/S0300483X24000751]
• 67. New approach methodologies (NAMs): identifying and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10964841/]
• 68. Strategic Vision for Adopting New Approach Methodologies [https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/strategic-vision-adopting-new-approach]
• 69. Network toxicology focused investigation on the impacts of ... [https://pubmed.ncbi.nlm.nih.gov/41206757/]
• 70. Clemens Wittwehr's Post - The FAIR AOP roadmap for 2025 [https://www.linkedin.com/posts/clemenswittwehr_the-fair-aop-roadmap-for-2025-advancing-activity-7353313457242353665-h94l]
• 71. Cross-species extrapolation of chemical sensitivity [https://www.sciencedirect.com/science/article/pii/S0048969720353298]
• 72. The EPA Adverse Outcome Pathway Database (Aop-Db ... [https://assessments.epa.gov/risk/document/&deid%3D352872]
• 73. Transparency in real-world evidence (RWE) studies to ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7472869/]